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 ABSTRACT 
 
 
T.gondii is a model organism of the phylum Apicomplexa that infects one third of 
the human population. While the majority of infections are asymptomatic or manifest 
with mild flu-like symptoms, toxoplasmosis can be fatal in immunocompromised 
individuals and in the developing fetus. The lytic cycle of tachyzoite-stage parasites 
causes damage to the host by repeated rounds of host cell invasion, intracellular 
replication and lysis of the host cell upon egress. 
 
Invasion is a key step for the parasite to maintain its intracellular lifestyle. Apical 
Membrane Antigen 1 (AMA1) is an adhesin released from a unique set of secretory 
organelles called micronemes. AMA1 plays a central role in the initial stages of host cell 
invasion. Although parasites without AMA1 are viable in culture, virulence in an animal 
model of infection is completely attenuated, highlighting AMA1’s functional importance. 
AMA1 is a type I transmembrane protein with a large ectodomain and a short 
cytoplasmic tail. The ectodomain of AMA1 interacts with domain 3 (D3) of rhoptry neck 
protein 2 (RON2), which in turn complexes with RONs 4, 5, and 8 in the host cell. 
Together, this complex of proteins forms the moving junction, through which the parasite 
pushes itself during invasion. Rhomboid proteases on the parasite surface cleave AMA1 
within its transmembrane domain and parasites expressing a non-cleavable form of 
AMA1 show reduced invasion of host cells and a growth defect. While much is known 
about the ectodomain of T. gondii AMA1 (TgAMA1), the fate of the TgAMA1 
cytoplasmic tail after cleavage remains unclear, its interacting partners remain 
unidentified, and its role in invasion or thereafter remains a mystery. 
 
 To address these questions, we: (a) explored the consequences of TgAMA1-
TgRON2 interaction during invasion and (b) generated allelic replacement (AR) parasites 
with point mutations across the tail of TgAMA1 to determine the effect of these 
mutations on the parasite’s ability to invade host cells. Quantitative proteomic techniques 
were used to analyze the proteins that bind to the tail of TgAMA1 under these different 
experimental conditions. The results from this work highlight the importance of 
TgAMA1 post-translational modifications, and potentially TgAMA1-binding proteins, in 
regulating invasion-related processes in T. gondii.  
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CHAPTER 1 - COMPREHENSIVE LITERATURE REVIEW 
1.1. Phylum Apicomplexa 
The Phylum Apicomplexa consists of unicellular eukaryotic parasites of both 
vertebrate and invertebrates. Most of these parasites have a characteristic apical complex, 
which is composed of a conoid, polar rings and a set of specialized secretory organelles 
called the micronemes and rhoptries. They also have a set of longitudinal sub-pellicular 
microtubules and a plastid-derived organelle called the apicoplast [1]. The number and 
size of these organelles differ between species of this phylum.  
There are three major sub-groups of the phylum Apicomplexa - gregarines, 
coccidia and hematozoa - along with the smaller cryptosporidia sub-group (Figure 1.1). 
The causative agents of malaria, species of the genus Plasmodium, are the most well-
known parasites of this phylum because they cause over one million human deaths 
annually ([2], [3]). Another parasite of the phylum, Toxoplasma gondii is believed to 
infect one third of the world’s population [4] and the infection can be fatal in 
immunocompromised individuals and the developing fetus [4]. Cryptosporidium causes 
mild to severe diarrhea that can be debilitating in immunocompromised patients [5]. 
Parasites of the genera Theileria and Neospora cause bovine abortion and coccidiosis in 
poultry, respectively, which lead to large economic losses in the agriculture and livestock 
industry ([6], [7]).  
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1.2. Toxoplasma gondii 
1.2.1. Life cycle of T. gondii 
T. gondii undergoes a sexual cycle in its definitive feline host while the asexual 
cycle takes place in intermediate hosts that include a wide range of warm-blooded 
animals (Figure 1.2).The sexual cycle is comprised of schizogony, gametogenesis and 
zygote fusion, all of which occur in the intestine of cats in enterocytes [8].  Infected cats 
shed oocysts into the environment. Excystation takes place in the gut of intermediate 
hosts, where tachyzoites quickly invade enterocytes and cross the epithelial barrier to 
infect macrophages, dendritic cells and intra-epithelial lymphocytes. They eventually 
reach the lymph nodes and spread to all the organs in the body. These tachyzoites invade 
cells and replicate through several rounds of endodyogeny, eventually leading to host cell 
lysis [9].  Parasites invade dendritic cells (DCs), which aid in rapid dissemination [10], 
and invasion of blood monocytes along with DCs enables the parasites to reach the brain 
[11]. Parasites are observed to replicate faster in monocytes and DCs [12].  
When the infected host is immunocompetent, a strong innate immune response 
against the tachyzoites induces stage conversion to a more dormant form called 
bradyzoites, which are encapsulated in tissue cysts [13]. Infected immunocompetent hosts 
develop an effective adaptive immune response against tachyzoites but remain infected 
with bradyzoites for life. The tissue cysts can sequester in the brain (neurons), eyes, and 
skeletal or cardiac muscle cells of the infected host and remain dormant [14]. 
Differentiation of skeletal muscle myoblasts into myotubes withdraws them from the cell 
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cycle, which induces stage differentiation of tachyzoites. This makes the skeletal muscle 
cells a preferred cell type for long term persistence of cysts in intermediate hosts [14]. 
The bradyzoites within these cysts can once again convert to tachyzoites when the 
immune system of the host is compromised, due to factors like illness (e.g. AIDS), 
chemotherapy or, in rare instances, old age [15]. When the intermediate host is preyed 
upon by a cat, the life cycle is completed (Figure 1.2). Humans can either be infected by 
ingesting food and water contaminated by oocysts or by eating undercooked meat of 
other animals infected with tissue cysts. Infected mothers can also transmit the parasite 
congenitally to their developing fetus ([9], [16]). There are three major clonal lineages of 
T. gondii (I-III) with varying virulence; type I strains are the most virulent in humans 
[17]. 
1.2.2. Tachyzoites 
Tachyzoites are the fast replicating, asexual infective forms of T. gondii that 
damage host cells by lysis. They are arc-shaped and approximately 2x6μm in dimension. 
Like other eukaryotic cells, they have a nucleus and organelles such as a Golgi complex, 
mitochondria, endoplasmic reticulum and ribosomes. Morphological features unique to 
the phylum include the apical ring and polar rings (3), the conoid, rhoptries (2-11), 
micronemes (19-38), dense granules (5-17), and a micropore (Figure 1.3). A series of 
interconnected flattened vesicles (alveolar sacs) forms the inner membrane complex 
(IMC), which lies directly beneath the plasma membrane. Together, the IMC and plasma 
membrane form the triple membrane pellicle of the parasite. The IMC is discontinuous, 
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being absent at the anterior tip, micropore and at the posterior tip of the parasite. The 
anterior, open end of the IMC encircles the conoid, which is a cylindrical compressed 
spring-like structure composed of 6-8 tubulin-based filaments. Twenty-two sub-pellicular 
microtubules arise from one of the polar rings at the apical end of the parasite and run 
longitudinally just beneath the IMC, forming a cytoskeletal framework for the parasite. 
Two short microtubules of unknown function are found in the center of the conoid. The 
secretory organelles and cytoskeletal framework of the parasite contribute to successful 
invasion into host cells and establishment of a parasitophorous vacuole [18]. 
1.2.3. Toxoplasmosis 
 Up to a third of the human population globally is infected with T. gondii [4]. 
Approximately 11% of the US population is seropositive, and as many as 60% of the 
population of Europe is chronically infected [19]. T. gondii is one of 31 pathogens that 
cause 9.4 million episodes of foodborne illness in the USA, and is responsible for 8% of 
the foodborne infections requiring hospitalization and 24% of the deaths due to 
foodborne illness [20]. There have been at least two major outbreaks of toxoplasmosis as 
a result of contaminated drinking water [21]. Direct human-to-human transmission has 
not yet been reported other than from mother to fetus [22]. Infection may also be acquired 
from organ transplants [23]. 
Acquired toxoplasmosis in immunocompetent individuals is usually self-limiting 
and subclinical but may manifest with flu-like symptoms and/or lymphadenopathy [4]. 
Acquired or reactivated toxoplasmosis in immunocompromised individuals (e.g., people 
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with AIDS or undergoing cancer chemotherapy) can be life threatening [24]. The central 
nervous system is affected, with clinical manifestations such as seizures, focal motor 
deficits, cranial nerve disturbances, sensory abnormalities, movement disorders, 
hemiparesis, and speech abnormalities. Encephalitis with cerebral lesions is the most 
common manifestation but in some cases patients may have chorioretinitis, pneumonitis, 
acute respiratory failure, hemodynamic abnormalities and multi-organ involvement ([24], 
[4]).  
 Clinical signs of congenital toxoplasmosis as established by Sabin in 1942 
include hydrocephalus or microcephalus, intracerebral calcification and chorioretinitis 
[18]. Pregnant women who are seropositive to the parasite prior to pregnancy do not 
transmit the infection to the fetus; parasites cross the placental barrier only when women 
acquire their first infection during pregnancy. Infected mothers are usually asymptomatic 
but the timing of infection is inversely proportional to the potential severity of disease in 
the developing fetus. When mothers are infected early in pregnancy, it can lead to 
spontaneous abortion or death of the fetus. Mothers infected later in pregnancy usually 
give birth to a normal baby, although without treatment the baby may develop 
chorioretinitis or growth delay ([25], [4]). The chance of congenital transmission also 
depends on timing, being highest in the last trimester of pregnancy. Ocular toxoplasmosis 
from either acute or congenital infection most commonly leads to chorioretinitis, 
associated with a classic “headlight in the fog” retinal appearance which is caused by 
severe inflammatory reaction in the retina leading to its scarring. These retinal scars are 
usually areas of recurring lesions [4]. 
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Treatment for acute toxoplasmosis is usually a combination of pyrimethamine and 
sulphonamides [18]. In immunocompromised patients, folic acid is also added to the 
treatment regimen [4]. The challenge lies in the management of side effects from long 
term use of drugs and prevention of relapses, especially in infected pregnant women and 
in immunocompromised individuals [26]. Furthermore, current drugs act against the 
tachyzoite stage of the parasite but not the tissue cysts, making chronic infections 
difficult to eradicate. Also, there are no vaccines for prevention of toxoplasmosis in 
human beings. Taken together, these points highlight the need for preventive vaccines 
and better drugs with fewer side effects to effectively manage human toxoplasmosis [27]. 
1.2.4. T. gondii as a model organism 
 The ease of culturing tachyzoites in vitro combined with recent advances in 
Toxoplasma molecular genetics make T. gondii an excellent model to generate testable 
hypotheses and further our understanding of apicomplexan biology [28]. At the same 
time, it is important to be aware of the biological differences between members of this 
phylum and the question at hand must be relevant when such comparisons are made [29]. 
Stable and transient transfection protocols with several kinds of selectable markers were 
first established in T. gondii ([30], [31], [32]) and later adapted to other systems such as 
Plasmodium ([33], [34], [35]), Neospora ([36], [7], [37]) and Eimeria [38]. Gene 
replacements by double homologous recombination were made much more efficient by 
the deletion of the Toxoplasma Ku80 gene [39], which is important for non-homologous 
end joining, enabling endogenous tagging and the generation of clean knock outs [40]. A 
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variety of conditional expression systems have also been developed to study essential 
genes in Toxoplasma ([41], [42], [43]). With the advent of the Crispr-Cas9 technology, 
genetic manipulation and generation of transgenic parasites can now be accomplished in 
a very short time (7-10days) [44]. Mouse models of infection are also well established in 
T. gondii and are used to study all infective stages of the parasite [18].  
 Genes from other apicomplexan species that are less amenable to molecular 
manipulation have been expressed in Toxoplasma, in trans, to study their function ([45], 
[46], [47]). This can be extremely useful in understanding the function of genes from 
organisms like Cryptosporidium, where continuous culture is not possible. Drug target 
identification and validation has also been performed in Cryptosporidium using 
Toxoplasma as a surrogate for complementation cloning and gene expression ([48], [49]). 
The classic validation of PKG as the target of compound 1 was first done by expressing 
Eimeria PKG in Toxoplasma ([50], [51], [52]). Despite some differences in biology, 
many aspects of apicomplexan morphology, metabolism, motility and invasion are 
similar, which makes T. gondii an attractive model organism for studying these processes 
[53].  
1.3. Secretory organelles 
1.3.1. Micronemes 
 Micronemes, found at the apical end of the parasite, are small organelles that 
secrete their contents constitutively and show upregulated secretion during interaction 
with the host cell. Microneme proteins are involved in parasite motility, invasion and 
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egress. Elevation of intracellular calcium induces the secretion of micronemes [54]. 
Kinases such as TgPKG and TgCDPK1 are important for microneme secretion ([52], 
[55]), and three other proteins - TgDJ1, TgDOC2 and TgPRP1 (parafusin related protein) 
- are required for microneme secretion in a calcium-dependent manner ([56]; [57], [58]). 
After secretion, the microneme proteins associate with the parasite plasma membrane. A 
subset of microneme proteins have transmembrane domains (AMA1, MIC2, MIC6, 
MIC8, MIC12, MIC16), while others (MIC3, M2AP, MIC1, MIC4) bind to and form 
complexes with the transmembrane proteins. Three of the best studied microneme protein 
complexes in T. gondii are: the AMA1-RON complex (RONs2, 4, 5, 8); MIC2-M2AP; 
MIC6-MIC1-MIC4; and MIC8-MIC3 [59]. Disruption of microneme proteins such as 
TgAMA1, TgMIC2 and TgMIC8 cause a severe invasion defect in parasites while 
disruption of members of the TgMIC1-6-4 complex was not lethal to the parasite despite 
its role in parasite invasion ([60], [61],  [43], [62]).   
Microneme proteins have several conserved domains, including thrombospondin 
1 type I (TSR), Von Willebrand A(WVA) or integrin (I) inserted, apple/PAN, epidermal 
growth factor (EGF)-like and lectin domains, each of which is believed to dictate specific 
interaction with receptors on the surface of host cells [18].  
1.3.2. Rhoptries 
 Rhoptries are club-shaped secretory organelles at the apical end of zoites whose 
contents are secreted during invasion, after microneme secretion, into the nascent 
parasitophorous vacuole [63]. The rhoptry contents include at least 30 proteins and a 
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variety of lipids. The lipids within rhoptries are cholesterol rich and are believed to form 
vesicles that transfer rhoptry proteins to the parasitophorous vacuole membrane (PVM) 
([64], [65], [66]).  
There are two distinct sub-compartments in rhoptries, namely the rhoptry neck 
and the rhoptry bulb, each enriched in a different subset of proteins. Proteins secreted 
from the neck are called rhoptry neck proteins (RONs). The RONs function early in 
invasion in the formation of the moving junction, which is a complex of RONs2, 4, 5, 8 
and the microneme protein, AMA1 [67]. Proteins secreted from the more posterior 
bulbous part of the rhoptries are called rhoptry bulb proteins (ROPs) [64]. Toxofilin is a 
rhoptry bulb protein that secreted into host cells during invasion where it associates with 
host actin, increasing its turnover and depolymerization and facilitating host cell invasion 
([68], [69]). Following secretion, ROP proteins are found in the lumen of the 
parasitophorous vacuole (e.g., ROP1), embedded in the PVM (e.g., ROP2) or 
translocated into the host cell (e.g., ROP16) [18].  
Rhoptry proteins have a variety of enzymatic functions and activities, including 
kinases (ROP2 family, ROP5, ROP18) [70], phosphatases (PP2C) [71], and proteases. 
Mouse cells respond to parasitism by activating immunity related GTPases (IRG) to 
enable clearance. The host cell IRGs are inactivated by TgROP18, ROP5 and ROP17, 
which ensure a safe environment for the parasite to replicate within the parasitophorous 
vacuole ([72], [73]). The rhoptry proteins that reach the host cell nucleus alter host gene 
expression, including genes involved in the immune response [66]. Rhoptry proteases are 
either involved in processing of rhoptry proteins or modification of the host cell ([74], 
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[64], [75]). Overall, rhoptry proteins function in providing a favorable intracellular 
environment for the growth of the parasite within its parasitophorous vacuole [66].  
1.3.3. Dense Granules 
 Following secretion of the micronemes and rhoptries, the contents of the dense 
granules are secreted into the parasitophorous vacuole [76]. Most dense granule (GRA) 
proteins are found in the lumen of the PV, the PVM or in the tubulovesicular network 
(TVN), nanotubules that connect to the PVM [77], and are important for parasite survival 
and replication. Some, however, translocate into the host cell nucleus where they regulate 
genes involved in the pro-inflammatory response and cause growth arrest. At least 16 
GRA proteins  have been identified so far, including nucleoside triphosphate isomerases 
(NTPaseI, II), protease inhibitors (TP1, TP2) and cathepsins (TgCPC 1, 2) [78], [79]. 
GRA proteins maintain a favorable intracellular niche for the parasite and are expressed 
throughout parasite replication. Some GRA proteins are also involved in formation of the 
cyst wall during stage conversion of tachyzoites to bradyzoites [76].  
 The sequential and coordinated secretion of proteins from the micronemes, 
rhoptries and dense granules enables Toxoplasma to establish infection and then grow 
and replicate within its intracellular niche.  
1.4. Host cell invasion 
The lytic cycle of tachyzoites involves host cell invasion, replication and egress 
(Figure 1.4). I focus here on invasion. Host cell invasion involves attachment, formation 
of a moving junction, penetration of the parasite into the host cell, and pinch off of the 
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PVM. Extracellular parasites are capable of crossing biological barriers and invade host 
cells using substrate-dependent gliding motility that is powered by the parasite’s motor 
complex. The motor complex is composed of MyosinA, its light chains (MLC1, ELC1, 
ELC2), and glideosome-associated proteins (GAP45, GAP40, GAP50, GAPM) [80]. The 
motor complex is tethered to the IMC1 via the GAP proteins ([81], [80]). In a three-
dimensional environment, tachyzoites exhibit corkscrew-like trajectories that are 
markedly different from the helical, twirling or circular gliding seen on two-dimensional 
glass coverslips ([82], [83]).  
In an extracellular tachyzoite, adhesins are secreted onto the plasma membrane 
from the micronemes. The cytoplasmic tails of these adhesins interact through an 
unidentified connector protein with short actin filaments within the parasite, which are 
displaced rearwards by the motor complex causing the parasites to move forward [84]. It 
was thought that the connector protein that linked the adhesin tails to the actin filaments 
was aldolase [85] but this was recently disproven [86]. Turnover of microneme adhesins 
takes place when they are cleaved by rhomboid proteases on the parasite surface [59]. 
Even though motor complex-dependent motility is considered important for invasion, 
parasites that are unable to glide are still able to invade, highlighting the possible 
existence of other myosin-independent mechanisms in invasion [87]. 
The surface of tachyzoites is decorated with GPI-anchored surface antigens (SAG 
proteins) that are deposited as trails behind the parasite as it glides. SAG proteins bind to 
sulfated proteoglycans on the surface of host cells, functioning in initial attachment [88]. 
Parasites pre-treated with anti-SAG1 antibody and mutant SAG1-deficient parasites had 
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an attachment defect, supporting a role for SAG1 in establishing initial contacts with the 
host cell ([88], [89]).  
Following initial attachment, the parasite engages in intimate attachment with the 
host cell by deploying TgAMA1 and members of the TgRON protein complex [90]. 
TgRON2 interacts directly with TgAMA1, and other TgRONs in the complex engage 
with cytoskeletal components of host cells ([91],[92]) (Figure 1.5). The interaction of 
TgAMA1 with members of the TgRON complex commits the parasite to invasion by 
formation of a moving junction through which the parasite penetrates into the host cell 
[93]. In addition to serving as a point of purchase for the invading parasite, the moving 
junction acts as a molecular sieve and prevents host cell transmembrane proteins and 
proteins in lipid rafts from diffusing into the forming PVM. This makes the vacuole non-
fusogenic with the host endolysosomal system [94]. Following secretion of micronemal 
proteins, rhoptry and dense granule proteins are secreted and function in the formation 
and maturation of the PVM and manipulation of host cell signaling and gene expression 
[9].  Host genes that are manipulated by the parasite and are important for its intracellular 
survival include those involved in regulation of cell death (e.g., hypoxia-inducible-factor 
1 (HIF1), and those genes involved in providing nutrients to the growing parasite 
(glucose transporter, glycolytic transcripts) [95]. Host cell genes such as twinfilin2, 
phospho-histidine phosphatase 1, mitogen activated protein kinase 7, myosin light chain 
interacting protein, protein tyrosine phosphatase receptor R, and peptidylprolyl isomerase 
2, which are important for maintaining host cell actin dynamics, also play an important 
role during invasion of parasites [96]. 
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1.5. Apical Membrane Antigen 1 (AMA1)  
1.5.1. Structure of AMA1 
 AMA1 is composed of a large N-terminal ectodomain, one transmembrane 
domain and a short cytoplasmic tail [97]. The ectodomain of TgAMA1 was expressed 
using the baculovirus expression system in insect cells, purified and crystallized [98]. The 
ectodomain has three structural sub-domains: domain I (DI) from Thr
67
 to Pro
287
, DII 
from Asn
288
 to Asn
415
 and DIII from Phe
416
 to Ala
487
. The ectodomain of AMA1 in 
Toxoplasma has 16 conserved cysteine residues that form disulfide bonds, and most of 
these residues are highly conserved across the apicomplexan phylum [99]. The 33 residue 
DII loop is found next to DI and has a disulfide bond to stabilize its positioning (Figure 
1.6). This loop acts as a structural gatekeeper, conferring selectivity in ligand binding to 
the ectodomain of AMA1 [100]. 
 Domain 3 of TgRON2 was identified as the region of TgRON2 to which 
TgAMA1 binds [101]. A synthetic cyclized peptide of TgRON2 containing the 
TgAMA1-binding residues, named TgRON2-2, was used for co-crystallization with 
TgAMA1 [102]. In the absence of TgRON2-2, the DII loop of AMA1 was found at the 
base of a hydrophobic groove. The DII loop of AMA1 was displaced by TgRON2-2, 
exposing a basic groove in TgAMA1 to which the U-shaped, acidic TgRON2-2 peptide 
binds tightly (Figure 1.7). Individual residues on each of the proteins important for 
binding were identified by a combination of structural prediction and molecular genetic 
manipulation [102]. 
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1.5.2. Rhomboid proteases and AMA1 
 Rhomboids were first identified as intramembrane proteases in Drosophila and 
shown to play a role in epidermal growth factor receptor (EGFR) signaling between cells 
[103]). They were subsequently identified in E.coli, where they are required for 
activation of quorum sensing [104]. In Saccharomyces cerevisiae, rhomboid proteases are 
localized to mitochondrial membranes where they are required for membrane fusion 
[105]. The largest number of rhomboid proteases is present in plants, where they function 
in mitochondria, chloroplasts, and the secretory pathway ([105], [106]). Mammalian cells 
have 14 classes of rhomboid proteases which are involved in trafficking, growth factor 
activation and degradation of membrane proteins [107]. Finally, parasites such as 
Toxoplasma (6) and  Plasmodium (8) were found to express rhomboid proteases which 
cleave adhesins and are involved in the invasion process [106]. In Entamoeba, rhomboid 
proteases are involved in migration and motility [108]. 
 Rhomboid proteases are transmembrane proteins [109] and behave quite 
differently from aqueous proteases when it comes to substrate identification, cleaving 
membrane proteins within their transmembrane domains. It is the membrane, rather than 
specific recognition sites on substrates, which control the gate dynamics of rhomboid 
proteases, keeping the TM helices of the substrate stable and the rhomboid gate closed, 
thereby inhibiting cleavage. Changes in substrate hydrophobicity and helix 
destabilization induce partial exposure into the aqueous environment, which allows the 
substrate to move into the catalytic active site of the rhomboid protease for cleavage 
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[110].   
 There are six rhomboid proteases in T. gondii. TgROMs1, 4, 5 are expressed in 
tachyzoites, TgROM4 in bradyzoites and TgROMs1-3 in sporozoites. TgROM6 is 
predicted to be in mitochondrial membranes and is basally expressed in tachyzoites and 
bradyzoites (Toxodb) [111]. Of the rhomboids expressed in tachyzoites, TgROM1 
localizes to the micronemes and mitochondria, TgROM4 is present in the plasma 
membrane and TgROM5 is also in the plasma membrane but concentrated at the basal 
end of the parasite ([112], [113]). Clean knockout studies of all three ROMs in 
tachyzoites revealed that, while they are not essential genes, they are important for host 
cell attachment and invasion [114]. TgROM4 was identified as responsible for the 
majority of intramembrane cleavage of microneme adhesins ([109], [114]). Mutational 
studies showed that when TgAMA1 cleavage was inhibited, parasites had an invasion 
and growth defect [115]. The precise function of rhomboid protease-mediated cleavage of 
micronemal adhesins remains unknown, but it may be involved in maintaining an 
anterior-to-posterior gradient of adhesins on the surface of the parasite [112].  
1.5.3. Role of AMA1 in invasion 
 The identification of TgAMA1 in T. gondii was based on its homology to 
Plasmodium AMA1. TgAMA1 was shown to be proteolytically cleaved and secreted by 
parasites in a calcium-dependent manner ([97],[116]). When parasites were treated with 
antiserum raised against recombinant TgAMA1, they had a 40% defect in invasion.  This 
combined with the inability to generate a parasite lacking TgAMA1, suggested that 
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TgAMA1 was an essential protein required for invasion ([116],[97]). A conditional 
TgAMA1 knockdown parasite was generated using the Tet-repressible system and this 
parasite had both an invasion defect and a defect in rhoptry secretion. The parasites 
lacking TgAMA1were able to attach to host cells but the attachment was not tight enough 
to allow for successful invasion [60]. TgAMA1 was later identified as a binding partner 
of TgRON2 and a component of the moving junction during invasion. TgRON2 is a 
transmembrane protein that forms a complex with RON4, 5, and 8, which is inserted into 
the host cell and interacts with the host cell cytoskeleton ([67], [93], [90], [117], [118], 
[91], [119], [120], [101], [121], [92]). Soon after the crystal structure of AMA1 was 
elucidated, the co-crystal structure of TgAMA1 with TgRON2 mapped the sites of 
interaction ([98], [102]). The high affinity interaction between AMA1 and RON2 led to 
the development of a high-throughput small-molecule screen to identify small molecules 
that would disrupt this interaction [122]. AMA1 has gained much attention over the years 
as a malaria vaccine candidate. It was shown recently that the TgAMA1-TgRON2 
complex was immunogenic and protective during a P. yoelii challenge in mice [123].  
 A clean knockout of TgAMA1 was generated using an inducible di-Cre system 
[62]. Despite a severe attachment defect, parasites lacking TgAMA1 were viable and 
those that could invade showed normal invasion kinetics with moving junction formation 
[62]. Nevertheless, the importance of TgAMA1 was re-established when the parasites 
lacking TgAMA1 were shown to be completely avirulent in an animal model of infection 
[124]. Furthermore, after 12 months of continuous culture, invasion of the TgAMA1 
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knockout parasites increased from 10% of wild-type levels to 20%. It was shown that in 
the absence of TgAMA1, another AMA isoform named TgAMA2 was upregulated 
(three-fold expression compared to the unselected parental line) and was able to interact 
with TgRON2 and functionally compensate for the absence of AMA1. In the absence of 
both TgAMA1 and TgAMA2, parasites still retained some residual invasion ability, and 
this was shown to be mediated through TgRON2L1, a homologue of TgRON2. 
TgRON2L1 did not bind to TgAMA1, TgAMA2 or TgAMA3. Instead it bound to yet 
another AMA isoform, TgAMA4, which was also upregulated in the AMA1 null parasite 
line (Figure 1.8) [125]. These data highlight both the importance of the AMA family of 
proteins to the parasite and the ability of parasites lacking AMA1 to compensate for its 
absence.  
1.5.4. The cytoplasmic tail of AMA1 
 The cytoplasmic tail of TgAMA1 is comprised of 63 amino acids with no 
recognizable domains or motifs and is not required for proper trafficking of TgAMA1 to 
micronemes [59]. In P. faciparum, the cytoplasmic tail of PfAMA1 was shown to be 
important for invasion ([126], [127]). The tails of P. vivax and P. berghei AMA1 can 
functionally substitute for the tail of PfAMA1, whereas the cytoplasmic tails from other 
microneme proteins cannot. The cytoplasmic tail of PfAMA1 was shown to be 
phosphorylated by PKA at position 610, and mutating this site to alanine caused an 
invasion defect ([126], [127]). Interestingly, in T. gondii, the residue corresponding to 
S610 is a negatively charged aspartic acid (D558). The tail of TgAMA1 is also known to 
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be phosphorylated, but on S527 and S537 [128]. Mutation of F546 and W547 near the C-
terminus of TgAMA1 to alanines dramatically reduced invasion ([59], [93]) through as 
an yet unknown mechanism [86]. The exact functional role of the cytoplasmic tail of 
AMA1 in any apicomplexan parasite remains to be determined. 
1.5.5. AMA1 as a vaccine candidate 
 The ability of AMA1 from Plasmodium species to illicit an immune response 
made it a potential vaccine candidate [129]. People naturally exposed to Plasmodium 
parasites or those who have had an infection have higher levels of antibodies against 
AMA1 and seropositivity increases with age [129]. These antibodies mainly recognize 
the DII and DIII regions on the ectodomain of AMA1. The antibodies against AMA1 
usually belong to sub-types IgG1 and IgG3 ([130], [131]).  Twenty two out of twenty six 
studies that used AMA1 from different Plasmodium species in vaccine trials using animal 
models were protective during a challenge with blood-stage Plasmodium parasites [132]. 
From these studies it was evident that vaccines with Plasmodium-derived AMA1 were 
immunogenic and protective, provided AMA1 was properly folded, but the inhibitory 
effect was species- and strain-specific [132]. The most antigenic regions of PfAMA1 are 
also regions of polymorphisms, which limits the use of PfAMA1 as a vaccine candidate 
to induce broad protective immunity. There are a total of 64 polymorphic positions in 
PfAMA1 with 9 in DI, 32 in DII, 11 in D3 and nine in the cytosolic region of 
PfAMA1[133]. Specific polymorphisms on PfAMA1 also influenced morbidity after 
infection [134]. Like PfAMA1, PvAMA1is also polymorphic but the areas of 
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polymorphisms differ from PfAMA1. In order to account for polymorphisms, current 
vaccines in trial contain more than two allelic forms of AMA1 [132]. 
1.6. Brief summary of dissertation 
 In order to understand the function of the cytoplasmic tail of TgAMA1, knock-
in parasites containing amino acid substitutions on the cytoplasmic tail of TgAMA1 were 
generated and analyzed for their ability to invade host cells. SILAC mass spectrometry 
was used to determine if these amino acid substitutions could cause proteins to interact 
differentially with the TgAMA1 cytoplasmic tail (Chapter 3). We showed that interaction 
of TgAMA1 with TgRON2 affects the cleavage of TgAMA1 by rhomboid proteases and 
leads to a decrease in phosphorylation of S527 on the TgAMA1 cytoplasmic tail (Chapter 
4), which may influence what parasite proteins bind to the tail. Finally, we showed that 
TgAMA1 is palmitoylated within its transmembrane region at C504 and knock-in 
parasites containing a point mutation, C504S, were characterized phenotypically (Chapter 
5). 
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Figure 1.1: Evolutionary tree of the Phylum Apicomplexa 
 
The Phylum Apicomplexa consists of gregarines, hematozoa and coccidia. Cryptosporidia are considered to 
originate from gregarines. Toxoplasma gondii forms cysts and belongs to the coccidian clade. The number 
and thickness of branches indicates diversity among the named species. Adapted with permission from 
Šlapeta, Jan and Victoria Morin-Adeline. 2011. Apicomplexa Levine 1970. Sporozoa Leucart 1879. 
Version 18 May 2011. http://tolweb.org/Apicomplexa/2446/2011.05.18 in The Tree of Life Web Project, 
http://tolweb.org/. © Jan Slapeta 
 
 
 
  
21 
 
Figure 1.2: Life Cycle of T. gondii. 
The sexual cycle of the parasite takes place in cats, which are the definitive hosts that shed oocysts. These 
oocysts are ingested by a wide range of warm-blooded intermediate hosts, including humans. The asexual 
lytic cycle takes place in these intermediate hosts and, after an immune response develops, the tachyzoites 
differentiate into tissue cyst forms called bradyzoites. When infected intermediate hosts such as rodents are 
preyed upon by cats, the cycle is complete. Adapted with permission from Macmillan Publishers Ltd: 
Nature Reviews Microbiology November; 10(11): 766–778. doi: 10.1038/nrmicro2858. © 2012 
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Figure 1.3: Intracellular organelles of Toxoplasma gondii 
 
Most apicomplexans have an apical complex with a conoid, polar rings and secretory organelles. Secretory 
organelles unique to members of phylum Apicomplexa include micronemes, rhoptries and dense granules. 
They also have an organelle of red-algal origin called the apicoplast. All alveolates have an inner 
membrane complex just beneath the plasma membrane. The infective asexual form, the tachyzoite, is 
represented in this image. Adapted with permission from J. P. Dubey et al. Clin. Microbiol. Rev. 1998; 
11:267-299. © 1998, American Society for Microbiology.  
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Figure 1.4: The lytic cycle of T. gondii 
The asexual lytic cycle of parasites involves invasion of tachyzoites into host cells, multiple rounds of 
replication and egress into the extracellular environment. The motor complex in tachyzoites (see text) 
powers essential processes such as invasion and egress. Image used with permission from Annu. Rev. 
Microbiol. 2015. 69:463–85 © 2015 by Annual Reviews. 
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Figure 1.5: TgAMA1-RON complex at the moving junction of T. gondii 
The ectodomain of TgAMA1 interacts with TgRON2 which in turn complexes with TgRONs2, 4 and 8, 
proteins secreted by the parasite into the host cell. Together, these proteins form the tight or moving 
junction, which provides traction for the invading parasite. From Science 22 July 2011:Vol. 333 no. 6041 
pp. 463-467. Reprinted with permission from AAAS. 
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Figure 1.6: The crystal structure of TgAMA1 
The ectodomain of TgAMA1 has 3 conserved domains, DI-DIII, N-terminal to a single transmembrane 
domain and a short cytoplasmic tail composed of 63 amino acids.  
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Figure 1.7: Binding of TgRON2 to TgAMA1 
Binding of TgRON2 displaces the DII loop of TgAMA1, exposing a basic patch complementary to the 
acidic patch on TgRON2 D3. From Science 22 July 2011:Vol. 333 no. 6041 pp. 463-467. Reprinted with 
permission from AAAS. 
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Figure 1.8: Functionally redundant AMA-RON complexes in T. gondii 
TgAMA1 forms the moving junction with the RON complex through interaction with TgRON2. Disruption 
of TgAMA1 led to upregulation of TgAMA2 whose interaction with TgRON2 is less stable than with 
TgAMA1. TgAMA2 was still able to form a functional moving junction through interaction with members 
of the RON complex. In the absence of TgAMA2 and TgAMA1, TgAMA4 was found to interact with 
TgRON2L1. Reprinted by permission from Macmillan Publishers Ltd: Nature Communications (DOI: 
10.1038/ncomms5098) © 2014 
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CHAPTER 2- METHODS 
2.1. Host cells and Parasite culture 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10mM 
HEPES, 10 units/ml  Penicillin, 10 units/ml  Streptomycin sulphate and 10% FBS at pH 
7.2 was used to grow human foreskin fibroblasts (HFFs; ATCC CRL-1643) at 37°C with 
5% CO2  and humidity. All wild-type and allelic replacement parasites were grown in 
HFFs maintained in DMEM with 1% FBS [1]. AMA1 conditional knockdown parasites 
[2] were maintained in DMEM with 1% FBS and mycophenolic acid (25μg/ml), xanthine 
(50μg/ml), pyrimethamine (1μM) and chloramphenicol (20μM). Thirty-six hours before 
experiments with the AMA1 conditional knockdown parasites, infected monolayers were 
switched to media containing the above-mentioned drugs for selection plus 1.5 μg/ml 
anhydrotetracycline (ATc) [2].  
Parasites were harvested from large intracellular vacuoles for all experiments. The 
monolayer was detached from the flask using a cell scraper, and parasites were forced out 
of the parasitophorous vacuole by syringe release using a 26 gauge hypodermic needle. 
Host cell debris was removed by filtering through a sterile 3µM Nuclepore (Whatman) 
filter. Unless otherwise indicated, parasites were then centrifuged at 2500 rpm at 25°C for 
four minutes, resuspended in media and used for the designated experiment. . 
2.2. Molecular biology 
2.2.1. Quick Change site-directed mutagenesis 
Point mutations on the cytoplasmic tail of TgAMA1 were introduced using the 
Quick Change II site-directed mutagenesis kit from Agilent Technologies (catalog # 
  
40 
200523). Primers containing the codon substitutions for the desired mutations were 
generated using the online tool 
(http://www.genomics.agilent.com/primerDesignProgram.jsp). With pA/TgAMA1
WT
 
Flag.BLE plasmid as a template, linear amplification without primer displacement was 
performed using designed primers in the presence of a high fidelity polymerase such as 
Pfu Ultra. The nicked linear amplification product was digested overnight with DpnI at 
37°C to remove methylated parental template followed by transformation into competent 
DH5α E.coli cells (Figure 2.1). The transformants were plated onto LB plates containing 
ampicillin. The colonies were then isolated and plasmid was extracted from an overnight 
culture using the Promega Wizard Plus miniprep kit. Sanger sequencing using primers 
that cover the open reading frame of TgAMA1 was performed to confirm the presence of 
the mutation at the desired position. The primer sets that were used to generate point 
mutations across the cytoplasmic tail of TgAMA1 are listed in Table 2.1. The advantage 
of this method is its simplicity. The primers do not have any extra modifications and up 
to seven adjacent point mutants can be inserted using the same primer set. 
2.2.2. Around the horn / phusion site directed mutagenesis 
Some point mutations were challenging to generate on the template 
pA/TgAMA1
WT
 Flag.BLE using the Quick Change method, in which case around the 
horn (ATH) mutagenesis was used instead. In this method, 5’phosphorylated primers 
were designed around the desired point mutation. The forward primer with the desired 
codon substitution annealed at the site of the point mutation and the reverse primer 
annealed one base to the left of the substitution site in the opposite direction. The 
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amplicons containing phosphorylated ends were then ligated with T4 DNA ligase and 
transformed into E.coli. The parental template was digested using DpnI prior to the 
ligation step remove methylated parental DNA. A high fidelity polymerase, Phusion, was 
used to avoid random mutations. Like conventional PCR, millions of copies of the 
amplicons containing the desired mutations can be generated and, even though this 
method requires phosphorylated primers that are more expensive than conventional 
primers, the efficiency of generating a vector with a desired point mutation, insertion or 
deletion is higher than Quick Change site-directed mutagenesis. A schematic for this 
method is shown in Figure 2.2 and the phosphorylated primers used to generate point 
mutations are listed in Table 2.1. 
2.2.3. Screening parasite clones by PCR  
 A schematic of double homologous recombination at the endogenous TgAMA1 
locus using the pA/TgAMA1
WT
 Flag.BLE vector is presented in Figure 2.3. The primer 
pairs used to check for integration at the correct locus are listed in Table 2.2. Parasites 
were harvested as described above and resuspended in DNAzol (Invitrogen#10503-027) 
for lysis. The DNA was precipitated with 100% ethanol and centrifuged at 6000 rpm for 
six minutes. The pellet was washed with 75% ethanol and resuspended in 8mM sodium 
hydroxide. The DNA was allowed to dissolve from the pellet at 55°C for 10 minutes. The 
pH was adjusted back to 7 using 1M HEPES. The DNA was further purified by ethanol 
precipitation with 0.1 volume of 3M sodium acetate at pH 5.3 and 2.5 volumes of 100% 
ethanol. This mix was incubated on ice for ten minutes followed by centrifugation at 
15000 rpm for 30 minutes. The pellet was washed twice with 75% ethanol and then 
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resuspended in autoclaved double distilled water. A template concentration of 
approximately 10µg/µl DNA resulted in successful amplification of the desired product. 
The PCR was set up using standard Taq polymerase conditions and the primer pairs 
shown in Figure 2.3. The PCR products were then checked for size on 1% agarose gel. 
 
2.3. Parasite Protocols 
2.3.1. Parasite transfections and selections 
Phleomycin-resistant parasites either containing wild-type or mutant TgAMA1 at 
its endogenous locus were generated using the vector pA/TgAMA1
WT
 Flag.BLE [2]. 
Quick Change or ATH mutagenesis was used to introduce the desired point mutation(s) 
into the TgAMA1 allelic replacement construct using the primers listed in Table 2.1. The 
vector was then double digested with XhoI and SacI restriction endonucleases, ethanol 
precipitated and resuspended in cytomix (120mM KCl, 0.15mM CaCl2, 10mM potassium 
phosphate at pH 7.6, 25mM HEPES-KOH at pH 7.6, 2mM EDTA and 5mM MgCl2) for 
transfection into Δku80ΔHXG strain parasites. Parasites were harvested for transfection 
as described in Section 2.1, resuspended in cytomix containing fresh 100mM ATP and 
500mM reduced glutathione, and mixed with the purified digested vector. The parasites 
were electroporated at 25µFD, 1.55 and 25Ω using the BioRad gene pulser and allowed 
to rest at room temperature for 15 minutes before infecting a fresh monolayer. After lysis 
of the monolayer or 48 hours post-transfection, the parasites were selected twice with 
50µg/ml phleomycin and maintained in 5µg/ml phleomycin until cloning by limiting 
dilution [2]. 
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2.3.2. Indirect immunofluorescence 
All allelic replacement lines were tested for localization of the introduced 
TgAMA1 by indirect immunofluorescence (IFA) on either extracellular or intracellular 
parasites. For IFAs using intracellular parasites, confluent monolayers of HFFs on 25mm 
circular glass coverslips were infected with either wild type or mutant parasites for 12 
hours, after which they were fixed with 2.5% (v/v) paraformaldehyde and permeabilized 
with 0.25% (v/v) Triton X-100 in PBS for 15 minutes each. After blocking the coverslips 
with 1% BSA in PBS for 30 minutes, parasites were probed for TgAMA1 with mouse 
anti-Flag (Sigma F3165) at 1:1000 dilution and for TgGAP45 with rabbit anti-TgGAP45 
(a generous gift from Con Beckers) at 1:1000 dilution for 15 minutes followed by 1:1000 
dilution of goat anti-mouse AlexaFluor 488 (Invitrogen# A11034) or goat anti-rabbit 
AlexaFluor 546 (Invitrogen # A11003) for 15 minutes.  Some parasites were probed for 
TgIMC1 with rabbit anti-TgIMC1 [3] at 1:1000 dilution instead of TgGAP45. The 
coverslips were mounted on glass slides and imaged using the 100x objective of a Nikon 
eclipse TE 300 epifluorescence microscope. 
For IFA with extracellular parasites, host cell debris was removed from parasite 
suspensions by filtration before attachment of the parasites to glass coverslips. All 
incubations were done at room temperature. Coverslips were pre-treated for 20 minutes 
with BD Cell-Tak (BD#354241) in 100mM fresh sodium bicarbonate at pH 8.0. Parasites 
were allowed to adhere to the Cell-Tak-treated coverslips for twenty minutes, fixed with 
4% (v/v) paraformaldehyde for 15 minutes, permeabilized with 0.25% (v/v) TX-100 for 
15 minutes and blocked with 1% BSA in PBS for 30 minutes. The fixed and 
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permeabilized parasites were then probed with the primary and secondary antibodies 
described above and mounted onto glass slides for epifluorescence imaging.   
2.3.3. Immunoblotting 
 Ten parasite clones from a 96-well plate were pooled, washed in 4 °C PBS at 
2000g for 4 minutes, extracted in 1x Laemmli sample buffer (50mM Tris-HCl, pH 6.8, 
2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) β-ME, 12.5mM EDTA, 0.02% (w/v) 
bromophenol blue), run on 12% SDS PAGE gels and transferred onto PVDF membranes 
using a semi-dry transfer apparatus (Fisher) at 65mA / gel for 1.45 hours. The blots were 
blocked overnight with Odyssey blocking buffer (LI-COR) and incubated with mouse 
anti-Flag (1:7500; Sigma) and rabbit anti-TgMLC1 (1:1000, generous gift from Con 
Beckers) for one hour followed by incubation with LI-COR secondary goat-anti mouse 
(IR680RD #926-68070) and anti-rabbit (IRdye800CW# 9263211) antibodies at 1:15000 
dilution for one hour. The blots were scanned using a LI-COR Odyssey Imaging System 
CLx, and band intensities were quantified using Image Studio version 2.0 software. Five 
individual clones were chosen from each allelic replacement line for a Flag Western blot 
to check Flag TgAMA1 expression levels.  
2.3.4. Plaque assay 
Parasites in large intracellular vacuoles were harvested, resuspended in DMEM 
with 1% FBS, counted, and added to a 12-well plate containing confluent HFF 
monolayers (50 parasites/well). The plate was allowed to incubate for 7 days in a 37°C 
incubator with 5% CO2 and humidity, and then stained with 2% crystal violet and 20% 
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methanol in PBS for five minutes at room temperature. The wells were then washed with 
water and the number of plaques per well was counted. For the plaque assays comparing 
the ARAMA1
WT
 and ARAMA1
C504S
 parasites, a total of eleven biological replicates were 
done, each in triplicate. In order to account for day-to-day variation, a linear mixed model 
with ANOVA was applied to the dataset to test for significance. 
2.3.5. Microneme Secretion Assay  
This assay was performed as described [4] with minor modifications. Briefly, 
parasites were harvested, pelleted at 1000g for eight minutes at 4°C and counted. 
Approximately 2x10
8
 parasites were resuspended in 50µl of microneme secretion media 
containing 2% w/v ovalbumin and 1% FetalPlex (Gemini Bio-products) in DMEM 
without FBS. GST and GST-D3 peptides (a generous gift from John Boothroyd) were 
prepared as 2 µM stocks in HBSS, and 50ul of stock was added to the parasite suspension 
so that the final concentrations of ovalbumin, FetalPlex and peptides were 1%, 0.5% and 
1μM respectively. Following incubation at 37°C for 30 minutes with CO2, parasites were 
placed on ice for 5 minutes and centrifuged at 1200g for 5 minutes. The pellet fraction 
was separated from the supernatant and each was dissolved in Laemelli’s sample buffer 
for analysis by Western blot. For the constitutive secretion assays with TgRON2-2, the 
assay medium was DMEM with 1% dFBS and 20mM HEPES and the total volume of 
parasites and peptide was 120µl [5]. For the microneme secretion assay with AMA1 
conditional knockdown parasites, the secretion media used was HBSS with 100mM 
HEPES and the parasites were incubated in a 37°C water bath for 15 minutes. The 
volume of the pellet fraction loaded in all cases corresponded to half the volume of the 
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supernatant fraction. Immunoblotting was performed as described above, with the 
following primary antibodies: anti-mouse TgMIC2 at 1:10,000 (generous gift from Vern 
Carruthers), mouse anti-Flag at 1:10,000 and rabbit anti-TgMLC1 at 1:1000 in Odyssey 
LI-COR block buffer. TgAMA1 and TgMIC2 band intensities in the pellet fractions were 
normalized to the TgMLC1 signal, and a ratio of the signal intensities for each of the 
proteins in the supernatant and pellet fractions calculated and plotted using Graph Pad 
Prism 6.  
2.3.6. Flow cytometry 
Parasites were harvested and resuspended in motility buffer (1xMEM, 1% FBS, 
10mM Glutamax, 10mM HEPES pH 7) or microneme secretion media with 1% 
ovalbumin and 0.5% FetalPlex. Approximately 3x10
7
 parasites were incubated with 
either GST or GST-D3 at 37°C on a nutator for 30 minutes. Parasites were prepared for 
flow cytometry as described in [6]. Briefly, after treatment, parasites were fixed using 4% 
paraformaldehyde in PBS for 20 minutes on ice. Parasites were washed 3x times in 
blocking buffer (1% w/v BSA, 1% v/v goat serum in PBS) and blocked for 20 minutes. 
Parasites were then incubated with 1:750 dilution of mouse anti-Flag, 1:500 dilution of 
rabbit anti-GST (ICL Antibodies #RGST-45A-Z) or 1:200 dilution of rabbit anti-SAG-
FITC (Abcam #ab20907) for 15 minutes. After four washes at 1000g for two minutes 
each, parasites were incubated with goat-anti-mouse AlexaFluor 546 or goat anti-rabbit 
AlexaFluor 488 secondary antibody at 1:500 dilution for 15 minutes. Parasites were 
washed four times and resuspended in 200 µl of blocking buffer. A MACS quant VYB 
from Miltenyi Biotech was used to count parasites using the Y1A channel and B1A 
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channel for AlexaFluor546 and 488 respectively. FlowJo_V10 was used to generate the 
scatter plots and the histograms. 
2.3.7. Invasion assay using laser scanning cytometry 
The two color invasion assay was done as described in [7] with minor 
modifications. Briefly, parasites in large intracellular vacuoles were harvested and 3 ml 
of parasite suspension at 1x10
6  
parasites/ml was used to infect confluent monolayers of 
HFF cells on 25mm coverslips in a 6-well plate. The parasites were allowed to settle onto 
the coverslips at room temperature for 20 minutes and then incubated at 37°C for 1 hour. 
The cells and parasites were then fixed with 3.1% paraformaldehyde, 0.06% 
glutaraldehyde in PBS for 30 minutes and blocked with 2% BSA in PBS for 1 hour. The 
extracellular parasites were stained with mouse monoclonal anti-SAG1 (αP30, Argene 
#11-132) at a dilution of 1:250, followed by goat anti-mouse R-phycoerythrin at 1:400 
dilution. The cells and parasites were then permeabilized with 0.25% TX-100 for 30 
minutes followed by blocking for an hour with 2% BSA in PBS. Extracellular and 
intracellular parasites were stained with mouse monoclonal anti-SAG1 antibody followed 
by 1:200 dilution of anti-mouse AlexaFluor 647. The coverslips were mounted on glass 
slides and the numbers of intracellular parasites were counted using a laser scanning 
cytometer. Every biological replicate was performed in duplicate. A student’s t-test was 
applied to the mean from biological replicates.  
The ARAMA1
WT
 and ARAMA1
C504S
 parasites were also allowed to invade: (a) 
for one hour at 37°C after sitting extracellularly for five hours at room temperature; and 
(b) for various times at 37°C ranging from 0 minutes to 4 hours.   
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2.3.8. Live imaging of parasite invasion  
 Two days prior to the experiment, an eight-well chamber coverglass (Nunc) was 
seeded with HFF cells. On the day of the experiment, parasites from a heavily infected 
flask with large intracellular vacuoles were harvested and resuspended at 1x10
8
 parasites 
/ 100ul in Endo buffer (44.7mM K2SO4, 10mM MgSO4, 106mM sucrose, 5mM glucose, 
20mM Tris H2SO4 and 3.5mg/ml BSA at pH 8.2; [2]). The parasites were allowed settle 
onto host cells (300μl/well) for about seven minutes on a heated stage maintained at 
37
°
C. The Endo buffer was then replaced with prewarmed motility buffer (1xMEM, 1% 
FBS, 10mM Glutamax, 10mM HEPES pH 7). Invasion was imaged at 100× 
magnification on a Nikon Eclipse TE300 inverted microscope under low-light conditions 
using differential interference contrast optics. Time-lapse images were captured using an 
iXon3 885 EMCCD camera (Andor) driven by NIS-Elements software (Nikon). The 
penetration time of individual invading parasites was measured as the time from first 
appearance of the constriction in the parasite membrane to its disappearance at the 
posterior end of the parasite. 
 
2.3.9. Parasite replication assay 
ARAMA1
WT
 and ARAMA1
C504S
 parasites were harvested and resuspended in 
DMEM with 1% FBS.  Parasites were counted and 5x10
5
 parasites were added to 
confluent monolayers of HFF cells on 25mm coverslips. At 14 hours post-infection, 
coverslips were fixed on ice with 100% cold methanol for 5 minutes. Indirect 
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immunofluorescence was performed using anti-TgGRA8 [8] (cite Carey GRA6/8 paper) 
and anti-TgGAP45 antibodies as previously described [8]. A total of three biological 
replicates were performed, each in triplicate, and 250 vacuoles were counted per 
coverslip. Two-way ANOVA with Sidak’s multiple comparisons test was performed as a 
test for significance. In a variation on this assay, harvested parasites were allowed to sit at 
room temperature in DMEM with 1% FBS for 4 hours prior to adding them to the HFF 
monolayers for the 14 hour replication assay.  
2.3.10. Parasite motility assay 
A 384-well Falcon Optilux plate (#353962) was coated with Cell-Tak for 20 
minutes at room temperature. The wells were washed with 1x PBS three times and 50µl 
of freshly harvested parasites at 1.5x10
7
 parasites/ml were added. Positive and negative 
control wells were supplemented with small molecule enhancers and inhibitors of 
motility, respectively [5]. The parasites were allowed to glide and deposit trails for 30 
minutes in a 37°C water bath. The samples were fixed with 2.5% (v/v) paraformaldehyde 
for ten minutes at room temperature. They were then gently washed with PBS and 
blocked for 30 minutes with 2% BSA in PBS followed by incubation with FITC-
conjugated rabbit anti-SAG antibody at 1:200 dilution. The wells were washed again 
gently with PBS and scored using an inverted epifluorescence microscope. The number 
and length of trails generated by wild-type parasites were scored as 0, by parasites with 
motility enhancer 130038 (10µM) as +2 and by parasites with motility inhibitor 112762 
(10 µM) as -2. Scoring on a 5 point scale (+2, +1, 0. -1, -2) was done blind two separate 
times and the mean scores were graphed using Graph Pad Prism 6. 
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2.3.11. Parasite growth competition assay 
Freshly harvested parasites were counted, and 1x10
5
 parasites of strains to be 
tested were added pairwise to a confluent monolayer of HFFs in a T25 flask (“passage 
zero”). After complete lysis of the host monolayer, 200µl of parasites in the supernatant 
were used to infect a fresh host cell monolayer. This was considered passage one. This 
process was repeated until passage eleven. Extracellular parasites at passages 0, 1, 3, 5, 7 
and 11 were analyzed by IFA using the protocol described in Section 2.3.2. All parasites 
were stained with anti-GAP45, and the subset of parasites expressing Flag-tagged 
TgAMA1 were identified by staining with anti-Flag. Growth assays were performed in 
three biological replicates, each in duplicate and 400 parasites were counted per cover 
slip. The percentage of the total parasites that were Flag positive was used to plot graphs. 
 2.4. Stable Isotope Labeling of Amino acids in Cell Culture (SILAC) 
2.4.1. SILAC labeling of host cells and parasites 
SILAC DMEM media (Thermo Scientific # 89985) was supplemented with 10% 
dialyzed FBS (Invitrogen # 26400-044), 10mM HEPES, 10units/ml each of penicillin and 
streptomycin sulphate. Heavy SILAC media also contained stable isotopic forms of 
“heavy” L-arginine-HCl (13C6, 
15
N4) at 0.398mM and L-lysine-2HCl (
13
C6,
 15
N2) at 
0.798mM (Thermo Fisher Scientific) The light media contained “light” isotopic forms of 
L-arginine and L-lysine at 0.398mM and 0.798mM respectively [9]. L-Proline was added 
at 40mg/l to the media in order to balance arginine to proline conversion. HFFs were 
grown in “heavy” or “light” SILAC media for about 5.5 passages. Two days prior to the 
experiment, 12 T75s of “heavy” and “light” labeled host cells were infected with 
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parasites. 
2.4.2. Immunoprecipitations 
Freshly harvested parasites from the 12 T75s from each “heavy” and “light” prep 
yielded a total of approximately 7-10x10
8
 parasites in 1000µl. An equal number of 
parasites from each line was used for immunoprecipitation. After washing with cold PBS, 
parasites were extracted on ice for 10 minutes in 1000 µl of TX-100 Lysis buffer (1%  
TX-100, 50mM Tris HCl pH 8, 150mM NaCl, 2mM EDTA (kinase inhibitor), 1:200 
protease inhibitors, and phosphatase inhibitors). Working stocks of phosphatase 
inhibitors were prepared separately and dissolved in water. It was comprised of sodium 
orthovanadate at 100mM, 1M beta-glycerophosphate and 125mM sodium and were 
added to the lysis buffers at final concentrations of 0.1mM, 1mM and 2.5mM 
respectively. Immunoprecipitation was performed using 0.0725mg/ml anti-AMA1 
antibody B3-90 [10] followed by incubation with 50µl of recombinant Protein-A 
sepharose beads (Life Technologies). Bound proteins were eluted by boiling in 150ul 1x 
sample buffer with β-mercaptoethanol, resolved on a 12% SDS-PAGE gel and 
Coomassie stained.  
 
2.4.3. Sample Preparation for Mass Spectrometry 
The gel lane was cut into 20 slices (recovering all bands except antibody heavy 
and light chains) and each slice was cut into small cubes. The cubes were kept in water 
until destaining, which was carried out by three room temperature incubations in 50mM 
NH4CO3, 50% acetonitrile (15 minutes each), followed by an overnight incubation in the 
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same buffer at 4°C. The gel pieces were then washed with 100% acetonitrile and, once 
opaque, dried and treated with 10mM DTT in 100mM NH4CO3 for 1 hour at 56°C to 
reduce all disulfide bonds. After cooling to room temperature, the samples were alkylated 
for 45 minutes in the dark in 50mM iodoacetamide, 100mM NH4CO3. The alkylating 
solution was then replaced with 100mM NH4CO3 and the gel pieces incubated at room 
temperature for 10 minutes, followed by dehydration with 100% acetonitrile. This 
swelling and drying of the gel slices were repeated two more times before digestion at 
37°C for 16 hours with 12ng/µl trypsin in a digestion buffer containing 100mM NH4CO3 
and 5% acetonitrile in water. Following digestion, the peptides were extracted from the 
gel slices by incubating them in 50µl 5% formic acid followed by 5% formic acid and 50 
% acetonitrile in water. The extracted peptides were collected in a fresh tube and the gel 
slices were extracted again with 100% acetonitrile.  The acetonitrile solution was mixed 
with the extracted peptides, then dried using a speedvac and resuspended in 20µl of 
buffer containing 2.5% formic acid, 2.5% acetonitrile in water. The samples were run in a 
LTQ Orbitrap Discovery mass spectrometer (Thermo Scientific). The RAW files were set 
up for search against the Toxoplasma database V8 (http://www.toxodb.org/toxo/) using 
Proteome Discoverer 1.4.  
2.4.4. SILAC data analysis 
The heavy/light ratio for each protein identified was normalized to the mean H/L 
ratio of all peptides identified in that experiment. The ratios were log2 transformed to 
generate a normal distribution [11].  Every protein chosen as a “hit” met the following 
criteria: three or more unique peptides from that protein were detected (peptide sequences 
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uniquely associated with the protein group); the H/L ratio of the protein was two standard 
deviations either above or below the mean H/L ratio of all peptides in the experiment; the 
H/L variability of the peptides recovered for that protein did not exceed 40% (coefficient 
of variability over all redundant peptides used for quantification); and the H/L count was 
over 3 (number of peptides used for quantification). The data were graphed using Graph 
Pad Prism6.  
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Figure 2.1: Schematic of Quick change mutagenesis 
Primers containing codon substitutions for the desired point mutation are used for linear amplification from 
a template containing the gene of interest. The methylated strands from the parental template are digested 
using DpnI restriction endonuclease. The vector with the desired mutation is then isolated from single 
colonies grown on selectable media (LB Amp) after transformation of competent E.coli cells. 
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Figure 2.2: Schematic of around the horn mutagenesis 
 
Primers containing 5’ phosphorylated ends are designed around the desired mutation and amplified with the 
vector containing the gene of interest. After digestion of the methylated parental template with DpnI, the 
5’phosphorylated ends of the amplicons are ligated using T4 DNA ligase. The vector with the desired 
mutation is then isolated from single colonies grown on selectable media (LB Amp) after transformation of 
competent E.coli cells. 
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Figure 2.3: Schematic of double homologous integration at the TgAMA1 locus 
 
(2.3.1) Schematic of the vector pA/TgAMA1
WT
 Flag.BLE integrating at the TgAMA1 locus via homology 
in  the 5’ and 3’ flanks. After allelic replacement, the parasite clones were resistant to phleomycin due to 
the presence of the Ble cassette. The site where the primer pairs anneal before and after allelic replacement 
are indicated in blue and red. (2.3.2) Table containing the primer pairs used to check integration of vector at 
the TgAMA1 locus and the expected product size before and after allelic replacement. 
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Table 2.1: Primers used for site-directed mutagenesis 
 
The table lists the desired amino acid substitutions on the cytoplasmic tail of TgAMA1, the primer 
pairs used to generate the mutations, in the vector pA/TgAMA1
WT
 Flag.BLE, and the primer 
sequences. ATH stands for around the horn mutagenesis; all other primers were designed for Quick 
change mutagenesis.  
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Table 2.2:  Primers used to check for vector integration at the TgAMA1 locus 
 
The primer combinations used to check for integration of the vector at the TgAMA1 locus as illustrated  
in Figure 2.3.  
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CHAPTER 3- FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS 
WITHIN THE CYTOPLASMIC TAIL OF TgAMA1 
3.1. Apical membrane antigen 1 and its role in parasite invasion 
 Apical membrane antigen 1 (AMA1) in T.gondii is a 63kDa type I 
transmembrane protein with a large ectodomain and a short cytoplasmic tail [1]. AMA1 
is highly conserved amongst apicomplexan parasites and localizes to secretory organelles 
called micronemes whose contents are discharged during the initial steps of parasite 
invasion in response to changes in intracellular calcium [2]. Following its secretion from 
the micronemes at the apical end of the parasite, AMA1 translocates anterior to posterior 
on the parasite surface. The ectodomain has 16 conserved cysteine residues that form 
disulphide bonds [1]. Early studies using antibodies to the ectodomain of TgAMA1 
showed inhibition of parasite invasion, which highlighted its importance in establishing 
infection of host cells [1]. A role for TgAMA1 in invasion was clearly established in 
parasites that conditionally repressed the expression of TgAMA1 upon addition of 
anhydrotetracycline [3].  These parasites were unable to tightly attach to host cells, which 
led to a severe invasion defect. Parasites lacking TgAMA1 also had a defect in rhoptry 
secretion. The ectodomain of TgAMA1 interacts with TgRON2, and TgRON2 forms a 
complex with TgRONs 4, 5, and 8. This interaction plays a crucial role in establishing the 
moving junction in an invading parasite. This TgRON complex is inserted by the parasite 
into the host cell where it also interacts with the cytoskeletal machinery of the host cell; 
both the receptor and the ligand are therefore parasite derived ([4], [5], [6], [7], [8], [9]). 
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The crystal structures of the TgAMA1 ectodomain, alone and in complex with TgRON2, 
have recently been solved ([10], [11]) 
  The transmembrane domain of TgAMA1 is indicated with dotted lines in Figure 
3.1, with sites that are susceptible to cleavage by rhomboid proteases represented by 
thunderbolts ([12], [13], [14]). There are three rhomboid proteases in Toxoplasma,  
TgROM1, 4 and 5, with TgROM4 being the major protease involved in processing of 
microneme adhesins like TgMIC2 and TgAMA1 after their secretion onto the surface of 
the parasite [15]. Mutations in the TgAMA1 cleavage sites reduced parasite growth as a 
consequence of reduced invasion [16].  
 The alignment in Figure 3.1 compares the cytoplasmic tail across several 
apicomplexan parasites. The short cytoplasmic tail of TgAMA1, composed of 63 amino 
acids, lacks any conserved domains. The fate of the cytoplasmic tail after cleavage of the 
TgAMA1 transmembrane domain remains unclear. There was some speculation that the 
tail of TgAMA1 was involved in parasite replication since a replication defect in 
parasites over-expressing a catalytically dead version of TgROM4 was rescued by over-
expression of the tail of TgAMA1 [17]. However, neither knockout parasites lacking 
TgROM4 generated using the conditional Di-Cre system nor parasites expressing a non-
cleavable version of AMA1 have a replication defect, disproving the requirement of 
TgAMA1 cleavage for replication ([18], [16]). In Plasmodium, the cytoplasmic tail of 
AMA1 plays a role in parasite invasion since parasites lacking the tail had a severe 
invasion defect even though the mutant protein still trafficked to the micronemes and 
localized to the parasite surface. The cytoplasmic tails of AMA1 homologues from other 
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Plasmodium species could functionally substitute for the cytoplasmic tail of P. 
falciparum AMA1 (PfAMA1) but the tails from other unrelated Plasmodium adhesins 
could not [19]. To understand the functional importance of individual amino acids within 
the cytoplasmic tail of TgAMA1, we mutated the residues indicated in Figure 3.1 for the 
reasons described in the next section.  
3.2. Residues of interest in the tail of TgAMA1 
3.2.1. Phosphorylation 
  In Plasmodium parasites, phosphorylation of the tail of AMA1 plays an 
important role in parasite invasion into host cells [19]. Two residues in the cytoplasmic 
tail of TgAMA1 were identified as sites of phosphorylation from a mass spectrometry- 
based proteomics study [20]. Phosphorylation on S527 had a significant A-score, which 
is a measure of confidence, and this modification was seen more often in extracellular 
parasites than in intracellular parasites. S537 was also phosphorylated but with a low 
confidence A-score. We hypothesized that these phosphorylation events can influence 
protein binding to the tail of TgAMA1, which could change the outcome of downstream 
signaling events. We tested this hypothesis by mutating S527 either to either a non-
phosphorylatable residue, alanine, or to a phosphomimemtic residue, aspartic acid, and 
determining the effect of the mutation on invasion and TgAMA1 binding partners.  
3.2.2. FW domain 
 Microneme proteins such as TgMIC2 and TgAMA1 to bind to aldolase 
(TgALD1) [21]. Aldolase was previously thought to function in invasion by forming a 
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bridge between the microneme proteins and the parasite’s acto-myosin motor machinery. 
When TgAMA1 residues F547 and W548 were mutated to AA, the parasites could no 
longer bind TgALD1 and had a severe invasion defect [22]. However, it was recently 
shown that an invasion defect in parasites lacking aldolase is only observed when the 
parasites are grown in the presence of glucose [23]. This is due to accumulation of 
fructose-1, 6- bisphosphate, which is toxic to the parasite. This highlighted the 
importance of aldolase in glycolysis and proved that physical interaction between 
TgALD1 and TgAMA1 or TgMIC2 had no role in invasion of parasites into host cells 
[23]. Nevertheless, when the residues F547 and W548 were mutated to AA, the parasites 
showed drastically reduced invasion [24]. Here, we made allelic replacement parasites 
with  both F546 and W548 mutated to alanine, as well as the single W548A mutation. 
3.2.3. PfAMA1 S610 is equivalent to D558 in TgAMA1 
  PfAMA1 has a serine in position 610 that is phosphorylated by Protein Kinase A 
(PKA) and this phosphorylation is important for parasite invasion [25]. Based on 
sequence alignments (Figure 3.1), TgAMA1 has an aspartic acid (D558) in the equivalent 
position. We mutated this site to either to alanine or serine. 
3.2.4. Carboxy-Terminal tyrosine 
  The cytoplasmic tail of AMA1 in most apicomplexan parasites has a tyrosine at 
its C-terminal end. In PfAMA1, the C-terminal tyrosine was shown to be important for 
aldolase binding [26]. We mutated  T. gondii Y569 to phenylalanine for functional 
studies.  
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3.3. RESULTS 
 
3.3.1. Screening and selection of clones 
The vector used for generating all allelic replacement constructs, pA/TgAMA1
WT
 
Flag.BLE, is shown in Figure 3.2. Transgenic parasites were generated and individual 
parasite clones were screened for integration at the right locus using the primer sets 
described in Figure 2.3. Figure 3.3 shows that PCR products of the desired length were 
generated from the transgenic parasites, confirming recombination of the vector at the 
endogenous TgAMA1 locus. Proper apical localization of the Flag-tagged TgAMA1 in 
each of the allelic replacement (AR) parasite clones was verified by IFA (Figure 3.4). 
Clones that showed equal expression of Flag-tagged wild-type and mutant TgAMA1 
(Figure 3.5) were selected for phenotypic analysis, and genomic DNA of the replaced 
locus was PCR amplified and sequenced in each to confirm the presence of the desired 
mutation. The AR parasites with point mutations in the cytoplasmic tail of TgAMA1 
generated in this study are listed in Table 3.1. 
3.3.2. Invasion  
A two-color invasion assay was performed with the AR parasites using the 
protocol described in chapter 2.3.7. Invasion levels of AR parasites expressing Flag-
tagged wild-type AMA1 (ARAMA1
WT
) were set to 100%. Of all the mutant lines tested, 
only ARAMA1
FW/AA
, ARAMA1
W/A
, and ARAMA1
S527D
 showed an invasion defect. The 
ARAMA1
W/A
 parasite line invaded to only 15% of the level of ARAMA1
WT
, and 
ARAMA1
FW/AA
 to 32% (Figure 3.6). The invasion assay comparing ARAMA1
WT 
and 
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ARAMA1
FW/AA
 parasites were performed on 8 separate days, each in duplicate. 
Surprisingly, the invasion of the ARAMA1
FW/AA
 parasites increased from 30% on day 1 
(March, 2013) to 50% on day 8 (April, 2014) (Table 3.3) and the expression of Flag-
tagged AMA1 detected by Western blot in the mutant parasites also changed over time in 
the ARAMA1
FW/AA
 parasites (Figure 3.5). Taken together, this suggests that the parasites 
adapted somehow over time as a consequence of continuous culture (see Section 3.3.5.3 
below).  
The non-phosphoryatable S527A mutation in the tail of TgAMA did not affect 
parasite invasion. However, parasites with a phosphomimetic S527D mutation showed a 
30% drop in invasion compared to ARAMA1
WT
 (Figure 3.6). Invasion assays with 
ARAMA1
S527D 
parasites at shorter or longer time points still resulted in 30% invasion 
defect compared to ARAMA1
WT
 showing that time was not a factor for this phenotype 
(Table 3.2). The data suggest that invasion efficiency is reduced when TgAMA1 is 
phosphorylated on S527. 
 
3.3.3. SILAC mass spectrometry as a method to identify new interacting partners of 
TgAMA1  
Stable Isotope Labeling of Amino acids in Cell culture (SILAC) mass 
spectrometry is an efficient method to identify and quantify protein-protein interactions 
[27]. Proteins are differentially labeled with non-radioactive isotopes in the form of either 
“heavy” or “light” versions of essential amino acids. Typically arginine and lysine are the 
amino acids used for differential labeling when samples are digested with trypsin [28].  
Leucine, tyrosine, lysine and methionine have also been used for differential labeling of 
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cells [27]. The SILAC method involves culturing of cells to incorporate the differentially 
labeled amino acids [29]. A SILAC ratio is determined by either using signal intensities 
or area under the “heavy” and “light” peaks of peptides from differentially labeled 
proteins.  
Here, paired lines of parasites were differentially labeled with either heavy or 
light isotopic versions of L-arginine and L-lysine as described in chapter 2.4. Elutions 
after IPs with TgAMA1 as bait were mixed in a 1:1 volume for analysis by SILAC mass 
spectrometry. The goal of these experiments was to identify differences in interacting 
partners as a consequence of amino acid substitutions in the tail of TgAMA1. Non-
specific proteins would be expected to have a SILAC heavy/light (H/L) ratio of one. 
TgAMA1 and its known interacting proteins such as members of the TgRON complex 
that bind to the ectodomain of TgAMA1 would also have a H/L ratio of one. In contrast, 
interacting partners whose binding to TgAMA1 change as a consequence of the amino 
acid substitutions in the cytoplasmic tail of TgAMA1 would have higher or lower SILAC 
ratios (Figure 3.7). 
3.3.4. Identification of potential new interacting partners of TgAMA1 
As a control experiment, ARAMA1
WT
 parasites were labeled with heavy isotope-
containing arginine and lysine and TgAMA1 knockout parasites [30] were labeled with 
light isotopic versions of the two amino acids, followed by TgAMA1 
immunoprecipitation and SILAC analysis. H/L ratios from all protein hits were 
normalized to the mean ratio of all peptides detected. Following normalization, the data 
were log2 transformed to generate a normal distribution. In principle, nothing should 
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come down in the pull down from the TgAMA1 knockout line. As expected, the top hits 
with a high heavy to light ratio were TgAMA1 itself and members of the RON 
complex;TgRONs2, 4, 5 and 8 (Figure 3.8). This proved that the immunoprecipitation 
was successful in pulling down known interacting partners of TgAMA1. The data were 
then used to shortlist proteins with three or more unique peptides identified and heavy to 
light (H/L) ratios two standard deviations or more above the mean of the experiment. 
There were five hits that matched these criteria, in addition to TgAMA1 and the proteins 
from the RON complex (Table 3.4). Four out of these five hits are annotated as 
hypothetical proteins in the Toxoplasma database (toxodb).  
From a previous study [31], TgME49_253370 was annotated in toxodb as 
TgRON4L, an orthologue of TgRON4 with one predicted signal peptide but no predicted 
transmembrane domain [20]. The function of TgRON4L remains unknown.  It could be 
another structural member of the AMA1-RON complex, it could help in formation of the 
complex or it could have a unique role that remains unidentified.  
TgME49_209170 is a hypothetical protein that we hypothesize is a new member 
of the TgAMA1-TgRON complex. It has a signal peptide but no transmembrane 
domains. It is unknown whether it is an essential protein. This protein was identified in 
multiple SILAC experiments comparing parasites expressing TgAMA1 with wild-type 
and mutant tails, but in no cases were the SILAC ratios significantly different (see 
below). This, combined with the fact that the protein has a predicted signal peptide, 
suggests that it may interact with the ectodomain of TgAMA1 or proteins that interact 
with the ectodomain. The expression profile of TgME49_209170 across the parasite’s 
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lytic cycle is more similar to that of the TgRON proteins that it is to that of TgAMA1 
(Figure 3.9). It is therefore unlikely that it TgME49_209170 functions as the elusive 
TgAMA1 chaperone [22], suggesting that it may instead be a part of the AMA1-RON 
complex or could help in the formation of this complex.  
TgME49_229140 had a high H/L ratio and is annotated as a MaoC domain- 
containing protein with no predicted transmembrane domain or signal peptide, consistent 
with it binding to the cytoplasmic tail of TgAMA1. The protein is conserved in 
apicomplexan parasites such as Eimeria, Hammonida, and Neospora species but absent 
in Plasmodium. It is predicted to have two domains from the hot-dog super family [32]. 
Proteins with this domain are usually involved in unsaturated fatty acid synthesis and it 
was previously annotated as a peroxisomal multifunctional domain containing protein. It 
does not share any homology with the peroxidases identified in T. gondii [33]. A protein 
BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) shows that there is conservation 
to some extent (not with high coverage) in plant species such as Arabidopsis and 
Rhizopus with proteins that have an enoylCoA hydratase function [34].  The function of 
this protein in T. gondii is unknown. 
The other two hits identified with a high H/L ratio were TgME49_258870 and 
TgME49_204340, which are both annotated as hypothetical proteins. TgME49_258870 
has no conserved domains but two potential transmembrane domains. TgME49_204340 
has one predicted transmembrane domain and one signal peptide. Upon endogenous 
tagging, this latter protein localized to the apical and sub-apical end of the parasite in 
addition to co-localization with TgMIC2 [35].  
  
69 
3.3.5. Changes in interacting partners as a consequence of a change in 
phosphorylation on the cytoplasmic tail of TgAMA1  
Comparing ARAMA1
S527A
 and ARAMA1
S527D 
parasites to ARAMA1
WT
 parasites 
in the invasion assay (Figure 3.6), suggested a role for phosphorylation / 
dephosphorylation in invasion. We therefore tested by SILAC whether these same 
mutations lead to changes in protein binding to TgAMA1. In all the pairwise 
comparisons, ARAMA1
WT
 parasites were labeled with light isotopic versions of L-
arginine and L-lysine and the mutants were labeled with the heavy amino acids. Proteins 
with a high SILAC ratio are therefore those that are pulled down preferentially by the 
mutant forms of TgAMA1, those with a low H/L ratio are pulled down preferentially by 
TgAMA1
WT
 and those with ratios close to one are proteins whose abundance in the pull-
down is unaffected by the tail mutations. 
3.3.5.1. ARAMA1
S527A 
(heavy) vs. ARAMA1
WT
 (light) 
Proteins with H/L ratios two standard deviations above and below the mean of the 
experiment and with more than three unique peptides detected are represented in Figure 
3.10. Ribosomal proteins were eliminated from the shortlist shown in Table 3.5 as they 
are highly abundant and unlikely to be of biological relevance in this context. The H/L 
ratio for TgAMA1 was close to one, as expected, and the hit with the highest ratio was 
the S527A-containing peptide. The fact that this peptide had a measurable ratio indicates 
that the heavy labeling efficiency was not 100% (since, if it were, there should be no 
light-labeled S527A-containing peptide in either sample). Members of the RON complex 
also had H/L ratios close to one, suggesting that phosphorylation of the tail of TgAMA1 
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is not necessary for binding of the ectodomain of TgAMA1 to the members of the RON 
complex. The hypothetical protein, TGME49_209170, again had a H/L ratio similar to 
that of the RON complex proteins, consistent with it being a previously unknown 
TgAMA1- or TgRON-binding protein. There were two hits that met the criteria of having 
more than three peptides and H/L ratios two standard deviations above the mean of the 
experiment, namely a eukaryotic porin protein and a WD (β-transducin repeat) domain 
containing protein (Table 3.5), each discussed further below. 
TgME49_263300, which is annotated as eukaryotic porin protein does not have a 
predicted signal peptide or transmembrane domains and has homologues in other 
Apicomplexans such as Eimeria, Plasmodium, Babesia, Neospora, Hammonida, 
Cryptosporidium and Sarcocystis. In other cells, members of this porin 3 super family 
play a role in diffusion of small molecules through voltage dependent anion selective 
channels on mitochondrial membranes [36]. The localization of this protein in T. gondii 
is unknown. However, it would be interesting to test if the phosphorylation state of 
TgAMA1 at S527 affects the movement of small molecules into or out of the parasite. 
TgME49_232380 is annotated in the database as a WD domain G-beta repeat 
containing protein, has two WD40 domains and does not have a signal peptide or any 
predicted transmembrane domains. It is conserved in Neospora, Hammonida, Eimeria, 
Babesia, Sarcocystis and Cryptosporidium but absent in Plasmodium parasites. Proteins 
with WD domains are known to play a role in signal transduction, apoptosis, autophagy, 
cell cycle control and transcriptional regulation [37]. For example, coronin in 
Toxoplasma has a WD40 domain which binds actin and stabilizes short actin filaments 
  
71 
[38]. It would be interesting to identify interacting partners of this protein and determine 
protein interactions that depend on the phosphorylation of TgAMA1. If this protein can 
bind to actin (either directly or indirectly), it could potentially act as bridge between the 
parasite’s invasion machinery and its motor complex. 
Hits with a H/L ratio two standard deviations below the mean of the experiment 
are those that lose their interaction with TgAMA1 when S527 is mutated to alanine. 
There were four hits that matched these criteria, two of which were annotated as 
hypothetical proteins (Table 3.5). TgGRA7 has two transmembrane domains and one 
predicted signal peptide. TgGRA7 complexes with several proteins in the secretory 
pathway [39]. These proteins bind to TgGRA7 as a mechanism to bury their 
transmembrane domain during their residence in dense granules [39]. In infected host 
cells, TgGRA7 also complexes with TgROP2 and TgROP4 [40]. It is a conserved protein 
only in Hammonida and Neospora.  
Anonymous antigen 1 was another hit with a low H/L ratio which has no 
predicted transmembrane domains or signal peptide and is conserved across several 
apicomplexan parasites such as Eimeria, Neospora, Plasmodium, Hammonida, Babesia, 
and Cryptosporidium. It is a 286kDa protein with an armadillo repeat domain, which is 
typically involved in protein-protein interactions. It did not behave as an AMA1-binding 
protein in the control experiment (AMA1
WT
 vs. AMA1 knockout), suggesting that it may 
bind non-specifically to sepharose-A beads due to its large size.  
The third hit with a low H/L ratio was TgME49_215220, which is annotated as 
TgGRA22, plays a role in regulating parasite egress [41] and is conserved in Hammonida 
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and Neospora. The other hypothetical protein hit TgME49_321650 is conserved only in 
Eimeria and Neospora and it has 38% identity to a putative kinase annotated in the 
Eimeria database. It has no signal peptide but one predicted transmembrane domain.  
3.3.5.2. ARAMA1
S527D 
(heavy) vs. ARAMA1
WT
 (light)  
The dataset comparing heavy labeled ARAMA1
S527D
 parasites to light labeled AR 
AMA1
WT
 parasites with shortlisted hits based on the criteria described above is shown in 
Figure 3.11 and Table 3.5. None of the hits identified had any predicted transmembrane 
domains or signal peptides, which suggests they are cytosolic and could therefore 
mediate interaction with the tail of TgAMA1. The hit with the highest ratio (ToxoID#) 
was a hypothetical protein conserved only in Eimeria, Hammonida and Neospora. It has 
a conserved domain with homology to a microneme-rhoptry protein in Theileria [42]. 
There were three protein hits that lost their ability to bind TgAMA1 as a 
consequence of the S527D mutation, namely: TgME49_216550, TgME49_205770 and 
TgME49_312650. TgME49_216550, annotated as S15 sporozoite expressed protein is 
highly conserved among apicomplexans such as Eimeria, Neospora, Hammonida and 
Plasmodium species. It was also identified in an mRNA expression screen that looked at 
proteins with an expression profile similar to TgMORN1, where it was named MSC1a 
(mature soluble cytoskeletal protein a; [43]). It localized to the apical end of the parasite, 
the basal complex, appeared as punctate spots along the periphery of the parasite and 
often formed rings on the basal end of the parasite. It did not co-localize with 
TgMORN1, IMC5 or IMC8 and was absent in the daughter cells during parasite division 
[43]. 
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TgME49_205570 is a hypothetical protein that has homologues in Eimeria, 
Neospora, Theileria, Plasmodium and Babesia. It has a bacterial surface antigen domain, 
which usually localizes to the outer membrane of the mitochondria in eukaryotes such as 
Saccharomyces where it is a component of the sorting and assembly machinery [44].  
TgME49_312630 is annotated as anonymous antigen 1 in the Toxoplasma 
database. It is a large protein with an armadillo repeat domain, which is known to be 
involved in protein-protein interactions. Unexpectedly, this same protein was observed 
with a low H/L ratio in the experiment that compared ARAMA1
S527A
 (heavy labeled) 
parasites to ARAMA1
WT 
(light labeled) parasites with no correspondingly high ratio in 
the control experiment.  This suggests that this protein may be pulled down non-
specifically, perhaps as a consequence of performing separate immunoprecipitations with 
differentially labeled parasites.  
3.3.5.3. ARAMA1
FW/AA
 (heavy) vs. ARAMA1
WT
 (light)  
Allelic replacement parasites with both F547 and W548 mutated to alanine had a 
significant defect in parasite invasion (Figure 3.6). We hypothesized that this defect in 
invasion is due to changes in the interacting partners of TgAMA1 as a consequence of the 
mutation. Of the hits with a high H/L ratio, the same WD domain-containing protein 
described above was observed. The hits with a low ratio were anonymous antigen 1 and 
the porin protein. The porin protein and WD domain containing protein were also 
identified with a high ratio in the SILAC experiment comparing ARAMA1
S527A
 (H) to 
ARAMA1
WT
 (L), and anonymous antigen 1 showed a low H/L ratio in the 
ARAMA1
S527A
 (H) to ARAMA1
WT
 (L) comparison.  
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However, TgAMA1 had the lowest H/L ratio in the dataset, which suggested that 
the FW/AA mutation somehow either decreased interaction with the TgAMA1 antibody 
or caused reduced expression or stability of the protein (Figure 3.12). The open reading 
frame of TgAMA1 in these mutant parasites was sequenced and shown to contain two 
amino acid substitutions in addition to F547A and W548A. The ARAMA1
F547A
 parasite 
line also had an additional random mutation in the ectodomain of TgAMA1. None of 
these additional mutations were present when the parasites were first generated. When 
combined with the increase in parasite invasion (Table 3.3) and decrease in 
TgAMA1
FW/AA
 expression levels over time (Figure 3.5), these data suggest that F547 and 
W548 are functionally important and that during continuous culture the parasites evolved 
additional mutations to counteract the deleterious effects of the inserted mutations.  
3.4. DISCUSSION 
3.4.1. Role of AMA1 phosphorylation in invasion 
In an attempt to determine the function of the cytoplasmic tail of TgAMA1, 
residues predicted to be important for TgAMA1 function were chosen for amino acid 
substitutions. It was surprising that most of the substitutions did not have an effect on 
parasite growth. Of all the allelic replacement parasite lines, only the ARAMA1
FW/AA
 and 
ARAMA1
W547A
 showed a delay in growth (data not shown). In invasion assays, the 
phosphomimetic mutant, ARAMA1
S527D
 was capable of only 70% invasion compared to 
ARAMA1
WT
 parasites while the non-phosphorylatable mutant, ARAMA1
S527
, did not 
show any invasion defect. This suggests that TgAMA1 phosphorylation is dynamic and 
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plays a role in parasite invasion. In Plasmodium, AMA1 is phosphorylated by Protein 
Kinase A [19] but in Toxoplasma the kinase(s) responsible for phosphorylation of the two 
serine residues on the cytoplasmic tail of TgAMA1 and the timing of their 
phosphorylation is unknown.  
Calcium fluxes were observed during parasite motility and a sudden decrease in 
intracellular calcium levels preceded parasite invasion [45]. The invasion result from this 
study suggests that the cytoplasmic tail of TgAMA1 has to be dephosphorylated for 
efficient invasion. If either the kinase or phosphatase responsible for regulating the 
phosphorylation state of S527 was affected by parasite intracellular calcium levels, these 
two processes could be related. This hypothesis would be hard to test without an antibody 
that recognizes the phosphorylation state of TgAMA1, because of the speed of invasion 
(~ 20 sec; [46]) and the difficulty of obtaining highly synchronized populations of 
invading parasites. 
3.4.2. SILAC in the study of protein-protein interactions 
The power of SILAC mass spectrometry in studying protein-protein interaction 
was highlighted in the control experiment, which compared proteins pulled down from 
heavy labeled ARAMA1
WT
 parasites and light labeled TgAMA1 knockout parasites, using 
a TgAMA1 antibody. As expected, TgAMA1 was the hit with the highest H/L ratio since 
only the ARAMA1
WT
 heavy labeled parasites expressed the protein. The fact that any 
light labeled TgAMA1 was detected showed that the labeling efficiency in the heavy 
parasites was not 100%. Other known interacting partners of the ectodomain of 
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TgAMA1, such as TgRON2, 4, 5 and 8, also had a very high H/L ratio which confirmed 
that the conditions used for immunoprecipitation were sufficient for identifying 
TgAMA1-associated proteins and that the mass spectrometer was sensitive enough to 
identify more than 3 unique peptides of each of these hits. In addition to known 
interacting partners identified in this experiment, there were at least three other hits with 
high H/L ratios and more than 3 unique peptides, suggesting that these hits could be new 
as yet unidentified proteins that bind to either the ectodomain or the cytoplasmic tail of 
TgAMA1. The next step would be to endogenously tag these proteins in parasites, 
perform a reverse immunoprecipitation, and probe for TgAMA1 by Western blot. Our 
attempts to generate a vector to endogenously tag TgME49_209170 using modified 
Gibson assembly were not successful, but classic restriction digestion-based cloning 
could be used to generate this vector.  
It was also interesting that all of the shortlisted hits from the control experiment 
had H/L ratios close to the mean in the other SILAC experiments that compared wild 
type parasites to parasites with point mutations on the tail of TgAMA1 (Table 3.4). This 
showed that these mutations on the cytoplasmic tail of TgAMA1 did not affect the 
binding of TgAMA1 to this particular subset of interacting partners. Another rationale for 
doing the control experiment was to see if hits from the other SILAC comparisons had 
high H/L ratios in the control experiment, which would indicate that they are true 
interacting partners of TgAMA1. This was the case only for members of the TgRON 
complex that were previously known to interact with TgAMA1. The shortlisted hits from 
these other experiments had ratios close to the mean in the control experiment. This 
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suggests that the amino acid substitutions on the C-tail of TgAMA1 changed the way 
some proteins interacted with AMA1. Based on bioinformatics analysis of the protein hits 
from each of the SILAC experiments discussed in the results section, testable hypothesis 
could be developed for the function of some of these hits. A first step would be to 
confirm that they interact with TgAMA1 by reciprocal pull downs or via co-
transformations using the yeast-two hybrid system.  
The results from these experiments highlight the power and sensitivity of SILAC 
quantitative mass spectrometry to identify known and potential new interacting partners 
of the bait protein, TgAMA1. The changes in the binding protein profile as a result of a 
single amino acid substitution in the cytoplasmic tail of TgAMA1, combined with the 
results from invasion assays indicate that S527 of TgAMA1 contributes to the function of 
TgAMA1 in invasion and that this may be mediated by S527 phosphorylation-induced 
changes in TgAMA1-binding partners.  
3.4.3. Safe amino acid substitutions 
The SILAC mass spectrometry analysis comparing ARAMA1
FW/AA
 parasites to 
ARAMA1
WT 
parasites compelled us to check the open reading frame of TgAMA1 in the 
ARAMA1
FW/AA
 parasites. Two additional random mutations were observed in the 
ectodomain of TgAMA1 along with the FW/AA mutation in its tail. These mutant 
parasites had a severe invasion defect when they were first tested, but over time invasion 
increased from 30% of wild type levels to 50% (Table 3.3). The parasites had been 
maintained in continuous culture suggesting that they partially adapted over time to the 
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fitness defect caused by the FW/AA mutation by incorporating additional compensatory 
mutations. It is unclear whether this was a dominant negative effect due to the functional 
importance of F547 and W548 or if the amino acid substitutions changed the tertiary 
structure of the protein and led to reduced function of the protein.  
While testing the functional importance of amino acids by mutation is useful, it is 
essential to minimize the chance that the amino acid substitution alters the structural 
folding of the protein, either locally or globally. A mathematical study was done to 
identify “safe” amino acids substitutions by comparing naturally tolerated mutations in 
select proteins whose structures are known [47]. Substitution matrices were generated 
based on the location of the amino acid in the protein structure and whether the side 
chains were buried or exposed. In cases where there was no structural information 
available on the protein of interest, a third table was generated with information for safe 
substitutions. Each substitution was assigned a value of (+) or (-), which meant that the 
substitution was either favorable or not. According to this study, phenylalanine could be 
substituted to either leucine or tyrosine whereas tryptophan could be substituted with 
asparagine, leucine, phenylalanine or tyrosine [47]. An open source software available 
online called PROVEAN from The Craig Venter Institute 
(http://provean.jcvi.org/index.php) uses an alignment-based scoring to predict safe amino 
acid substitutions. Every amino acid substitution is given a score and if the score is above 
a set threshold, it is considered neutral or safe. Substitutions with scores below the set 
threshold are considered deleterious.  This program predicted F/L and F/Y substitutions 
as neutral but predicted F/A, W/A, W/N, W/F, W/Y and W/L substitutions as deleterious 
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[48]. All the substitutions made on the cytoplasmic tail of TgAMA1 in this study other 
than the FW/AA and F/A mutations were predicted to be neutral.  To understand the role 
of FW domain on the function of TgAMA1, F547 should be mutated to a more 
conservative residue such as leucine or tyrosine. It will be hard to test the functional 
importance of W548 by mutation considering the lack of safe options for substitution. 
3.4.4. Deletion of AMA1 C-tail to understand its function 
Our preliminary attempts to generate allelic replacement parasites lacking the 
cytoplasmic tail of TgAMA1 revealed that the mutant protein mislocalized: the truncated 
TgAMA1 appeared as spots all over the parasite (Figure 3.13). However, it is known that 
a tail-less AMA1 can traffic properly to the micronemes and can localize to the apical 
end of the parasite [22] when expressed in wild-type parasites that still express an 
exogenous copy of the full-length protein. In Plasmodium, parasites that had GFP in 
place of the cytosolic tail of AMA1 showed normal localization compared to wild-type 
parasites [19].  Taken together, these data suggest that the cytoplasmic tail of AMA1, 
composed of 62 amino acids, provides structural stability to TgAMA1 and enables it to 
have the right conformation. In order to study the overall function of the tail, we will 
replace the endogenous TgAMA1 allele with one that contains GFP in place of the tail of 
TgAMA1. Phenotype analysis of the parasite line will be undertaken, and SILAC mass 
spectrometry comparisons of this parasite line and ARAMA1
WT
 parasites will be used to 
generate a list of proteins that interact with the cytoplasmic tail of TgAMA1. The 
quantitative nature of the SILAC experiment makes it valuable as a starting point to 
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elucidate the function of the cytoplasmic tail of AMA1 and the proteins to which it binds.  
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Figure 3.1: Multiple sequence alignment of the tail of AMA1 across several apicomplexan 
parasites 
The dotted lines indicate transmembrane region and the thunderbolts represent rhomboid protease cleavage 
sites. The amino acid substitutions introduced into the tail of TgAMA1 are highlighted above the 
alignment. Tg-Toxoplasma gondii, Nc-Neospora caninum, Pf- Plasmodium falciparum, Pk- Plasmodium 
knowlesi, Pc- Plasmodium chabaudi, Pv- Plasmodium vivax, Bb-Babesia bovis, Et- Eimeria tenella. 
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Figure 3.2: Map of vector pA/TgAMA1
WT
 Flag.BLE used to generate allelic replacement parasites 
with amino acid substitutions across the tail of TgAMA1 
The open reading frame (ORF) of TgAMA1 and a Ble resistance cassette were placed between the 5’ and 
3’ flanking sequences of TgAMA1. The vector was designed to integrate into the endogenous locus via the 
flanking regions by double homologous integration.  Point mutations were introduced into the vector 
template to generate parasite lines with amino acid substitutions across the tail of TgAMA1. Parasites were 
selected for Ble resistance. The Ampicillin resistance cassette and an origin of replication were used to 
amplify the vector in bacterial cells. 
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Figure 3.3: Diagnostic PCR for individual clones with wild-type or mutant TgAMA1, confirming 
allelic replacement at the endogenous TgAMA1 locus 
Blue dotted lines indicate PCR with primers p1 and p2, which would give a 0.7kb product after allelic 
replacement (**) and a 2kb product in the parental Δku80ΔHXG parasite line (*). Red dotted lines indicate 
PCR with primer pair p3 and p4, which would give a 2.5kb (##) product after allelic replacement and a 
1.5kb (#) product in the parental Δku80ΔHXG parasite line. The illustration for how allelic replacement by 
double homologous recombination occurs, along with the primer pairs used here for diagnostic screening is 
shown in Figure 2.3.   
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Figure 3.4: Immunofluorescence of allelic replacement parasites expressing Flag-tagged wild-type or 
mutant TgAMA1 confirming the apical localization of TgAMA1 in each 
IFA was performed with intracellular parasites (left panel) and extracellular parasites (right panel) using 
anti-Flag and anti-IMC1 antibodies. The merged image from both channels contain a scale bar =5μM.  
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Figure 3.5: Western blot comparing Flag-TgAMA1 expression levels in allelic replacement parasite 
lines  
TgMLC1 was probed as a loading control. All parasites expressed similar amounts of Flag-TgAMA1 
except the FW/AA parasite line, which showed reduced expression over time (2013 vs. 2014). 
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Figure 3.6: Two-color invasion assay comparing parasites expressing wild-type and mutant alleles of 
TgAMA1 
The invasion of human foreskin fibroblasts by each of the allelic replacement parasite lines was quantified 
by laser scanning cytometry. The number above each column is the mean invasion of the respective 
parasite line. The numbers of biological replicates are indicated (n), each of which included two technical 
replicates. One way ANOVA with uncorrected Fisher’s LSD test was applied to compare each mutant 
parasite line to the wild-type. ARAMA1
WT
 invasion was always considered as 100%. AR AMA1 
S527D
 had 
a 30% invasion defect compared to ARAMA1
WT 
with a p value of 0.0159. ARAMA1
 FW/AA 
and 
ARAMA1
WA 
parasites invaded only 30% and 15% of the ARAMA1
WT
 parasites, respectively, each with p 
value <0.0001. AR AMA1
FA
 parasites were excluded from statistical tests since they were only tested once 
because they were found to have developed an extra mutation in the ORF during routine culture. 
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Figure 3.7: Schematic for quantitative mass spectrometry using SILAC 
Parasites were grown in host cells labeled either with heavy or light isotope of arginine and lysine. 
Parasites were lysed and immunoprecipitated with TgAMA1 antibody. Eluates were mixed 1:1, resolved by 
SDS PAGE and Coomassie stained. The lane was cut into 20-30 gel slices excluding the antibody heavy 
and light chains indicated with *. Proteins were extracted from gel slices and digested with trypsin for LC-
MS/MS. Contaminants will have 1:1 ratio and differentially interacting proteins will either have high or 
low H/L ratios. 
 
 
  
88 
 
Figure 3.8: SILAC results from ARAMA1
WT 
(H) vs. TgAMA1 knockout parasites (L) 
Graph of log2 transformed SILAC H/L ratios comparing proteins immunoprecipitated fromARAMA1
WT 
(heavy labeled-H) parasites and TgAMA1 KO (light labeled -L) parasites. The ratios were normalized to the 
mean H/L ratio of all peptides in the experiment. Dotted line indicates two standard deviations above the 
mean ratio of all peptides in the experiment. Hits that are known to interact with the ectodomain of 
TgAMA1 have a high H/L ratio in addition to more than 3 peptides identified by the mass spectrometer and 
are indicated in plain type. Previously unknown potential interacting partners of TgAMA1 (i.e., with 
SILAC ratios 2SD or more above the mean and three unique peptides identified) are indicated in bold type. 
For all hits, the Toxodb ID, name of the protein, number of unique peptides identified, and SILAC ratio are 
indicated. 
 
 
  
89 
 
 
Figure 3.9: A comparison of the cell cycle expression of TgME49_209170, TgAMA1, and members of 
the TgRON complex 
Image adapted from http://www.toxodb.org/toxo/. TgME49_209170 has an expression profile more similar 
to the TgRONs than to TgAMA1.  
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Figure 3.10: SILAC results from ARAMA1
 S527A 
(H) vs. ARAMA1 
WT 
(L) parasites 
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not 
affected by the mutation have H/L ratios similar to TgAMA1 itself. Hits 2SD above and below the mean of 
the experiment are labeled red and green, respectively. Hits are labeled along with accession number, 
protein description, number of unique peptides identified and H/L ratio.  
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Figure 3.11: SILAC results from ARAMA1
S527D 
(H) vs. ARAMA1
WT
 (L) parasites 
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not 
affected by the mutation have H/L ratios similar to TgAMA1 itself. Hits 2SD above and below the mean of 
the experiment are labeled red and green, respectively. Hits are labeled along with accession number, 
protein description, number of unique peptides identified and H/L ratio. 
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Figure 3.12: SILAC results from ARAMA1
FW/AA
 (H) vs. ARAMA1
WT
 (L) parasites 
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not 
affected by the mutation have H/L ratios of ~1. Hits 2SD above and below the mean of the experiment are 
labeled red and green, respectively. Hits are labeled along with accession number, protein description, 
number of unique peptides identified and H/L ratio. TgAMA1 had the lowest ratio, suggesting either 
reduced expression in the mutant or that the mutant could no longer bind TgAMA1 antibody. 
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Figure 3.13: IFA on a mixed (non-clonal) population of parasites in which the endogenous TgAMA1 
allele has been replaced with TgAMA1 lacking the cytoplasmic tail. 
The Flag Δctail mutant had a Flag tag within its ectodomain and was stained with anti-Flag (green) and 
anti-TgIMC1 (red). Scale bar = 5µm. The truncated protein lacks the normal distinct apical localization of 
TgAMA1 (e.g., see Fig 3.4). 
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Table 3.1: List of clonal allelic replacement (AR) parasite lines generated for this study. 
The table lists ten allelic replacement parasite lines generated and the clone number chosen for study. The 
presence of the mutation was confirmed in each case by PCR of the TgAMA1 locus using genomic DNA as 
template followed by sequencing. In addition apical localization was confirmed by IFA (Figure 3.4) and 
normal levels of Flag expression confirmed by Western blot (Figure 3.5).  
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Table 3.2: Two color invasion assay comparing ARAMA1
WT
 parasites to ARAMA1
S527D
 parasites at 
two different time points 
The numbers represent mean invasion from one biological replicate, with two technical replicates.  
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Table 3.3: Two color invasion assay comparing ARAMA1
WT
 to ARAMA1
FW/AA
 on eight separate 
days 
The ARAMA1
WT
 invasion level was set to 100% in each experiment. The % invasion shown for each 
biological replicate is the mean from two technical replicates.  Invasion levels went from 20-30% soon after 
the parasites were generated to 50% after a year of continuous culture, which may be an indication of the 
parasites adapting under the selective pressure of culture. 
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Table 3.4: Comparing hits from control SILAC experiment to other experiments 
Hits in red are two standard deviations (2SD) above the mean H/L ratio of all peptides detected in the 
experiment and hits in green are 2SD below the mean H/L ratio. The values of the mean, 2SD above the 
mean and 2SD below the mean of each experiment are indicated on top of every column. In addition to the 
accession number, the description of each protein hit, the number of unique peptides detected and their 
mean SILAC ratio, and the number of predicted transmembrane domains (TM) and signal peptides (SP) are 
listed.  
 
 
 
 
 
 
 
 
 
 
  
98 
 
Table 3.5: Comparing hits from ARAMA1
WT
 vs. ARAMA1
S527A
 and ARAMA1
WT
 vs. ARAMA1
S527D
 
to other SILAC experiments 
The mean H/L ratio from all peptides, 2SD above the mean and 2SD below the mean for each experiment 
are indicated above each column. Hits in red are two standard deviations (2SD) above the mean H/L ratio 
of all peptides detected in the experiment and hits in green are 2SD below the mean H/L ratio. The values 
of the mean, 2SD above the mean and 2SD below the mean of each experiment are indicated on top of 
every column. In addition to the accession number, the description of each protein hit, the number of 
unique peptides detected and their mean SILAC ratio, and the number of predicted transmembrane domains 
(TM) and signal peptides (SP) are listed.  
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 CHAPTER 4 - TgAMA1-TgRON2 INTERACTION AND ITS EFFECT ON 
PARASITE BIOLOGY 
4.1. Introduction 
4.1.1. AMA1 is secreted from micronemes and is important for parasite invasion 
Members of the phylum Apicomplexa have three unique sets of secretory 
organelles, the micronemes, rhoptries and dense granules, which play distinct roles 
during and after parasite invasion. Micronemes are located at the apical end of the 
parasite. Their contents are secreted constitutively at a basal level [1], and secretion 
increases during parasite interaction with the host cell [2]. Secretion can also be 
stimulated by increasing parasite intracellular calcium levels using calcium ionophores 
such as ionomycin and A23187 [3].  
Apical Membrane Antigen1 (AMA1) is a highly conserved type I transmembrane 
microneme protein which plays a role in parasite attachment during the initial steps of 
invasion into host cells ([4],[5] [6], [7], [8], [9], [10]). The link between AMA1 and 
invasion was first established when parasites pre-treated with AMA1 antibody were 
shown to be unable to invade ([5], [11]).  Parasites conditionally depleted of AMA1 also 
had a severe invasion defect [9]. However, T. gondii AMA1 (TgAMA1) was shown to be 
nonessential through the generation of a clean TgAMA1 knock-out line [12]. The 
TgAMA1 knockout parasites invaded to only ~20% of the level of wild-type parasites, but 
those that invaded did so with normal invasion kinetics. These parasites showed an 
attachment defect, resulting in the formation of fewer plaques. From these data, the 
authors concluded that TgAMA1 functions early in invasion but is not required for 
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parasite internalization [12]. However, it was subsequently shown that there is plasticity 
and redundancy between several different isoforms of AMA, with the AMA homologues 
AMA2 and AMA4 each able to functionally compensate to some extent for the loss of 
AMA1 [13]. Despite this functional redundancy, parasites lacking AMA1 are completely 
avirulent and elicit a protective immune response in infected mice [14]. These data 
highlight the importance of AMA1 in the parasite’s lytic cycle and confirm the emerging 
idea that parasites have redundant or compensatory mechanisms to survive in the absence 
of genes essential for survival [15].  
4.1.2. TgAMA1 binds TgRON2 and forms a complex at the moving junction 
 In the early stages of invasion, the tachyzoite progresses from a loose and distant 
attachment with the host cell membrane to a more intimate attachment in the form of the 
moving junction [11]. The parasite reorients so the apical secretory organelles can release 
their contents, aiding the invasion process [11]. The parasite is physically constricted as it 
passes through the moving junction between the two cells and into a parasite-derived 
parasitophorous vacuole [16]. The vacuole membrane ultimately pinches off from the 
host cell plasma membrane, surrounding the fully internalized parasite and completing 
invasion [17].  
Mass spectrometry-based analysis of TgAMA1 pulldowns revealed that AMA1 
complexes with rhoptry neck proteins, namely TgRON2 and TgRON4, and co-staining of 
invading parasites for TgAMA1 and TgRON4 revealed the co-localization of these two 
proteins at the moving junction [16]. Further studies revealed that RONs 2, 4, 5 and 8 
form a heterooligomeric complex with TgAMA1 at the moving junction ([18], [19], [20], 
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[21], [22], [23]). 
Interaction of AMA1 with RON2 is important for the parasite to form a moving 
junction and complete invasion [24]. Two independent studies showed that domain 3 
(D3) is the region of TgRON2 that interacts directly with TgAMA1 ([25], [26]). Co-
crystal structures of TgAMA1 bound to a D3-containing peptide from TgRON2 revealed 
that the D3 peptide inserts into a basic patch of TgAMA1 by displacing TgAMA1 
domain II ([27], [28]). Thus, the ectodomain of TgAMA1 binds to TgRON2, which in 
turn complexes with RONs 4, 5, and 8 at the moving-junction during invasion. The RON 
complex is inserted into the host cell, where it interacts with the host cytoskeleton. Thus, 
the parasite inserts its own receptor for AMA1 into the host cell [29]. 
4.1.3. AMA1 is cleaved by rhomboid proteases 
AMA1 on the parasite surface is cleaved within its transmembrane domain by 
rhomboid proteases. Inhibition of cleavage by mutation of residues within the 
transmembrane domain caused an invasion and growth defect [30]. The sites within the 
transmembrane domain required for cleavage were identified using an in-vitro cleavage 
assay, in which TgAMA1 expressed in COS cells was cleaved by co-expressed 
TgROM5. In parallel studies, Santos et al showed that parasites over-expressing 
TgROM4 had a replication defect that could be rescued by expressing the cytoplasmic 
tail of TgAMA1, leading to the suggestion that rhomboid-mediated cleavage of TgAMA1 
plays a role in regulating parasite replication [31]. However, our lab subsequently showed 
that parasites expressing non-cleavable TgAMA1 replicate normally [30], as do parasites 
lacking TgAMA1 entirely [12]. Taken together, these data show that TgAMA1 and 
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TgAMA1 intramembrane cleavage play a role in invasion but not parasite replication.   
Of the three rhomboid proteases expressed in tachyzoites, TgROM4 appears to be 
the major protease responsible for cleaving TgAMA1([32], [33]). Even in the absence of 
all three rhomboid proteases, there was residual cleavage of microneme protein TgMIC2 
indicating that the parasite may have other ways of cleaving surface adhesins. It was also 
shown that cleavage was important for initiation of invasion but not penetration into host 
cells [32]. In this study we wanted to establish the downstream effects of TgAMA1 
binding to TgRON2 and determine if this interaction can affect what proteins bind to the 
cytoplasmic tail of TgAMA1. Unexpectedly, we found that engagement of TgAMA1 
with TgRON2 inhibits rhomboid-mediated TgAMA1 cleavage. 
4.2. Results 
4.2.1. Treatment of parasites with the D3 peptide of TgRON2 reduces shedding of 
TgAMA1 from the parasite surface 
 Allelic replacement parasites expressing Flag-tagged TgAMA1 were treated 
with either GST or GST-D3 in constitutive microneme secretion assays. When parasites 
were treated with 5µM GST-D3, we observed on average a six-fold decrease in the 
amount of TgAMA1 ectodomain recovered in the assay supernatant (Figure 4.1.1and 
Figure 4.1.2, top panel). The effect was dose-dependent, with full inhibition of shedding 
at GST-D3 concentrations of 0.1 µM and higher, partial effects at 0.01 µM, and no effect 
at 0.001 µM or less (Figures 4.1.1 and 4.1.2). In contrast to the results with TgAMA1, 
GST-D3 caused no significant decrease in the amount of shedding of another microneme 
protein, TgMIC2, even at concentrations as high as 1 µM (Figures 4.1.1, 4.1.2, bottom 
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panel, 4.2.1 and 4.2.2). Similar results were observed when microneme secretion was 
induced with calcium ionophore: treatment of parasites with GST-D3 but not GST 
resulted in a decrease in TgAMA1 ectodomain shedding, with little or no effect on the 
shedding of TgMIC2 (Figure 4.3).  
 To confirm that the GST-D3 peptide was specifically associated with TgAMA1 
in these experiments, we treated parasites with either GST or GST-D3 and performed a 
GST pulldown as previously described [25]. TgAMA1 was recovered on the glutathione-
Sepharose beads when parasites were treated with GST-D3 but not GST (Figure 4.4).  
4.2.2. Treatment of parasites with GST-D3 inhibits the cleavage of TgAMA1, not its 
trafficking onto the parasite surface  
The reduced amount of TgAMA1ectodomain recovered in the assay supernatant 
after GST-D3 treatment could be due to either reduced trafficking of full-length 
TgAMA1 from the micronemes onto the parasite surface, or reduced cleavage of 
TgAMA1 once it reaches the surface. As a first step in discriminating between these 
possibilities, parasites were treated with either GST or GST-D3 and the amount of Flag-
tagged TgAMA1 ectodomain on the surface of the parasites was measured by flow 
cytometry. There was a significant increase in the amount of TgAMA1 on the parasite 
surface in GST-D3-treated parasites compared to parasites treated with GST alone 
(Figure 4.5.1) As a control, we also measured the amount GPI-anchored TgSAG1 on the 
parasite surface [32] and found it to be unaffected by GST-D3 treatment (Figure 4.5.2). 
As with the microneme secretion assay, the effect of GST-D3 on TgAMA1 in the flow 
cytometry assay showed a clear dose-dependence, with increased TgAMA1 surface 
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abundance in parasites treated with 0.01µM GST-D3 or higher and little to no effect 
below 0.001 µM GST-D3 (Figure. 4.6). 
TgAMA1 and TgMIC2 are secreted from a different subset of micronemes than 
TgMICs3, 8 and 11 [34]. TgMIC3 is a soluble protein that is escorted to the parasite 
surface via its interaction with the transmembrane protein TgMIC8 [35]. Cleavage of 
TgMIC8 was indirectly tested by staining the surface of parasites with anti-TgMIC3 
antibody after treatment with GST or GST-D3 and measuring surface fluorescence by 
flow cytometry. There was no significant difference in the amount of TgMIC3 on the 
surface of GST-D3-treated parasites compared to GST-treated parasites (Figure 4.7). 
To control for any artefactual effects of the GST fusion, we also tested the effect 
of His-tagged TgRON2-2 (a kind gift from Marty Boulanger) in microneme secretion 
assays. TgRON2-2 is a cysteine-dicyclized synthetic peptide that contains the TgAMA1-
binding residues within the TgRON2 D3 domain [27]. Like GST-D3, TgRON2-2 caused 
a dose-dependent decrease in the amount of TgAMA1 ectodomain shed into the assay 
supernatant, readily detectable by both western blotting (Figure 4.8.1 and 4.8.2) and flow 
cytometry (Figure 4.8.3 and 4.8.4). Maximal inhibition of TgAMA1 shedding was 
observed at TgRON2-2 concentrations of 0.1µM or higher, a slight decrease was 
observed at 0.01 - 0.001 µM, and no effect was seen at peptide concentrations below 
0.0001µM (Figure 4.8.4). TgRON2-2 concentrations as high as 2.5 µM had no effect on 
the shedding of TgMIC2 (Figure 4.8.1) or TgMIC8 (Figure 4.9). 
 Taken together, these data demonstrate that treatment of parasites with peptides 
derived from the TgAMA1-binding region of TgRON2 results in the reduced shedding of 
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the TgAMA1 ectodomain from the parasite surface. The effect is specific to TgAMA1; it 
is not observed for other microneme proteins (TgMIC2, TgMIC3 and TgMIC8) or the 
GPI-anchored protein, TgSAG1.  
4.2.3. Effect of GST-D3 binding on noncleavable and hypercleavable mutants of 
TgAMA1  
If pre-treating parasites with GST-D3 causes a trafficking defect, we would 
expect to find less TgAMA1 on the surface of wild-type parasites (Figure 4.10.1), but we 
in fact found more, suggesting that treatment with GST-D3 peptide inhibits cleavage 
rather than trafficking (Figure 4.5.1 and 4.10.2). To independently confirm this, we made 
use of parasites that contain both a tetracycline-repressible copy of wild-type TgAMA1 
and a second, Flag-tagged copy of TgAMA1 which is either wild-type (AMA1
WT
) or 
contains mutations within its transmembrane domain that render it resistant to cleavage 
by rhomboid proteases (AMA1
AG/FF+GG/FF
) or make it hypercleavable (AMA1
L/G
) [30]. 
In parasites expressing the non-cleavable form of TgAMA1 (Figure 4.10.3), we 
would expect significantly less TgAMA1 on the surface if GST-D3 reduces the 
trafficking of TgAMA1, but little or no difference in the amount of TgAMA1 on the 
surface if GST-D3 treatment inhibits cleavage (since cleavage is already low in these 
parasites; Figure 4.10.1). The latter scenario was what we observed experimentally with 
the non-cleavable AMA1
AG/FF+GG/FF
 parasites (Figure 4.10.2).  
If GST-D3 treatment inhibits cleavage rather than trafficking, we would also 
expect GST-D3 treatment to result in a decrease in TgAMA1 shedding even in the 
hypercleavable mutant (Figure 4.11.1) and a slight decrease in shedding was indeed 
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observed (Figures 4.11.2 and 4.11.4).   
Taken together, these data argue strongly that the binding of TgRON2 to 
TgAMA1 on the surface of the parasite reduces TgAMA1 intramembrane cleavage by 
rhomboid proteases. 
4.2.4. Parasites expressing hypercleavable TgAMA1 invade less efficiently  
 The interaction of TgAMA1 with members of the TgRON complex occurs at the 
moving junction of an invading parasite (reviewed in [36]). We hypothesize that 
interaction of TgAMA1 with TgRON2 at the moving junction inhibits cleavage of 
TgAMA1, which stabilizes the junction and forms an anchor for the parasite penetrating 
into the host cell. To test this hypothesis, live invasion assays were performed to compare 
the kinetics of invasion of AMA1
WT
 parasites to parasites expressing the AMA1
L/G
 
hypercleavable mutation. AMA1
WT 
parasites took an average of 16.1 seconds to 
internalize (range 10.33-24.34 sec), whereas the AMA1
L/G
 parasites took significantly 
longer, on average 20.7 seconds (range 13.04- 39.36 sec; Figure 4.12).  
 Taken together, these data suggest a model in which the binding of TgRON2 to 
TgAMA1 at the moving junction protects the TgAMA1 molecules that are actively 
engaged in host cell penetration from rhomboid-mediated cleavage, enabling efficient 
host cell invasion. 
4.2.5. Interaction of TgAMA1 with TgRON2 reduces phosphorylation on the tail of 
TgAMA1 at S527 
A phosphoproteomics analysis of T. gondii revealed two phosphorylation sites on 
the cytoplasmic tail of TgAMA1that are ten amino acids apart (S527 and S537). 
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Phosphorylation of S527 was detected with higher confidence than S537, and more often 
in extracellular than intracellular parasites [37]. We set out to test if the phosphorylation 
on the cytoplasmic tail of TgAMA1 changed when TgAMA1 interacted with TgRON2. 
We also wanted to determine if a change in TgAMA1 phosphorylation results in proteins 
binding differentially to the TgAMA1 cytoplasmic tail. To test if such outside-in 
signaling occurs, extracellular parasites were pretreated with either 5µM GST or GST-
D3, lysed and an anti-AMA1 antibody was used to pull down TgAMA1. The TgAMA1 
bands from a Coomassie stained SDS-PAGE gel were cut out, trypsin digested and 
analyzed by mass spectrometry (figures 4.13.1 and 4.13.2) (LC-MS/MS). Using unrelated 
tryptic peptides for normalization, phosphorylation of TgAMA1 on S527 was found in 
this semi-quantitative experiment to be reduced by 34% upon treatment with GST-D3 
compared to treatment with GST.   
A more quantitative, SILAC-based approach was then undertaken to confirm and 
quantify this reduction in S527 phosphorylation following treatment with GST-D3. 
Parasites labeled with heavy or light isotopes of arginine + lysine were treated with 5µM 
GST-D3 or GST, respectively. Anti-TgAMA1 pull-downs were done for each sample, 
and the eluted proteins resolved by SDS-PAGE and Coomassie stained. A doublet was 
observed at 75kDa, which is where FlagTgAMA1 usually runs on these SDS-PAGE gels. 
The upper and lower bands of the doublet from each of the samples (arrows, Figure 
4.14.1) were excised, digested with trypsin and analyzed by LC-MS/MS.  Upper bands 1 
and 3 were compared to each other and lower bands 2 and 4 were compared. In each 
case, the heavy/light (H/L) ratio of the pS527-containing peptide was measured relative 
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to the H/L ratio of all other TgAMA1 peptides recovered (Figure 4.14.2).  In both 
comparisons, the H/L ratio of the pS527-containing peptide was 60% lower than the 
mean H/L ratio of all the other TgAMA1 peptides. However, two errors were made in 
this experiment: 1) there were no phosphatase inhibitors in the lysis buffer and 2) the 
elutions from the pull-downs were run separately rather than mixing prior to SDS-PAGE. 
Although the data were normalized to other TgAMA1 peptides, mixing the samples prior 
to electrophoresis would have eliminated variations in how the bands were excised and/or 
the amount of polyacrylamide carried into the analysis.   
The same SILAC experiment was repeated, but this time with the addition of 
kinase and phosphatase inhibitors to the parasite lysate and mixing of the eluates from the 
two IPs in a 1:1 ratio prior to electrophoresis (Figure 4.15). Again, the H/L ratio of the 
pS527-containing peptide in each sample was compared to the H/L ratio of all TgAMA1 
peptides recovered in that sample. The analysis revealed a 34% reduction in S527 
phosphorylation following treatment with GST-D3. Taken together, these data suggest 
that when the TgAMA1 ectodomain interacts with TgRON2, it sends an outside-in signal 
that leads to dephosphorylation of S527 on the TgAMA1 cytoplasmic tail.   
4.2.6. The dynamics of phosphorylation on S527 may change the way TgAMA1 
interacts with other proteins  
To test if dephosphorylation on S527 changes interacting partners of the 
cytoplasmic tail of TgAMA1, the entire lane from the immunoprecipitation experiment 
above (Figure 4.15) was cut into 20 gel slices and prepared for LC-MS/MS. Potential 
binding proteins were identified using the cut off criteria described in Chapter 2.4.4, and 
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log2-transformed SILAC ratios from the experiment were plotted in Figure 4.16. 
TgAMA1 had an H/L ratio similar to TgRONs 2, 4, 5 and 8, which confirmed that the 
immunoprecipitation had worked and pulled down equal amounts of known interacting 
partners of TgAMA1. Hits with H/L ratios two standard deviations above the mean of the 
experiment are highlighted in red in Figure 4.16 and those that were 2 standard deviations 
below the mean are highlighted in green. The shortlisted hits were annotated as proteins 
involved in amino acid production, transcription, RNA binding and protein degradation. 
The relevance of these proteins to invasion is not obvious. One problem with the design 
of this experiment is that all the TgAMA1 in the cell is pulled down, including the subset 
that is bound to GST-D3, the subset that is on the surface but not bound to GST-D3 and 
all the remaining TgAMA1 in the micronemes. Thus, it might be difficult within this 
dataset to identify proteins specifically bound to TgAMA1 interacting with GST-D3.  
To address this limitation, heavy and light labeled parasites treated with GST-D3 
and GST, respectively, were lysed and a GST pull-down was preformed to enrich for 
TgAMA1 molecules interacting with GST-D3. The unbound fraction from the GST pull-
down was then used in an immunoprecipitation with anti-TgAMA1 antibody  to pull 
down the remaining TgAMA1 and its interacting partners. Elutions from each of the pull-
downs were mixed in a 1:1 volume, resolved by SDS-PAGE, and Coomassie stained. The 
entire lane was cut into 20 bands and processed for analysis by LC-MS/MS (experimental 
strategy summarized in Figure 4.17). 
We predicted that TgAMA1 would have the highest H/L ratio in the experiment 
(since it should be pulled down from the GST-D3 but not GST sample). However, 
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TgAMA1 had ratios similar to TgRONs 4, 5 and 8 (Figure 4.18), all approximately 1. 
Since GST-D3 is expected to compete for the interaction of TgAMA1 with TgRON2, we 
also predicted that no heavy TgRON2 would be recovered in the GST-IP and this is what 
we observed. Only a few hits had more than 3 unique peptides, which was one of our 
shortlisting criteria. Of all the hits, eukaryotic porin protein had the highest ratio with 3 
unique peptides identified (Figure 4.18). This protein is annotated as a voltage-dependent, 
anion-selective channel. In other systems, it is known to localize to the mitochondrial 
membranes. This hit is of potential interest as it was one of the highest hits in the SILAC 
mass spectrometry experiment comparing heavy labeled ARAMA1
S527A
 parasites to 
ARAMA1
WT
 parasites (Chapter 3.3.5.1). The fact that TgAMA1 was not the protein with 
the highest SILAC ratio could mean that: (a) the GST pull down was not completely 
successful in pulling down all the GST-D3-bound TgAMA1; (b) the actual amount of 
TgAMA1 bound to GST-D3 is small, below the limit of detection; (c) the GST beads 
need to be washed more thoroughly to reduce non-specific binding of proteins (including 
TgAMA1). 
The unbound fraction from the GST pull down was used in an 
immunoprecipitation with anti-TgAMA1 antibody and the log2 H/L SILAC ratios of the 
recovered proteins are plotted in Figure 4.19.  The H/L ratio of TgAMA1 was similar to 
members of the TgRON complex in this sample, as expected. However, there were no 
hits with more than 3 unique peptides 2 SD above or below the mean and for this reason 
hits 1 SD above the mean are also shown in Table 4.1. The ratios from all the other 
SILAC experiments described in Chapter 3 are also listed in Table 4.1 to identify 
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potentially interesting recurring hits. Hits 1 SD above the mean of the experiment with 
more than 3 unique peptides included: TgROP5, a predicted rhoptry kinase; myosinA, 
which forms a part of the parasite glideosome complex; and CDC48-CY, a cell division 
protein. 
As an independent approach to determining if phosphorylation of S527 influences 
proteins binding to the tail of TgAMA1, a SILAC quantitative mass spectrometry 
experiment comparing ARAMA1
S527A
 (heavy labeled ) to ARAMA1
S527D
 (light labeled) 
was performed. Before normalization, the H/L ratio of most of the proteins recovered 
(including TgAMA1) was approximately 1. The ratios were normalized to the mean of 
the experiment and log2 transformed (Figure 4.20).  Hits that had at least 3 unique 
peptides with a H/L ratio 2SD above (in red) or below (in green) the mean of all peptides 
in the experiment plus an H/L variability of less than 40% were shortlisted (Figure 4.20 
and Table 4.2). The protein with the highest ratio was catalase, which lacks any 
transmembrane domains and signal peptides, but has homologues in Eimeria, Neospora, 
Sarcocystis and Hammonida. Catalase catalyses the conversion of hydrogen peroxide into 
water and is involved in regulating ROS mediated stress responses [38]. Another protein 
with a high H/L ratio was annotated as a hypothetical protein with one transmembrane 
domain and one signal peptide and homologues in Eimeria, Plasmodium, Neospora, 
Sarcocystis and Hammonida. NTPases I & II had a low H/L ratio; these are highly 
abundant proteins in the parasite and play a role in parasite egress [39]. Most 
interestingly, three other microneme proteins that are known to form a protein complex 
(TgMIC1, MIC4 and MIC6; [35]) all had low H/L SILAC ratios.  Unfortunately, the few 
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hits with a high H/L SILAC ratio in this experiment did not have a correspondingly high 
ratio in the experiment comparing ARAMA1
S527A
 (H) and ARAMA1
WT
 (L) parasites 
(Table 4.2 and Section 3.3.5.1). Conversely, hits with a low H/L ratio from this 
experiment did not have a high ratio in experiments comparing ARAMA1
S527D
 (H) to 
ARAMA1
WT 
(L) (Table 4.2 and Section 3.3.5.2). To confirm that any of these 
interactions are real, this experiment must be repeated at least two more times including a 
replicate where the heavy and light labels are reversed.  
4.2.7. GST-D3-reduced secretion of TgAMA1 is independent of the phosphorylation 
state of S527  
Treatment of parasites with GST-D3 reduces TgAMA1 intramembrane cleavage 
(Figure 4.1.1).  Pre-treating parasites with GST-D3 also reduces phosphorylation of S527 
on the cytoplasmic tail of TgAMA1. To test if the phosphorylation state of TgAMA1 
affects its cleavage, ARAMA1
WT
, ARAMA1
S527A
 and ARAMA1
S527D
 parasites were 
compared in a microneme secretion assay. There were no significant differences in 
constitutive secretion of TgAMA1 in ARAMA1
S527A
 or ARAMA1
 S527D
 parasites 
compared to ARAMA1
WT
 parasites (Figure 4.21). Next, microneme secretion assays 
were performed comparing ARAMA1
WT
 parasites to ARAMA1
S527D
 and ARAMA1
S527A
 
parasites treated with either 1µM GST or 1µM GST-D3 (Figure 4.22).  All three parasite 
lines showed a similar, dramatic decrease in secretion of TgAMA1 but not TgMIC2 upon 
treatment with GST-D3. Thus, the effect of GST-D3 on the secretion of TgAMA1 is 
independent of S527 phosphorylation. 
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4.3. Discussion 
In this study we show that treating parasites with the D3 domain of TgRON2 
reduces shedding of the TgAMA1 ectodomain but not that of TgMIC2, TgMIC3 or 
TgMIC8. As little as 0.1μM of the GST-D3 peptide was sufficient to cause this effect. 
We confirmed that GST-D3 interacts with TgAMA1 and we showed that a similar effect 
is observed using a synthetic cyclic peptide encompassing the TgAMA1-binding domain 
of TgRON2. Using flow cytometry and parasites expressing either wild type TgAMA1, 
non-cleavable TgAMA1 or hypercleavable TgAMA1, we showed that GST-D3 treatment 
inhibits intramembrane cleavage of TgAMA1, not its trafficking to the parasite surface. It 
is unlikely that this effect is mediated through general inhibition of the rhomboid 
proteases, since peptide treatment did not change processing of TgMIC2 and TgMIC8, 
which are thought to be cleaved by the same proteases [32]. It is known that interaction 
of TgRON2 with TgAMA1 induces conformational changes in TgAMA1 [27]; perhaps 
these conformational changes alter TgAMA1’s susceptibility to cleavage by rhomboid 
proteases. TgROM4 is the major protease involved in cleaving microneme proteins, but 
TgAMA1 is also cleaved to a lesser extent by TgROM5 ([32], [33]). It is not currently 
known if TgRON2 binding inhibits cleavage of TgAMA1 by TgROM4, TgROM5 or 
both. 
In addition to reducing the cleavage of TgAMA1, TgRON2-TgAMA1 interaction 
also reduced the phosphorylation of S527 on the cytoplasmic tail of TgAMA1. To test if 
this reduction in phosphorylation translated into changes in proteins that interact with the 
cytoplasmic tail, we turned to quantitative SILAC mass spectrometry. Comparing labeled 
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parasites pre-treated either with GST-D3 or GST proved uninformative, probably because 
a total TgAMA1 pull-down was performed following parasite treatment and the subset of 
TgAMA1 molecules interacting with the GST-D3 peptide was likely small compared to 
the total TgAMA1 pool. It would also be hard to capture any transient or weak 
interactions by these methods.  In order to capture the subset of TgAMA1 molecules 
interacting with GST-D3, a GST pull-down was attempted; however, the yield of proteins 
recovered was not high enough to come to any definitive conclusions.  
As an alternative way to identify proteins whose interaction with AMA1 is 
affected by S527 phosphorylation, we used SILAC mass spectrometry to compare 
proteins binding to TgAMA1 in the S527 phosphomimetic mutant, ARAMA1
S527D 
vs. the 
S527 non-phosphorylatable mutant, ARAMA1
S527A
.  This experiment was only 
performed once and must be repeated to confirm the significance of the hits. Cross-
comparison of hits from all SILAC experiments involving phosphorylation mutants did 
not highlight any particularly promising new TgAMA1 interacting partners. 
Parasites expressing the S527 non-phosphorylatable and phosphomimetic 
versions of TgAMA1 secreted similar levels of TgAMA1 compared to the wild-type 
parasites and all three lines were similarly affected by treatment with GST-D3. The 
reduced cleavage of TgAMA1 upon binding to TgRON2 therefore appears to be 
independent of the phosphorylation state of S527. Nevertheless, the phosphomimetic 
mutant of TgAMA1 shows a 30% reduction in invasion and the kinetics of invasion are 
slower in hyper-cleavable TgAMA1 mutants suggesting that both phosphorylation and 
ligand-mediated regulation of TgAMA1 intramembrane cleavage play a role in 
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optimizing host cell invasion efficiency by T. gondii. 
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Figure 4.1: Treatment of parasites with GST-D3 peptide reduces the shedding of TgAMA1 
but not TgMIC2 
 
  (4.1.1.) Western blot of microneme secretion assay using ARAMA1
WT
 parasites treated with 5μM GST-
D3 or GST and probed with anti-TgMIC2, anti-Flag (TgAMA1) and anti-TgMLC1. P = Pellet, S = 
Supernatant. Image is representative of 3 biological replicates. (4.1.2.) Signal intensity ratio of ectodomain 
in the supernatant /full length protein in the pellet (normalized to TgMLC1) from three independent 
microneme secretion assays were plotted for TgAMA1 (top panel) and TgMIC2 (bottom panel). Paired 
signal intensity values from each biological replicate were plotted using the same color. A paired one tailed 
t-test revealed a significant decrease in secreted TgAMA1 in parasites treated with GST-D3 (p=0.0295) 
with no corresponding significant decrease in the secretion of TgMIC2. Black arrows indicate full 
lengthTgAMA1 and TgMIC2 and red arrows indicate the corresponding shed ectodomains. 
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Figure 4.2: Titration of GST-D3 peptide in a microneme secretion assay 
 
(4.2.1)  Western blot of microneme secretion assay using ARAMA1
WT
 parasites treated with 1μM GST and 
five serial dilutions of GST-D3 peptide ranging from 1μM to 0.0001μM. P represents the pellet fraction and 
S the supernatant, probed with anti-TgMIC2, anti-Flag (TgAMA1) and anti-TgMLC1. GST-D3 caused a 
dose-dependent decrease in the amount of TgAMA1 (but not TgMIC2) ectodomain released into the assay 
supernatant. (4.2.2)  Quantification of the western blot in Figure 4.2.1. The pellet sample loaded was from 
half the number of parasites as the supernatant the supernatant. Therefore, after normalizing the pellet 
signals to the corresponding TgMLC1 signal, the pellet signal intensity was doubled. Signal intensity ratio 
of shed ectodomain in the supernatant /full length protein in the pellet (after normalizing to TgMLC1 and 
correcting for parasite equivalents loaded) was plotted for TgAMA1 (black bars) and TgMIC2 (gray bars). 
 
 
 
 
  
122 
 
Figure 4.3: GST-D3 reduces secretion of TgAMA1 even in the presence of ionomycin 
 
Microneme secretion was induced in ARAMA1
WT
 parasites for 5 minutes at 37°C with or without 1μM 
ionomycin in addition to treatment with either GST or GST-D3. Western blot was performed on the pellet 
(left) and supernatant (right) fractions with antibodies to TgMIC2, TgAMA1 and TgMLC1. A 30 minute 
constitutive secretion assay (no ionomycin treatment) was performed in parallel. Reduction in secretion 
was in all cases only observed for TgAMA1 in parasites treated with GST-D3. 
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Figure 4.4: GST-D3 but not GST interacts with TgAMA1 and reduces secretion of TgAMA1 
 
An immunoprecipitation was performed with GST beads after parasites were treated with either GST or 
GST-D3. Equivalent amounts of input fractions, unbound fractions and a 10-fold excess of elution fractions 
were probed for TgAMA1 and GST. TgAMA1 eluted only in GST-D3 treated parasites but not with GST- 
treated parasites. A microneme secretion assay was performed on the same day to show that GST-D3 
reduces secretion of TgAMA1 by 6.15 fold, while there was no change in the secretion of TgMIC2 upon 
GST-D3 treatment. TgMLC1 was used as a loading control to normalize the pellet fractions. * indicates full 
length protein and # indicates shed ectodomain of the microneme proteins, TgMIC2 and TgAMA1. P= 
pellet and S= supernatant.  
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Figure 4.5: GST-D3 treatment increases the amount of TgAMA1 but not TgSAG1 on the 
surface of parasites 
 
Left: Unstained ARAMA1
WT
 parasites and parasites stained with primary antibody alone were used as 
controls (indicated in black and grey) to gate the channels for stained parasites. Parasites treated with GST 
are indicated in purple and parasites treated with GST-D3 are represented in orange. Right: median 
fluorescence intensity for each treatment from 5 independent biological replicates. Paired median intensity 
values from each biological replicate were plotted using the same color; bars represent median with range. 
A parametric two tailed t-test with Mann Whitney test was used as a test for significance. GST-D3 causes a 
significant accumulation of TgAMA1 (p=0.0159) on the parasite surface (4.5.1, right panel) which can be 
seen as a rightward peak shift in orange in the histogram (4.5.1, left panel). A similar peak shift is not 
observed for TgSAG1 (p=0.6667) (4.5.2 left panel).  
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Figure 4.6: Titration of GST-D3 treatment by flow cytometry 
 
(4.6.1) ARAMA1
WT
 parasites were incubated in DMEM with 1% FBS and 10mM HEPES with 0.0001μM 
-1μM of GST-D3 (orange) or 1μM GST peptide (purple) and the amount of TgAMA1 on the parasite 
surface determined by flow cytometry. Scatter plots of parasites treated with each concentration of GST-D3 
were superimposed over the scatter plot from GST-treated parasites. The x-axis plots the AF 488–GST 
fluorescence using the B1 channel and the y-axis plots the AF 546-Flag TgAMA1 fluorescence using the 
Y1 channel. (4.6.2) Percentage of parasites that were Flag and GST positive relative to the total number of 
parasites.  
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Figure 4.7: Treatment of parasites with GST-D3 does not cause a significant increase in the 
amount of TgMIC3 on the parasite surface 
 
(4.7.1) Median fluorescence intensity of anti-TgMIC3-stained ARAMA1
WT
 parasites treated with either 
1µM GST-D3 (in orange) or 1µM GST (in purple) is shown in the histogram. There was no shift in the 
orange peak compared to the purple peak indicating that D3 treatment did not increase the amount of 
TgMIC3 on the surface of the parasites. Unstained parasites and parasites with primary antibody alone are 
shown in black and grey respectively. (4.7.2) The graph plots median fluorescence intensity from 3 
independent biological replicates with values from each replicate indicated with matching colors. A non-
parametric two tailed t-test was performed to test if the differences in fluorescence between the two 
treatments were significantly different. The comparison was non-significant with p=0.4.Plot represents 
median with range.  
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Figure 4.8: Parasites treated with TgRON2-2 also show reduced secretion of TgAMA1 but 
not TgMIC2 
 
 (4.8.1) Western blot from microneme secretion assay comparing untreated ARAMA1
WT
 parasites (control) 
to parasites treated with 2.5μM TgRON2-2. TgMLC1 was used as loading control. Black arrowheads 
indicate full length protein and red arrowheads indicate shed ectodomain. (4.8.2) Quantification of signal 
intensity of shed ectodomain/full length TgAMA1 in the pellet (normalized to TgMLC1) from three 
biological replicates (each represented by a different color) indicates a significant reduction in secretion of 
TgAMA1 in parasites treated with 2.5μM TgRON2-2 compared to control. p=0.0070 calculated using 
paired one tailed t-test. Bars represent median with range. (4.8.3) Titration of the effect of TgRON2-2 in a 
microneme secretion assay. Blots were probed for TgAMA1 (anti-Flag) and TgMIC2 in addition to 
TgMLC1 which was used as a loading control. (4.8.4) Signal intensity ratio of shed ectodomain/full length 
TgAMA1 in the pellet (normalized to TgMLC1) for both TgAMA1 (black) and TgMIC2 (gray). 
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Figure 4.9: TgRON2-2 treatment of parasites does not cause a decrease in secretion of 
TgMIC8 
 
(4.9.1) Western blot from a microneme secretion assay comparing ARAMA1
WT
 parasites treated with 
2.5µM TgRON2-2 to untreated parasites (control). * indicates full length protein in the supernatant due to 
parasite lysis. TgMLC1 was used as a loading control. (4.9.2) Quantification of signal intensity from 
biological n=3. Signal intensity ratio of ectodomain in the supernatant to full length TgMIC8 in the pellet 
(normalized to TgMLC1) is shown. Matching colors indicate paired signal intensity values from each 
biological replicate. A paired parametric one tailed t-test was performed and p=0.2437 indicated no 
significant change in the secretion of TgMIC8 upon treatment with TgRON2-2. Bars indicate mean with 
SEM. 
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Figure 4.10: GST-D3 causes reduced cleavage of TgAMA1 but not reduced trafficking to the parasite 
surface 
(4.10.1) Schematic representing the two sets of possible outcomes from treatment of parasites with GST-
D3. If GST-D3 reduces cleavage of TgAMA1, then there would be more surface TgAMA1 (red spikes) on 
AMA1
WT
 parasites after GST-D3 treatment compared to GST treatment. There would likely be no 
difference in surface TgAMA1 in GST- vs. GST-D3-treated parasites expressing non-cleavable TgAMA1 
(AMA1
AG/FF+GG/FF
). On the other hand, if GST-D3 affects trafficking of TgAMA1 to the parasite surface, 
we would expect less TgAMA1 on the surface of both AMA1
WT
 and AMA1
AG/FF+GG/FF
. parasites following 
treatment with GST-D3. (4.10.2) Flow cytometry showed that GST-D3 caused a significant increase in 
surface TgAMA1 in AMA1
WT
 parasites (top panel; p=0.0159). Representative histogram on the left panel 
shows the shift in median fluorescence intensity (MFI) of surface TgAMA1 in parasites treated with GST-
D3 (orange) compared to GST (purple). This GST-D3-induced shift in MFI was not observed in parasites 
expressing non-cleavable AMA1
AG/FF+GG/FF
 (bottom panel; p=0.6571). Data from 5 biological replicates 
using each parasite line are shown. The graph plots median with range. Significance was determined using 
a non-parametric two tailed t-test. The Y1A channel was used to gate the parasites stained with anti-Flag 
(TgAMA1) followed by AF546 secondary antibody. (4.10.3) A microneme secretion assay was performed 
using conditional AMA1
WT
 and AMA1
AG/FF+GG/FF
 parasites treated with either GST or GST-D3. The 
decrease in secretion of TgAMA1 was evident in AMA1
WT
 parasites but not in the parasites expressing 
non-cleavable TgAMA1
AG/FF+GG/FF
. * indicates full length protein in the supernatant due to parasite lysis. 
The number of parasite equivalents loaded from the pellet fraction (P) was half that of the supernatant 
fraction (S) in this experiment. TgMLC1 was used as a control for lysis and loading. 
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Figure 4.11: Treatment of parasites expressing hyper-cleavable TgAMA1 with GST-D3 
caused a significant reduction in shedding of TgAMA1 
 
(4.11.1) Schematic comparing the two sets of possible effects of GST-D3 treatment on AMA1
WT
 and 
AMA1
L/G 
parasites. (4.11.2) Western blot from a microneme secretion assay using AMA1
WT
 parasites and 
AMA1
L/G 
parasites treated either with GST or GST-D3. * indicates full length protein in the supernatant 
due to parasite lysis. The number of parasite equivalents loaded from the pellet fraction (P) was half that of 
the supernatant fraction (S) in this experiment. TgMLC1 was used as a control for lysis and loading. 
(4.11.3)  Quantification of the microneme secretion assay shown in 4.11.2. The signal intensity ratio of 
TgAMA1 ectodomain in the supernatant to full length protein in the pellet (normalized to TgMLC1) is 
shown. Matching colors indicate paired signal intensity values from five biological replicates. Error bars 
represent mean with SEM. GST-D3 treatment reduced secretion of TgAMA1 with p=0.0006, calculated 
using a paired one tailed t-test. (4.11.4) GST-D3 reduced secretion of TgAMA1 in AMA1
L/G 
with 
p=0.0249.  
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Figure 4.12:  Parasites expressing hyper-cleavable AMA1
L/G
 showed a significant delay in 
invasion compared to parasites expressing AMA1
WT
  
 
Live synchronized invasion assays were performed and the duration for penetration into host cells was 
measured in seconds. A two-tailed unpaired t-test with Welch’s correlation revealed a significant difference 
in invasion kinetics of parasites expressing hyper-cleavable TgAMA1 compared to parasites expressing 
wild type TgAMA1 (p<0.0001). Bars represent mean with SEM.
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Figure 4.13: Semiquantitative analysis shows that treatment of parasites with GST-D3 
reduced phosphorylation on TgAMA1 S527 by 34% 
 
(4.13.1) An immunoprecipitation with anti-TgAMA1 antibody was performed following treatment of 
parasites with 5µM GST-D3 or GST. The TgAMA1 bands (boxed) were cut from a Coomassie-stained 
SDS-PAGE gel, subjected to trypsin digestion and analyzed by LC-MS/MS. (4.13.2) The amino acid 
sequences of the five most readily identifiable tryptic peptides and the phosphorylated S527-containing 
tryptic peptide from both the untreated and GST-D3-peptide-treated samples were confirmed by MS
2
. (a) 
Representative reference peptide, unnormalized. Red = untreated; blue = GST-D3 treated. Numbers 
indicate relative abundance, based on integrated areas of extracted precursor ions. (b) Phosphorylated S527-
containing peptide, normalized to the average relative abundance of the five reference peptides. GST-D3 
treatment decreases the relative abundance of this peptide (compared to untreated) by 34%.  Reference 
peptide (panel a): KSVTENHHLIYGSAYVGENPDAFISK; Charge +3, Monoisotopic m/z 959.480 
(+0.89mmu/+0.93ppm). S527-containing peptide (panel b): GVQAAHHEHEFQpSDR; Charge +3, 
Monoisotopic m/z 609.924 (+0.34mmu/+0.56ppm). 
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Figure 4.14: Quantitative SILAC analysis shows a 60% reduction in the pS527-containing 
peptide relative to the other TgAMA1 peptides in parasites treated with 5μM GST-D3 
 
(4.14.1) The upper and lower bands of the TgAMA1 doublet from “heavy” labeled GST-D3-treated 
parasites are indicated as (1) and (2), respectively. The corresponding TgAMA1 doublet bands from “light” 
labeled GST-treated parasites are indicated as (3) and (4). (4.14.2) The H/L SILAC ratios were obtained by 
comparing bands (1) vs. (3) and (2) vs. (4). The average H/L ratios of all the TgAMA1 peptides recovered 
were 0.659 and 0.363 in the two samples, as indicated. The ratios of the phosphorylated S527-containing 
peptide in the two samples were 0.259 and 0.144, each 60% less than the corresponding average ratio. This 
experiment was performed in the absence of phosphatase inhibitors.  
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Figure 4.15: SILAC analysis shows that GST-D3 treatment of parasites resulted in a 34% 
reduction of phosphorylation on S527 of TgAMA1 
 
Mean H/L SILAC ratios of all TgAMA1 peptides compared to the ratio of the p527-containing peptide. 
The mean of other peptides was 34% higher than the ratio of p527-containing peptide.  The 
immunoprecipitation was done in the presence of kinase and phosphatase inhibitors and the eluates from 
the IPs were mixed 1:1 prior to SDS-PAGE.  
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4.16: Hits from the SILAC experiment comparing GST-D3-treated parasites (H) to GST-
treated parasites (L) 
 
Log2 transformed SILAC ratios were normalized to the mean ratio of all peptides recovered in the 
experiment. Hits that were 2 standard deviations above the mean (red) or 2 SD below the mean (green) are 
indicated along with the number of unique peptides identified and the H/L ratio. TgAMA1 itself and known 
interacting partners of TgAMA1 such as TgRONs 2, 4, 5 and 8 are also highlighted.  The table below lists 
the hits along with their annotated functions.  
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Figure 4.17: Redesigned experimental flow to isolate the subset of TgAMA1 molecules 
interacting with GST-D3 from total TgAMA1 
 
Heavy-labeled ARAMA1
WT
 parasites pre-treated with GST-D3 and light-labeled ARAMA1
WT
 parasites 
pre-treated with GST were used in a pull-down with GST beads in an attempt to isolate and identify the 
subset of TgAMA1 interacting specifically with GST-D3. The unbound fraction from the first pull-down 
was then used as input for a TgAMA1 immunoprecipitation, to isolate/identify all the TgAMA1 that did not 
interact with GST-D3.  
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Figure 4.18:  Proteins recovered in the GST IP after treatment with GST-D3 (H) or GST (L) 
 
See Figure 4.17 for experimental design. Hits 2SD above the mean (in red) and hits 2SD below the mean 
(in green) are indicated with number of unique peptides identified and the H/L SILAC ratio. The table 
below compares the H/L ratios of the hits from this experiment to other SILAC experiments described in 
Chapter 3, in which parasites expressing wild-type TgAMA1 were compared to parasites with mutations in 
the tail of TgAMA1.  
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Figure 4.19: Proteins recovered in the anti-TgAMA1 IP following the GST pull-down 
 
See Figure 4.17 for experimental design. Members of the RON complex had H/L ratios similar to 
TgAMA1. No peptides with ratios 2SD or more above or below the mean H/L ratio for the experiment 
were identified.  
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Figure 4.20: SILAC comparison of proteins pulled down with TgAMA1 in ARAMA1
S527A 
(H) 
vs. ARAMA1
S527D 
(L) parasites 
Hits 2SD above (red) or below the mean (green) ratio of all peptides are indicated, with number of unique 
peptides identified and their H/L ratios. All ratios were normalized to the mean of the experiment and log2 
transformed. 
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4.21: ARAMA1
S527A
 and ARAMA1
S527D 
parasites secrete similar amounts of TgAMA1 and 
TgMIC2 ectodomain compared to the ARAMA1
WT
 parasites 
 
The image shown is representative of three biological replicates. The signal intensity of shed TgAMA1 
ectodomain/full length protein in the pellet (normalized to TgMLC1) is shown in the bottom panel. A one 
tailed t-test was used to test for significance. Secretion of TgAMA1 in ARAMA1
WT
 and ARAMA1
S527A
 
parasites were similar with p=0.4205 and a comparison of ARAMA1
WT
 parasites to ARAMA1
S527D
 
parasites also showed no significant difference (p=0.2320). Bars indicate mean with SEM.  
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Figure 4.22: GST-D3 reduces secretion of TgAMA1 but not TgMIC2 in both ARAMA1
S527A
 
and ARAMA1
S527D
 parasites 
Microneme secretion assay and western blot of ARAMA1
S527A
 and ARAMA1
S527D  
parasites after treatment 
with GST or GST-D3. As a control, ARAMA1
WT 
parasites were treated with GST. The number of parasite 
equivalents loaded from the pellet fraction (P) was half that of the supernatant fraction (S) in this 
experiment. A reduction in TgAMA1 (but not TgMIC2) secretion was observed in both mutant parasite 
lines.
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Table 4.1: A comparison of the hits from the anti-TgAMA1 IP from GST or GST-D3-treated 
parasites (Figure 4.19) to those from all the other SILAC experiments described in Chapter 3 
 
The number of transmembrane domains (TM) and signal peptides (SP) for each hit is indicated along with 
the SILAC H/L ratios and total number of unique peptides identified in each experiment. Hits that were 
2SD above the mean of the experiment are highlighted in dark red, those that were 1SD above the mean in 
light red and those that were 2SD below the mean highlighted in dark green.  
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Table 4.2:  Shortlisted hits from the experiment comparing ARAMA1
S527A 
(H) to 
ARAMA1
S527D 
(L) 
 
TgAMA1 had a H/L SILAC ratio close to that of members of the RON complex. There were two hits that 
were 2SD above the mean of the experiment (in red) and six hits 2SD below the mean of the experiment (in 
green). SILAC ratios from other experiments described in Chapter 3 are included for comparison.  
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CHAPTER 5 - TgAMA1 PALMITOYLATION 
5.1. Introduction 
5.1.1. Protein acylation and palmitoylation 
 Attachment of fatty acids onto proteins is termed acylation. There are multiple 
ways a protein can be acylated, including N-myristoylation, N-palmitoylation and S-
palmitoylation. N-myristoylation involves a stable covalent attachment of a 14 carbon 
saturated fatty acid, myristate, to an N-terminal glycine residue [1]. This irreversible 
modification is either co-translational or post-translational and is involved in protein-
protein interaction or protein-lipid interaction [2]. The attachment of palmitate on a 
cysteine residue is called palmitoylation. When the 16 carbon saturated palmitate is 
attached covalently and reversibly to cysteine via a thio-ester linkage, it is called S-
palmitoylation. When the palmitate is added to an N-terminal cysteine through a stable 
amide linkage, it is called N-palmitoylation (Figure 5.1) [3]. Palmitoylation of a 
membrane protein increases its hydrophobicity and membrane association. 
Palmitoylation, like many other post-translational modifications, is dynamic and plays a 
role in subcellular trafficking of proteins, protein-protein interaction, protein stability and 
even transcriptional regulation ([4], [1], [5], [6]). In addition to S- and N-palmitoylation, 
O-palmitoylation occurs when the palmitate is attached to the hydroxyl group of serine 
residues; this modification in histones was shown to regulate gene transcription [7]. 
Protein-acyl transferases (PATs) catalyze the enzymatic addition of palmitate to 
cysteines and palmitoylthioesterases catalyze its removal. There are 2 classes of PATs: 
PATs that contain a DHHC domain (Asp-His-His-Cys) and transfer palmitate to 
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intracellular proteins, and membrane bound O-acyl transferases (MBOAT) that transfer 
palmitate to secreted proteins. There are 2 classes of palmitoylthioesterases, namely 
protein palmitoylthioesterases (PPT1, PPT2) and acyl protein thioesterases (APT1, 
APT2) [8]. 
5.1.2. Palmitoylation in members of phylum Apicomplexa 
 Over 400 proteins were found to be palmitoylated in the asexual schizont stage 
of Plasmodium falciparum by quantitative mass spectrometry [9]. These included 
proteins involved in invasion such as members of the motor complex (PfGAP45, 
PfMTIP), signaling proteins (PfCDPK1), structural proteins (PfALV4, 5), proteases 
(ROM4), and membrane-anchoring proteins (PfGAPM2, 3). Several other proteins 
involved in secretion and transport, membrane channels, chaperones, kinases and 
phosphatases were also identified. Expression of each of the 12 PATs is regulated in a 
stage-specific manner. An MBOAT family homologue was also identified in P. 
falciparum was and shown to be important for replication in the intra-erythrocytic stage 
of the parasite [10]. The exact number of APTs and PPTs in P. falciparum is unclear but 
there are several other proteins that have been found to have the alpha/beta hydrolase fold 
which is characteristic of palmitoylthioesterases [11]. Thus, palmitoylation likely plays 
an important role in the lifecycle of Plasmodium, across several stages.  
 Evidence of palmitoylation and its role in regulating protein targeting in T. 
gondii came from studies involving TgPKG, TgGAP45, TgISP1-3, and Hsp20  ([12], 
[13], [14], [15]). Several proteins involved in invasion such as TgAMA1, TgRON4, 
TgROP2, TgMIC2, 3, 4, 7 and TgMLC1 were also predicted to be palmitoylated. There 
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are 17 predicted DHHC-PATs homologous to human PATs in the T. gondii genome [16]. 
Further evidence for a role for palmitoylation in parasite biology came from a study 
where parasites were treated with 2-bromopalmitate (2-BP). 2-BP is an analogue of 
palmitic acid that prevents amino acid palmitoylation. Parasites treated with 2-BP showed 
reduced levels of invasion, altered motility and changes in parasite shape and 
morphology [16]. Similar effects on invasion and morphology were seen in intra-
erythrocytic stages of P. falciparum parasites treated with 2-BP [9]. Sixteen putative 
DHHC-PATs were shown to be expressed in tachyzoites [17]. One of the four predicted 
PPTs, TgPPT1, was confirmed to have thioesterase activity ([18], [19]). When TgPPT1 
was inhibited by a small molecule JCP174, parasites showed increased invasion, motility 
and microneme secretion [19]. Thus, T. gondii, like P. falciparum, has the machinery to 
palmitoylate proteins and palmitoylation may play an important role in regulating 
parasite motility, microneme secretion, invasion and morphology.  
 A proteomics-based approach using 17-octadecyonic acid (17-ODYA) labeling 
and immunoprecipitation identified 312 palmitoylated membrane proteins in T. gondii, 
including proteins involved in every aspect of the parasite’s lytic cycle.  The 17-ODYA 
bound to the labeled proteins could also be clicked to an azido-rhodamine fluorophore for 
detection by SDS-PAGE, and this reaction was reversible upon addition of 
hydroxylamine for bona fide S-palmitoylated proteins [20]. The same study compared the 
palmitome of Toxoplasma and Plasmodium and identified differences in palmitoylation 
of homologous proteins. AMA1 was among the proteins found to be palmitoylated in 
Toxoplasma but not in Plasmodium; other proteins were palmitoylated in both parasites.  
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5.2. Results 
5.2.1. TgAMA1 palmitoylation 
ARAMA1
WT 
parasites with a Flag-tagged copy of wild-type TgAMA1 were 
labeled with 17-ODYA and immunoprecipitated with anti-Flag sepharose beads. 
TgAMA1 was found to be 17-ODYA labeled, and labeling was reversed upon addition of 
hydroxylamine (Figure 5.2) [20], confirming that AMA1 is palmitoylated in T. gondii. 
5.2.2. Generation of allelic replacement parasites with the TgAMA1 C504S mutation  
TgAMA1 contains 16 highly conserved cysteines that form disulfide bonds and, 
because they are on the ectodomain of the protein, these would be unlikely sites for 
palmitoylation. The signal peptide also contains a cysteine residue, but this would be 
absent from the mature protein. The only other cysteine in TgAMA1 is Cys504, which is 
found within the predicted transmembrane domain, close to the cytosolic face of the 
membrane. Based on these considerations, we hypothesized that Cys504 was the most 
plausible site for palmitoylation [21,22].   
Amino acid substitutions are a useful tool to understand the function of individual 
residues in a protein of interest. The substitution should ideally not disrupt the protein 
folding or the way in which it interacts with other neighboring residues. It is therefore 
very important to choose an amino acid with the most similar size and charge for 
substitutions. The substitution of cysteine at position 504 on TgAMA1 with serine was 
tested for safe substitution using the online program Provean 
(http://provean.jcvi.org/index.php), a tool that predicts the biological impact of amino 
acid substitutions as either neutral or deleterious [23]. The program categorized both 
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C504S and C504A substitutions as safe and neutral but we chose to substitute cysteine to 
serine because of similarity in size and because studies in many other systems have used 
this substitution ([24], [25], [26]). 
ARAMA1
C504S
 parasites were generated using our standard allelic replacement 
vector (Figure 3.2) mutagenized by the around the horn mutagenesis. Parasites were 
transfected, selected twice with phleomycin and cloned by limiting dilution. Diagnostic 
PCR and sequencing of genomic DNA were used to confirm the presence of the mutation 
in the correct locus (Figures 5.3.1, 5.3.2 and data not shown). The mutant clones were 
also checked for similar levels of Flag TgAMA1 C504S expression compared to the 
ARAMA1
WT
 parasites, as shown in Figure 5.3.3.  
5.2.3. C504 is necessary for and likely the site of palmitoylation on TgAMA1 
 Both ARAMA1
WT
 and ARAMA1
C504S
 parasites were metabolically labeled with 
17-ODYA and labeled proteins were clicked to an azido-rhodamine fluorophore. A Flag 
IP followed by scanning for rhodamine fluorescence revealed that fluorescence was 
observed in ARAMA1
WT
 parasites but not in ARAMA1
C504S
 parasites (Figure 5.4). This 
suggested that C504 was likely the major and likely the only site for palmitoylation on 
TgAMA1. 
5.2.4. Non-palmitoylatable TgAMA1 localizes normally to the apical end of the 
parasites 
 Palmitoylation in other systems has been shown to regulate localization of 
proteins [27]. In order to test if TgAMA1 with the C504S mutation had altered 
localization, we performed IFA with intracellular ARAMA1
WT
 and ARAMA1
C504S
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parasites (Figure 5.5). The mutation did not alter the apical localization of TgAMA1 
suggesting that palmitoylation of TgAMA1 does not regulate its localization. This is 
consistent with previous observations that the ectodomain of TgAMA1, and not its 
transmembrane domain or C-terminal domain, is necessary for TgAMA1 localization in 
parasites [28].  
5.2.5. ARAMA1
C504S 
parasites secrete more microneme proteins than ARAMA1
WT
 
parasites 
 Microneme secretion assays revealed that ARAMA1
C504S
 parasites secreted 
more TgAMA1 and TgMIC2 over a 30 minute assay than ARAMA1
WT 
parasites (Figure 
5.6). This effect was unique to microneme proteins, as it was not observed with either 
rhoptry or dense granule proteins [20]. These data suggest that palmitoylation of 
TgAMA1 plays a previously unrecognized role in regulating microneme secretion. 
5.2.6. ARAMA1
C504S 
parasites form fewer plaques than ARAMA1
WT
 parasites 
 Data from 11 biological replicates revealed that ARAMA1
C504S 
parasites form 
~30% fewer plaques than ARAMA1
WT
 parasites in standard plaque assays (Figure 5.7.3). 
The decrease in plaque numbers was not accompanied by a corresponding decrease in the 
size of the plaques (Figure 5.7.4). This suggested that this mutation could be affecting the 
first round of parasite invasion but not replication or subsequent invasion events.  
5.2.7. ARAMA1
C504S 
parasites invade just as well as ARAMA1
WT
 parasites 
 A two-color invasion assay quantified using a laser scanning cytometer showed 
no difference in invasion between ARAMA1
C504S 
and ARAMA1
WT
 parasites (Figure 
5.7.1).  In the invasion assay, parasites were allowed to settle onto the host cell 
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monolayers for 20 minutes at 23°C before one-hour incubation at 37°C. When the 
parasites were left on the monolayer for various times (0-8hr) before scoring invasion, a 
gradual increase in the number of invaded parasites was observed, but no difference 
between the ARAMA1
C504S 
and ARAMA1
WT
 parasites (Figure 5.7.2 and data not shown). 
Thus the C504S mutation on TgAMA1 does not affect host cell invasion. 
5.2.8. ARAMA1
C504S 
parasites replicate indistinguishably from ARAMA1
WT
 
parasites 
 Intracellular replication assays in which parasites were fixed and counted 10 
hours post infection showed that ARAMA1
C504S 
parasites replicate at the same rate as 
ARAMA1
WT
 parasites (Figure 5.8).  
 5.2.9. Growth competition assay showed a slight delay in the growth of 
ARAMA1
C504S 
parasites 
 Since ARAMA1
C504S
  and ARAMA1
WT
 parasites differ by only a single amino 
acid, they cannot be readily distinguished by immunofluorescence so a standard direct 
growth competition assay [29] is not feasible. Instead, an equal number of each parasite 
line was mixed pairwise with TgAMA1 knockout parasites [30] parasites in separate 
growth competition assays. The TgAMA1 knockout parasites were chosen as the 
reference line for the competition assays since they were YFP positive and could be 
easily distinguished from the non-fluorescent competitor line. The knockout parasites 
were equally outcompeted by the ARAMA1
C504S 
 and ARAMA1
WT
 lines; almost all the 
parasites in the assay were YFP negative by passage 3 (Figure 5.9.1).  
Another growth competition assay was set up, this time comparing each of the 
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allelic replacement lines pairwise with the wild-type parental line, Δku80Δhxg (Figure 
5.9.2). At passage 0, equal numbers of ARAMA1
WT
 and Δku80Δhxg parasites were 
added to the host cells; the same was done for the growth competition assay comparing 
ARAMA1
C504S
 parasites to Δku80Δhxg parasites. There was a slight but significant 
growth delay observed in the ARAMA1
C504S 
vs. Δku80Δhxg parasites, most pronounced 
between passage 0 and passage 1 but, surprisingly, the Δku80Δhxg parasites did not take 
over the culture and the difference in growth was not even significant at passage 5. This 
suggests that ARAMA1
C504S
 parasites have a slight delay in growth compared to the 
Δku80Δhxg parasites shortly after initial infection, but the rate of growth is similar 
thereafter.  
5.2.10. Prolonged incubation of extracellular ARAMA1
C504S
 parasites affects 
progression from one parasite/vacuole to two parasites/vacuole 
Even though the same extracellular parasites were used in the invasion assays 
(Figure 5.7.1; done first) and plaque assays (figure 5.7.3; done second), the parasites sat 
on the bench top for at least an hour between the two assays. To test if the longer 
incubation at room temperature could account for the difference in plaque numbers when 
there was no effect on invasion, ARAMA1
C504S 
 and ARAMA1
WT
 parasites were 
harvested and incubated at room temperature for 4 hours, after which an invasion assay 
was performed for 1 hour at 37
o
C. The invasion levels were again indistinguishable 
between the two parasite lines (Figure 5.10.1). However, after incubation of extracellular 
parasites for 4 hours at room temperature, a replication assay was also set up and counts 
were made 14 hours post infection. The ARAMA1
C504S 
showed a significant delay in 
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progressing from 1 parasite per vacuole to 2 parasites per vacuole compared to 
ARAMA1
WT
 parasites (Figure 5.10.2). 
5.3. Discussion  
A chemical-proteomics-based approach was used to identify S-palmitoylated 
proteins in T. gondii. Of the 312 proteins identified, TgAMA1 was validated to be S-
palmitoylated using 17-ODYA labeling and azido-fluorophore detection. By process of 
elimination, Cys504, within the transmembrane domain of TgAMA1, was predicted to be 
the likely site for palmitoylation. Allelic replacement parasites were generated with a 
Flag-tagged copy of either wild-type TgAMA1 or TgAMA1 with a C504S substitution. 
The C504S mutation resulted in loss of 17-ODYA labeling on TgAMA1, demonstrating 
that Cys504 is essential for, and likely the site of, palmitoylation on TgAMA1.  
Since palmitoylation is known to influence localization of proteins, we checked to 
see if the C504S mutation altered TgAMA1 localization, which it did not. The 
ARAMA1
C504S
 parasites did not have an invasion or replication defect but, surprisingly, 
consistently formed fewer plaques compared to the ARAMA1
WT
 parasites. In growth 
competition assays, ARAMA1
C504S
 parasites appeared to have a slight delay in growth at 
the earliest time points post infection. These apparently conflicting observations were 
ultimately explained by the observation that, after incubation for a few hours at room 
temperature, fewer of the ARAMA1
C504S
 parasites were able to progress from one 
parasite/vacuole to two parasites/vacuole after invasion than ARAMA1
WT
 parasites. The 
biological relevance of this observation is unclear. However, it could be a consequence of 
the other, more interesting phenotype observed: ARAMA1
C504S
 parasites show 
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significantly enhanced microneme secretion compared to ARAMA1
WT
 parasites. The 
enhanced secretion of microneme proteins in the mutant parasites while they are 
extracellular might exhaust them of a protein that is normally secreted from the 
micronemes intracellularly and that is in some way necessary to complete the lytic cycle. 
Further studies will be required to test the hypothesis that microneme secretion occurs 
intracellularly and plays a role in the parasite’s lytic cycle. 
 
 
 
 
 
 
 
 
 
 
 
  
158 
 
Figure 5.1: Protein palmitoylation and myristoylation 
Diagram showing the chemical structure of a cysteine residue modified by S- or O-palmitoylation, and a 
glycine residue modified by myristoylation.  This image is adapted with permission from Macmillan 
Publishers Ltd: [Nature Reviews Molecular Cell Biology] (Linder, M.E. and R.J. Deschenes, 
Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol, 2007. 8(1): p. 74-84.), 
Copyright (2007).  
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Figure 5.2: TgAMA1 is palmitoylated 
Parasites were labeled with 17-ODYA and clicked to azido-rhodamine fluorophore. A Flag IP was 
performed and a rhodamine fluorescence scan (R-scan) was done on SDS-PAGE gels. The 17-ODYA 
signal was seen only in AMA1-Flag parasites and this labeling disappeared upon addition of hydoxylamine 
indicating that TgAMA1 is S-palmitoylated. Western blot with anti-Flag antibody confirmed that the Flag 
pull-down was successful. These data were generated by our collaborator Ian Foe, using parasite lines we 
generated and provided to him.  
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Figure 5.3: Generation of allelic replacement parasites containing the C504S mutation on TgAMA1 
(5.3.1) Schematic for double homologous recombination at the TgAMA1 locus. Primers p1-p4 were used to 
check for proper integration of the vector pA/TgAMA1
WT
Flag.Ble at the TgAMA1 genomic locus; see 
Figure 5.2.2. (5.3.2) Diagnostic PCR showing that the ARAMA1
C504S 
clone selected for further study 
(clone # 54) had undergone integration of the construct at the right locus. The predicted sizes of the 
amplicons in parasites with the correct integration are indicated above the lanes. (5.2.3) Western blot 
comparing the ARAMA1
C504S
 clones to the ARAMA1
WT
 clone, confirming that they have similar 
expression levels of the Flag-tagged TgAMA1. 
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Figure 5.4: TgAMA1 is palmitoylated and Cys504 is essential for its palmitoylation 
ARAMA1
C504S
 and ARAMA1
WT
 parasites were labeled and processed as described in Figure 5.2. The wild-
type form of TgAMA1 labeled with 17-ODYA, as expected, but the mutant C504S form of TgAMA1 did 
not. These data were generated by our collaborator Ian Foe, using parasite lines we generated and 
provided to him. 
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Figure 5.5: C504S mutation on TgAMA1 does not alter its apical localization 
IFA shows that the Flag-tagged AMA1 localizes properly to the apical end of intracellular parasites.  
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Figure 5.6: Microneme secretion assay shows increased secretion of TgAMA1 and TgMIC2 in 
ARAMA1
C504S 
parasites compared to ARAMA1
WT
 parasites 
FL denotes full length TgMIC2 and TgAMA1 and ECTO denotes the shed ectodomain. TgMLC1 was used 
as loading control. The volume of the pellet (P) fraction was half the volume of the supernatant (S) fraction. 
There was 1.7-fold more TgAMA1 and 1.2-fold more TgMIC2 secreted by ARAMA1
C504S
 parasites 
compared to ARAMA1
WT
 parasites. 
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Figure 5.7: ARAMA1
C504S
 parasites invade as well as ARAMA1
WT
 parasites but form fewer plaques 
(1) ARAMA1
C504S
 and ARAMA1
WT 
parasites showed similar levels of invasion in a two-color invasion 
assay. Data are from three biological replicates, each done in duplicate, and mean % invasion relative to 
ARAMA1
WT 
is indicated above the histogram. A two-tailed student t-test yielded p=0.1821. Error bars 
indicate SEM. (2) ARAMA1
C504S
 and ARAMA1
WT
 parasites showed similar levels of invasion from 0.5 to 
8 hours. Data represent the mean number of intracellular parasites from one biological replicate with 
technical duplicates. All assays were performed on the same day except for the 8 hour time point. (3) 
ARAMA1
C504S
 parasites form significantly fewer plaques than ARAMA1
WT
 parasites. The data are from 11 
independent plaque assays, each done in triplicate. Two-way ANOVA was performed to account for day-
to-day variation as a random effect. The dataset was analyzed using a linear mixed model. When data from 
ARAMA1
WT 
were compared to ARAMA1
C504S
 parasites, Pr>F was less than 0.0001, which means the 
difference between the two was significant. The least square means estimate for the dataset was used to plot 
the graph, with the calculated standard error of 1.7154 used as error bars. (4) Representative image of the 
plaque assay, stained with crystal violet 7 days post infection; numbers below the images indicate the 
number of plaques counted in each. 
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Figure 5.8: Intracellular replication assay comparing ARAMA1
WT
 vs. ARAMA1
C504S
 parasites 
showed no significant difference 
Equal numbers of the two parasite lines were used to infect host cells on circular coverslips. 10 hours post 
infection, IFA was performed with anti-GRA8 and anti-GAP45 antibodies and vacuoles containing 1, 2, 4 
and >4 parasites were counted and plotted as percentage of total vacuoles scored. 250 vacuoles were 
counted per coverslip. The data represent biological triplicates, each done in duplicate. Two-way ANOVA 
was performed to test for significance.  
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Figure 5.9 Growth competition assays  
(1)  Growth competition assays comparing TgAMA1 knockout vs. ARAMA1
C504S
 parasites (green) and 
TgAMA1 knockout vs. ARAMA1
WT
 parasites (red). Equal numbers of parasites were seeded onto confluent 
host cell monolayers, and the percentage of YFP positive (TgAMA1 knockout) extracellular parasites was 
scored at passage 0, 1 and 3. Error bar indicate SEM. In both cases, the knockout parasites were completely 
overgrown by the competitor strain by passage 3. (2) Growth competition assay comparing Δku80Δhxg vs. 
ARAMA1
WT
 parasites (red) and Δku80Δhxg vs. ARAMA1C504S parasites (green). Extracellular parasites 
were analyzed by IFA at passages 0, 1, 3, 5, 7, 9 and 11; the allelic replacement parasites were identified 
with anti-Flag antibody and total parasite counts were made with anti-GAP45 antibody. The data are from 
three independent experiments, each done in duplicate; error bars indicate SEM. An unpaired t-test using a 
false discovery rate of 1% FDR was used to check for significance. * p<0.05; ns =non-significant.  
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Figure 5.10:  Incubating extracellular parasites at room temperature for 4-5 hours does not change 
invasion but delays replication in ARAMA1
C504S
 parasites   
 
(1) Invasion assay comparing ARAMA1
WT 
vs. ARAMA1
C504S 
parasites after incubation as extracellular 
parasites at room temperature (~23°C) for five hours. Data represent the mean % invasion relative to 
ARAMA1
WT
 from three independent experiments, each done in duplicate. An unpaired two tailed t-test 
was performed to test for significance. ns = not significant. (2) Replication assay comparing AR AMA1
WT 
vs. AR AMA1
C504S
 parasites after incubating them extracellularly at room temperature (~23°C) for four 
hours prior to infection.  The AMA1
C504S
 parasites showed a significant delay in progressing from one 
parasites/vacuole to two parasites/vacuole. Data are from three independent experiments, each done in 
duplicate. Parasites in vacuoles were counted 14 hours post infection. Two-way ANOVA showed a 
significant differences in 1 parasite/vacuole (**p=0.0092) and 2 parasites/vacuole (*p=0.0164) between the 
two parasite lines. 
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CHAPTER 6 – SUMMARY AND FUTURE DIRECTIONS 
6.1. Summary of mutations introduced into the cytoplasmic tail of TgAMA1 
 Six residues on the cytoplasmic tail of TgAMA1 were chosen for substitution, 
namely: S527, S537, F546, W547, D558, and Y569. Allelic replacement (AR) “knock-
in” parasites were generated, in which the endogenous TgAMA1 was replaced by a Flag-
tagged copy of TgAMA1 containing amino acid substitutions at these positions in its 
cytoplasmic tail. 
6.1.1. Phosphorylation mutants of AMA1 
 In P. falciparum, phosphorylation of S610 on PfAMA1 by PKA was required 
for successful parasite invasion into host cells [1]. In T. gondii, a phosphoproteomics 
study identified S527 and S537 as sites of phosphorylation on TgAMA1 [2]. When S527 
and S537 were mutated to alanine, there was no obvious change in the growth rate of the 
parasites during routine culture, and ARAMA1
S527A
 parasites invaded host cells as well 
as ARAMA1
WT
 parasites. However, mutation of S527 to a phosphomimetic aspartic acid 
reduced invasion by 25% (Figure 3.6). This suggested that, like in P. falciparum, 
TgAMA1 phosphorylation plays a role in host cell invasion but in T. gondii it may be the 
dynamics of phosphorylation that are important for invasion. We did not succeed in 
generating a vector for mutating both S527 and S537 into aspartic acid, which might lead 
to a more severe invasion defect.  
  
 The residue corresponding to S610 in PfAMA1 is D558 in TgAMA1, based on 
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sequence alignment (Figure 3.1). The change from serine to aspartic acid is seen only in 
Toxoplasma and Eimeria, not in Plasmodium, Neospora or Babesia. In order to 
understand the functional significance of this substitution, we generated AR parasites 
with D558A or D558S mutations on the cytoplasmic tail of TgAMA1. These parasites 
did not exhibit any obvious growth delay during culture and did not show a defect in 
invasion of host cells; this residue therefore does not appear to be as functionally 
important in TgAMA1 as it is in PfAMA1. 
6.1.2. The FW domain and terminal tyrosine in the cytoplasmic tail of TgAMA1 
 The FW motif in TgAMA1 was shown to bind to aldolase in an in-vitro binding 
assay [3]. TgAMA1 conditional knockdown parasites expressing TgAMA1 with the 
FW/AA mutation had a severe invasion defect ([4],[3]). We showed here that allelic 
replacement parasites with the TgAMA1 FW/AA mutation also have a significant 
invasion defect (average invasion compared to wild-type =32%). Parasites with W547 
mutated to Ala only invaded to 15% of the level of WT parasites. Initial invasion assays 
using parasites with a F546 to Ala mutation also showed an invasion defect (Figure 3.6), 
but this parasite line had developed an extra mutation on the ectodomain of TgAMA1. 
ARAMA1
FW/AA 
parasites showed delayed growth in culture but, over time, the expression 
levels of the mutant TgAMA1 in these parasites decreased (Figure 3.5) and their invasion 
levels went from 31% to 50% (Table 3.3). During this time, the introduced copy of 
TgAMA1
FW/AA
 developed two additional mutations in its ectodomain suggesting that the 
parasite was adapting to fitness costs associated with the FW/AA mutation. Whether the 
FW motif functions in interaction with other proteins or whether it is required to maintain 
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the conformation of TgAMA1 remains unclear. It would be interesting to check if other 
isoforms of AMA, such as TgAMA2 and TgAMA4 are upregulated in the culture-
adapted line to compensate for the loss of TgAMA1 function in caused by the FW/AA 
mutation. 
 The FW motif in AMA1 along with the terminal tyrosine residue mediate 
binding to aldolase, which in turn binds actin ([3],[5]). This led to a widely accepted 
hypothesis that adhesins such as TgAMA1 form the bridge between extracellular ligands 
and the intracellular motor machinery, by binding to aldolase, which in turn binds to 
actin. However, a recently published study disproved the requirement of aldolase for 
parasite invasion [6]. In our studies, ARAMA1
Y569F
 did not show any defects in invasion 
(Figure 3.6). However, our yeast-two hybrid analysis showed that the cytoplasmic tail of 
TgAMA1 does physically interact with aldolase and that the FW/AA mutation abolished 
this interaction (Appendix I). The functional importance of the terminal tyrosine and FW 
motif in TgAMA1 remain unclear, but they may influence how TgAMA1 interacts with 
other proteins. 
6.1.3. Generation of ARAMA1
ΔcYFP
 
 In P. falciparum, the cytoplasmic tail of PfAMA1 is required for successful 
parasite invasion [7]. The functional role of the cytoplasmic tail of TgAMA1 in T.gondii 
remains unclear. In addition to introducing point mutations in the tail of TgAMA1, we 
attempted to generate a knock-in parasite line lacking the cytoplasmic tail of TgAMA1 
entirely. In the absence of the tail, TgAMA1 mislocalized and appeared as punctate spots 
in extracellular tachyzoites (Figure 3.13). However, only the ectodomain of TgAMA1 is 
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involved in its proper trafficking to the micronemes ([7], [3]), suggesting that the 
cytoplasmic tail of TgAMA1 contributes its proper folding and stability. Attempts to 
generate a vector to replace the cytoplasmic tail of TgAMA1 with YFP were not 
successful. Generating parasites with YFP in place of the cytoplasmic tail of TgAMA1 
would be important to truly understand the function of the short cytoplasmic tail of 
TgAMA1. 
6.2. Future Directions 
6.2.1. Functional analysis of important genes 
 The generation of clean TgAMA1 knockout parasite lines using rapamycin-
induced di-Cre gene excision forced investigators to question the essentiality of several 
genes such as TgAMA1 and TgMyoA ([8], [9]). It is important to distinguish between 
essentiality and importance since not all important genes are essential, and the choice of 
technology used for gene disruption could influence the phenotypic outcome. Phenotypic 
plasticity in functionally important genes is a mechanism by which parasites can maintain 
their fitness to ensure survival [10]. For example, TgMyoC functionally compensates for 
the loss of TgMyoA [8]. Similarly, different AMA isoforms (TgAMA2 and TgAMA4) 
can functionally compensate for the loss of TgAMA1 [11]. Acetyl-CoA synthetase 
(TgACS) and ATP citrate lyase (TgACL), both of which are required for the production 
of acetyl-coA for acylation of proteins, can functionally compensate for each other [10].  
 These data suggest that perhaps the best way to disrupt functionally important 
genes is by using conditional expression of genes with tight control of gene expression. 
For example, a conditional TgAMA1 parasite line can be generated by swapping the 
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endogenous promoter for TetO7sag4 regulatable promoter upstream at the endogenous 
TgAMA1 locus by double homologous recombination [12] and expressing an extra copy 
of WT or mutant AMA1 with a tet-regulatable RNA aptamer at the UPRT locus [13]. 
ATc could be used to conditionally repress the endogenous copy of TgAMA1 as well as 
activate translation of the extra copy at the UPRT locus. Alternatively, better versions of 
the CRISPR-Cas systems (Cpf1 instead of Cas9) could be used to generate inducible 
knock downs [14]. Recent discovery of anti-CRISPR proteins in bacteriophages (AcrF1-
3) could be implemented to conditionally knock down genes of interest using the 
CRISPR-Cas technology [15].  
6.2.2. Safe amino acid substitutions 
 The choice of amino acid substitution is generally made after consideration of 
size, charge, polarity and hydrophobicity along with position of the residue in the primary 
structure of the protein. The substitution of one amino acid for another should not disrupt 
the tertiary structure of the protein. Phenotypes associated with phosphomimetic 
mutations can be difficult to interpret since proteins are not normally phosphorylated 
prior to their folding. It is therefore hard to predict if substituting Ser to Asp or Glu is 
mimicking phosphorylation or affecting protein folding. Some groups prefer to replace 
Ser with Glu over Asp since the former has a similar size to phosphoserine. In this study, 
replacement of S527D caused an invasion defect. If this mutation caused a global or a 
local change in the folding of TgAMA1, then the same invasion defect might not be seen 
in S527E mutants. Similarly, it would be important to check if mutating the FW motif to 
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leucines rather than alanines would change the phenotype. Online tools such as Provean 
and algorithms that predict safe amino acid substitutions based on the position of the 
amino acids in proteins should be used as guidelines to choose amino acids for 
substitutions ([16], [17]).  
6.2.3. Identification of kinases and phosphatases that regulate dynamic 
phosphorylation of TgAMA1  
 Dynamic phosphorylation in eukaryotes is regulated by complementary kinases 
and phosphatases. In Toxoplasma gondii, calcium-dependent kinases (TgCDPK1, 
TgCDPK2, TgCDPKif3) and TgPKG contribute to invasion of tachyzoites into host cells 
[18]. Studies using parasites loaded with the calcium indicator Fluo-4 AM revealed 
fluxes in the intracellular calcium levels in T. gondii with bursts of calcium release 
corresponding to increased motility. A parasite committed to invasion showed a 
corresponding drop in intracellular calcium [19]. The presence of extracellular calcium 
enhanced motility and invasion of tachyzoites into host cells [20]. Moreover, 
phosphorylation on TgAMA1 was detected more often in extracellular parasites than in 
intracellular parasites [2]. If phosphorylation on TgAMA1 is dependent on calcium, then 
one would expect to see changes in its phosphorylation state with the use of calcium 
chelators such as BAPTA-AM or calcium ionophores such as ionomycin. From the mass 
spectrometry analysis presented in this dissertation, we know that the stoichiometry of 
phosphorylation on TgAMA1 is so low that it is often hard to detect the phosphopeptide 
by LC-MS/MS. Detecting phosphorylation on TgAMA1 might be made more efficient 
with an antibody that detects phosphorylated S527 and/or S537. Such an antibody could 
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be used to identify the differences in phosphorylation on TgAMA1 in extracellular 
parasites vs. intracellular parasites, or during invasion. The sensitivity of detection could 
be improved using Phos-tag gels, which resolve phospho-and dephospho forms of 
proteins [21]. Furthermore, a phospho-TgAMA1 antibody in combination with TgAMA1 
antibody could be used in a proximity ligation assay using OLINK technology ([22], 
[23]). This would increase detection of phosphorylated TgAMA1 either through 
fluorescence microscopy or by Western blot.  
 Of the four protein phosphatases identified in T. gondii, TgPP1 was important 
for invasion while TgPP2B was important for parasite attachment ([24], [25]). The 
intensity of phosphorylated proteins increased when T. gondii lysates were 
immunodepleted of TgPP1 in a 
32
P labeling experiment. The profile of co-eluting 
proteins after IP with antibody to TgPP1changed upon treatment with TgPP1 inhibitor, 
okadaic acid [24]. The localization of this phosphatase and its substrate profile remain 
unknown. To test if TgAMA1 is a substrate of TgPP1, a pulldown could be performed 
using parasite lysates with an antibody to TgPP1 followed by Western Blot with antibody 
to TgAMA1. As a control, parasites could be treated with okadaic acid before IP. If 
TgAMA1 is a substrate for TgPP1, then it would not be detected in samples where 
parasites were treated with okadaic acid. If TgAMA1 is not the substrate for TgPP1, then 
another phosphatase that is regulated by calcium, TgPP2B or calcineurin, could be tested 
in a similar manner using cyclosporinA or FK506 which are small molecule inhibitors of 
TgPP2B. Interestingly, this phosphatase localizes to the apical and basal end of 
extracellular parasites [25]. Perhaps the presence of calcineurin at the apical end of the 
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parasite aids in attachment by dephosphorylation of adhesins in a calcium-dependent 
manner. We observed in our experiments that TgAMA1 is dephosphorylated upon its 
interaction with TgRON2. It would be interesting to test if this happens at the moving 
junction by staining invading parasites using OLINK technology and phosphoAMA1 
antibody. 
6.3. Use of SILAC to identify protein-protein interactions 
6.3.1. Potential new interacting partners of TgAMA1 by SILAC 
 In order to identify interacting proteins of TgAMA1, proteins differentially 
pulled down in a TgAMA1 IP from ARAMA1
WT
 parasites (H) and TgAMA1 knockout 
parasites (L) were compared by SILAC-based quantitative mass spectrometry. Since 
TgAMA1 was used as bait, it had the highest H/L ratio in the dataset, as expected. Other 
known interacting partners of the ectodomain of TgAMA1, including RONs 2, 4, 5, and 
8, also had high H/L ratios.  
 Three additional hits from this experiment that may be new TgAMA1-binding 
proteins could be further characterized by endogenous tagging and generation of 
knockouts. This would enable determination of their localization and if they are part of 
the AMA1-RON complex, and confirmation of their binding to TgAMA1 with reverse 
IPs. The first of these hits was TgRON4L, a paralogue of TgRON4. The function of this 
protein is unknown, nor is it known if it is a member of the RON complex. Second, 
TgME49_209170, a hypothetical protein with no known functional motifs, was identified 
with a H/L ratio similar to members of the RON complex in all SILAC-based 
comparisons presented in this dissertation. This hypothetical protein has an expression 
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pattern similar to the RON proteins (Figure 3.8) and a signal peptide. The third hit of 
interest was a MaoC domain- containing protein, whose homologs in other systems play a 
role in fatty acid metabolism. The absence of any transmembrane domains or signal 
peptides suggests that this protein could interact with the cytoplasmic tail of TgAMA1, 
which could be tested in a yeast two-hybrid assay or by proximity ligation in-situ assay 
(P-LISA) [26]. This hit had a low ratio in the SILAC experiment comparing ARAMA1
WT
 
and ARAMA1
S527A
, suggesting that the phosphorylation state of TgAMA1 could play a 
role in regulating its interaction with this protein. Perhaps the phosphorylation state of 
S527 on TgAMA1 directs this protein to the region of the membrane where energy from 
fatty acid metabolism is needed to power gliding motility and penetration of host cells. 
Recent studies have disproven the role for aldolase in connecting the adhesins to actin 
filaments; perhaps one of the hits identified in this experiment serves instead as the 
“connector” protein. 
6.3.2. Differential binding of proteins as a consequence of the TgAMA1 tail 
phosphorylation 
 There were two potentially interesting hits from the SILAC-based experiment 
comparing parasites expressing wild-type TgAMA1 to parasites expressing either 
nonphosphorylatable or phosphomimetic S527 TgAMA1 mutations. The first hit was a 
hypothetical protein, TgME49_321650, which interacted more with TgAMA1 containing 
the S527A mutation, and has a homologue in Eimeria annotated as a putative kinase. This 
hit is an interesting candidate for further analysis. Secondly, anonymous antigen 1, a 
large protein with an armadillo repeat domain, had low H/L SILAC ratios in experiments 
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comparing ARAMA1
WT
 parasites (H) to either ARAMA1
S527A
 (L) or ARAMA1
S527D
 (L) 
parasites, suggesting either that its interaction with TgAMA1 is affected by the dynamics 
of S527 phosphorylation or that the S527D substitution does not accurately mimic a 
phosphorylated serine residue in this protein (see Section 3.3.5.2). Note that neither of 
these hits had a correspondingly high ratio in the control experiment that compared 
ARAMA1
WT
 parasites to the TgAMA1 knockout parasites. For the first hit, the mutation 
in TgAMA1 could influence new binding partners which may not be detected in the 
control experiment. The fact that anonymous antigen1 was detected in all SILAC 
experiments except for the control experiment, with a large number of unique peptides 
identified without any corresponding change in the SILAC ratio suggests that it could be 
binding non-specifically to the beads (Table 3.5).   
6.3.3. Guidelines for SILAC-based experiments 
 Even though SILAC quantitative mass spectrometry is a powerful tool for 
identifying new protein interacting partners, it is important to acknowledge several key 
issues prior to data analysis and interpretation. Variations can be introduced at every step 
during sample preparation that could change the outcome of such an experiment. First, 
labeling of cells and parasites is usually never taken to completion (i.e., the natural 
“light” isotopic forms of Arg and Lys in parasites are never 100% replaced by the 
“heavy” forms). This would not present a problem if comparisons were made using 
“heavy” and “medium” isotopes of amino acids [27]. When comparisons are made using 
heavy and light isotopes, it is recommended to calculate labeling efficiency and adjust the 
H/L ratios accordingly. Second, despite counting parasites for every experiment and 
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using equal numbers of parasites for each IP, differences between samples may be 
introduced during the washes that precede lysis. Therefore, quantifying protein in the 
parasite lysates (e.g., using a BCA test) before priming the lysates with TgAMA1 
antibody would ensure equal protein input for IPs. Variations in the amount of non-
specific protein coming down in the IP can also be introduced from variations in either 
the volume of beads used or washing steps (before and after IP). Finally, variations could 
come from performing separate IPs and elutions. To overcome this problem, beads from 
each heavy or light IP could be mixed prior to washes and elution. Since TgAMA1was 
used as bait in the pulldowns, one could always normalize all datasets to the mean ratio 
of the TgAMA1 peptides but this would still not distinguish between specific and non-
specific protein interacting partners. Finally, the confidence assigned to hits increases 
when the same results repeat in at least two biological replicates. 
6.3.4. Alternative approaches to identify proteins that interact with the cytoplasmic 
tail of TgAMA1 
  Parasites over-expressing the soluble, myc-tagged cytoplasmic tail of TgAMA1 
[56] could be used to pull down interacting proteins in an IP using anti-myc antibody. 
Protein identification by mass spectrometry followed by reverse IPs could be performed 
to validate true interacting partners of the cytoplasmic tail of TgAMA1. Functionally 
redundant isoforms that can compensate for the absence of AMA1, namely TgAMA2 and 
TgAMA4 [11], also have cytoplasmic tails.  It would be interesting to over-express the 
myc-tagged cytoplasmic tails of TgAMA2 or TgAMA4 in the TgAMA1 knock out 
parasites and determine if they bind to proteins that normally bind to the cytoplasmic tail 
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of TgAMA1 or if they bind to a different set of proteins. The fact that TgAMA2 also has 
the conserved FW motif in its cytoplasmic tail suggests that it could bind to the same or a 
similar “connector” protein linking the adhesin to the motor machinery. SILAC 
quantitative mass spectrometry could also be used to identify interacting partners of the 
TgAMA1 C-tail by comparing the proteins pulled down from differentially labeled 
ARAMA1
WT
 vs. ARAMA1
ΔcYFP
 parasites using the anti-TgAMA1 tail antibody, UVT59 
[28].  
 An alternative method to SILAC quantitative mass spectrometry for 
identification of differentially binding proteins would be to perform an IP using 
35
S 
metabolically labeled parasites. The proteins pulled down with anti-AMA1 or anti-Flag 
antibody from 
 35
S labeled ARAMA1
S527A
 or ARAMA1
S527D
 parasites could be compared 
to those from ARAMA1
WT
 parasites. Proteins that differentially interact with TgAMA1 
as a consequence of changes in phosphorylation of S527 on the cytoplasmic tail of 
TgAMA1 might be identified with increased sensitivity using this method. The bands of 
interest could later be excised and identified using mass spectrometry. Finally, validation 
of every protein-protein interaction could be done either by yeast two-hybrid analysis or 
co-immunoprecipitations of TgAMA1 with tagged prey proteins in parasites. 
6.4. Palmitoylation on AMA1 
6.4.1. Summary 
 A proteomics-based study identified S-palmitoylated proteins in T. gondii which 
were implicated in maintaining parasite morphology, motility, invasion, development and 
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egress [29]. One of the proteins identified to be palmitoylated was TgAMA1.  
 We identified C504 as necessary for, and likely the site of, palmitoylation on 
TgAMA1. Knock-in parasites expressing Flag-tagged AMA1 with a C504S mutation 
were generated and showed that palmitoylation plays no role in the trafficking and 
membrane localization of AMA1. However, parasites with the C504S mutation showed 
increased microneme secretion, revealing a previously unrecognized role for TgAMA1 
and its palmitoylation in regulating microneme secretion [29]. 
 The ARAMA1
C504S
 invaded host cells and replicated indistinguishably from 
ARAMA1
WT
 parasites. However, in a plaque assay ARAMA1
C504S
 parasites formed 
fewer plaques with no difference in plaque size. In a growth competition assay, the 
ARAMA1
C504S
 parasites had a slight delay in growth and this delay was more prominent 
in the first 12 hours post infection. The plaque assays were set up following the invasion 
assays, suggesting that the C504S mutation might somehow be affecting the viability of 
the extracellular parasites during the time between initiation of the two assays. When 
extracellular ARAMA1
C504S
 and ARAMA1
WT
 parasites were incubated at room 
temperature for 4-5 hours, they showed identical invasion into host cells but the 
ARAMA1
C504S 
parasites exhibited a significant delay in their ability to transition from 
one parasite/vacuole to two parasites/vacuole once intracellular. 
 Neither TgAMA1 nor its intramembrane cleavage directly regulate parasite 
intracellular replication ([4], [6], [30]). Perhaps premature depletion of microneme 
proteins prior to invasion in the extracellular ARAMA1
C504S
 parasites, due to upregulated 
microneme secretion, contributes to the slight delay in replication of parasites after they 
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invade. It would be interesting to determine if microneme secretion occurs intracellularly 
and, if so, if this plays some role in promoting parasite replication. The microneme 
proteins tested in our secretion assays were TgMIC2 and TgAMA1, which are both 
trafficked to the micronemes via the RabGTPase-dependent pathway. Proteins that are 
known to localize to other microneme compartments by a RabGTPase-independent 
pathways are TgMIC8, TgMIC3 and TgMIC11 [31]. It would be interesting to check if 
palmitoylation of TgAMA1 affects secretion of this other subset of microneme proteins 
as well.  
6.4.2. TgAMA1 palmitoylation and interacting proteins 
  Palmitoylation, like many other post translational modifications, is dynamic and 
is involved in processes other than protein trafficking such as protein-protein interaction 
([32], [33]). It is also possible that lack of palmitoylation on TgAMA1 could affect the 
way TgAMA1 interacts with other proteins, perhaps sequestering protein(s) required for 
optimal initiation of replication in newly invaded parasites. This could explain why 
ARAMA1
C504S 
parasites form fewer plaques without any change in plaque size. This 
hypothesis could be tested by using TgAMA1 as bait for IP followed by SILAC 
quantitative mass spectrometry comparing differentially labeled ARAMA1
WT
 and 
ARAMA1
C504S
 parasites. 
35
S labeling of parasites followed by IP comparing the two lines 
would be an alternative method to find differentially interacting proteins.  
6.5. TgAMA1-TgRON2 interaction 
6.5.1. Summary 
 It is known that domain 3 (D3) of TgRON2 interacts with TgAMA1 [34]. We 
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observed two distinct effects on TgAMA1 when parasites were treated with GST-D3. 
First, there was a reduction in phosphorylation of S527 on the cytoplasmic tail of AMA1. 
Second, there was a reduction in secretion of the TgAMA1 ectodomain into the culture 
supernatant, and this effect was not observed for other microneme proteins. Analysis by 
flow cytometry revealed that the reduction in secretion of TgAMA1 after treatment with 
GST-D3 was due to reduction in intramembrane cleavage of TgAMA1, presumably by 
rhomboid protease(s). Using parasites with a hypercleavable form of TgAMA1, we 
showed that too much cleavage of TgAMA1 made invasion less efficient. These data 
suggest that TgAMA1-TgRON2 interaction at the moving junction alters the 
conformation of TgAMA1 such that it becomes resistant to cleavage by rhomboid 
proteases. This could provide traction and support for maximally efficient invasion of the 
parasite into host cells. Furthermore, the TgRON2-induced dephosphorylation of S527 on 
the cytoplasmic tail of TgAMA1 may affect the proteins that bind to the tail, i.e., serving 
as an outside-in signal to the parasite that it is engaged with the host cell. In a recent 
study of a calcium-dependent phosphatase in parasites, calcineurin, parasites 
conditionally depleted in calcineurin were treated with TgRON2 peptide. This treatment 
caused an antagonistic effect, where the presence of TgRON2 peptide slightly improved 
invasion of tachyzoites into host cell in the absence of calcineurin. This suggests that the 
binding of TgAMA1 to TgRON2 requires phosphorylation on TgAMA1 [25]. The effect 
of S527 phosphorylation on GST-D3 binding to TgAMA1 could be determined in a GST 
pull-down from GST-D3-treated ARAMA1
S527A 
and ARAMA1
S527D
 parasites, followed 
by anti-GST western blotting. 
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6.5.2. Proteins that differentially bind to TgAMA1 when it is engaged with TgRON2 
 An attempt to isolate the subset of proteins that interact with the cytoplasmic tail 
of AMA1 when its ectodomain was bound by GST-D3 using SILAC quantitative mass 
spectrometry was unsuccessful. Even though parasites were pre-treated with saturating 
amounts of GST-D3 peptide, the GST pull-down did not yield sufficient amounts of 
protein for high confidence detection by LC-MS/MS. Perhaps there was not enough 
TgAMA1 on the surface of parasites prior to pre-treating parasites with GST-D3. 
Addition of a calcium ionophore such as ionomycin could help increase the amount of 
TgAMA1 on the parasite surface during GST-D3 treatment of parasites. In addition to 
incorporating ionomycin, covalent cross-linking of GST-D3 to TgAMA1 on the parasite 
surface prior to lysis for IP could help isolate the protein subsets that bind TgAMA1 upon 
its interaction with TgRON2. We showed here that the His-tagged TgRON2-2 peptide 
had the same effect on AMA1 cleavage as GST-D3; perhaps an affinity pull down using 
His-tagged TgRON2-2 would be more efficient than a GST pull-down with GST-D3.  
6.5.3. Alternate approaches to detect changes in the phosphorylation state of 
TgAMA1 due to its interaction with TgRON2 
 
32
P metabolically labeled parasites [35] could be used for TgAMA1 pull-downs 
following treatment with either GST or GST-D3 peptide, and the relative amounts of 
32
P 
incorporation measured by phosphorimaging (for the 
32
P signal) and quantitative western 
blotting (for TgAMA1) ([35]). Alternatively, proteins from parasites treated with either 
GST or GST-D3 peptide could by analyzed by 2D gel electrophoresis and Western 
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blotting with anti-TgAMA1 antibody; although not always easy to reproduce, we know 
from preliminary experiments that TgAMA1 resolves as two spots on a 2D-gel 
immunoblot, and the migration of these spots changes upon mutation of S527A or S527D 
(data not shown). A more straightforward method to quantify changes in TgAMA1 
phosphorylation would be to use an antibody to TgAMA1 that recognizes phosphorylated 
TgAMA1 in a Western blot, following treatment of parasites either with GST or GST-D3 
peptide. 
6.5.4. Timing and specificity of TgAMA1 cleavage 
 Rhomboid proteases are intramembrane proteases, which cleave proteins within 
their transmembrane domains. Plasma membrane dynamics control both the gate 
dynamics of the rhomboid proteases and the transmembrane helix stability in its protein 
substrates ([36], [37]). When HEK293 cells expressing TgAMA1 and TgROM5 were 
treated with 1µM GST-D3, no reduction in cleavage of TgAMA1 was observed 
(unpublished data from Sin Urban).  This could mean that 1 µM GST-D3 peptide was not 
saturating in this system or that an additional T. gondii protein (not present in the 
HEK293 system) is necessary for the GST-D3-induced block in cleavage. It could also 
mean that this effect was specific for TgROM4 and not TgROM5, although this is 
unlikely because parasites lacking TgROM4 were also sensitive to treatment with GST-
D3 (Figure 6.1); in this case most of the residual cleavage of TgAMA1 is likely due to 
TgROM5 [6]. It would be useful to test the ability of TgROM4 expressed in HEK293 
cells to cleave TgAMA1 in the presence and absence of GST-D3, but to date no-one has 
succeeded in heterologously expressing functional TgROM4.  
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 It is known that in the absence of TgROM4, there is an accumulation of full 
length MIC2 on the surface of ionomycin-treated parasites. This supports the theory that 
rhomboid proteases help to maintain a gradient of microneme adhesins on the parasite 
plasma membrane [38].  The localization of TgROM4 and TgROM5 are known but the 
localization of TgROM5 in the absence of TgROM4 remains unclear [30]. It is not 
known if TgROM5 can localize to areas of the plasma membrane typically occupied by 
TgROM4 in its absence to help maintain the gradient of a few microneme adhesins. It is 
also unclear if rhomboid proteases are present in the invading end of the parasite after the 
formation of a moving junction or if the proteases cut adhesins behind the junction of an 
invading parasite. 
6.5.5. Fate of the cytoplasmic tail of TgAMA1 after cleavage by rhomboid proteases 
  The question remains if the cytoplasmic tail of TgAMA1 persists after 
cleavage, either within the cytosol or attached to the membrane (possibly due to 
palmitoylation), or if it is degraded. Dual confocal IFA with antibodies to the ectodomain 
and to the cytoplasmic tail of TgAMA1 during parasite invasion were attempted but did 
not have the resolving power to reveal differences in localization between the tail and 
ectodomain. Perhaps superresolution or expansion microscopy or a combination of both 
could be used to track the cytoplasmic tail of TgAMA1 in extracellular and invading 
parasites [39]. The hypercleavable TgAMA1
L/G
 parasites could be useful for this purpose 
since they would produce more of the cytoplasmic tail than wild-type parasites.     
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6.6. Dimerization-inducing motifs in the transmembrane domain of proteins and 
their effect on intramembrane cleavage by proteases 
 Several single pass and multipass transmembrane proteins have one or more 
motifs (GxxxG) that promote dimerization within their transmembrane domains and two 
examples are presented in this section. Analysis of crystal structures of proteins with 
GxxxG motifs in their TM domain suggest that this motif may maximize inter-facial van 
der Waals interaction and hydrogen bonding while the transmembrane helices interact 
with one another [40]. Not all proteins with this motif can dimerize through their 
transmembrane helices and studies suggest that other motifs can have a similar effect. 
Other factors that determine transmembrane helix dimerization include membrane 
composition, post-translational protein modifications and other residues that promote 
dimerization (small, polar, ionizible and aromatic) within the transmembrane domains. It 
is unclear if specific residues can prevent dimerization of TM helices [40].  
 An example of a protein with two GxxxG motifs in its TM domain is epidermal 
growth factor receptor (EGFR), a type I transmembrane protein with a large ectodomain, 
a single transmembrane domain and an intracellular kinase domain. The interaction of 
EGFR ectodomain with its ligand can induce conformational changes on the N-terminal 
and C-terminal transmembrane helices which can lead to homodimerization followed by 
activation of the kinase domain in the cytoplasmic region of EGFR [41]. Amyloid 
precursor protein (APP) is another example of a single pass transmembrane protein with 
three successive GxxxG motifs, two of which are in its TM domain. In humans, APP 
cleaved by β and γ secretases into peptides of varying length and accumulation of one 
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peptide in particular, Aβ42 is implicated in Alzheimer’s disease [42]. Importantly, it was 
shown that this dimerization protected APP from cleavage by the secretases [43].  
6.6.1. Dimerization motif in the transmembrane domain of TgAMA1 
 TgAMA1 has one GxxxG motif in its TM domain but the AMA1 homologs in 
Plasmodium do not contain such motifs (Figure 3.1). A multiple sequence alignment of 
TgAMA1 and APP generated using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) is shown in Figure 6.2. The GxxxG motif in 
TgAMA1 aligns well with one of the three GxxxG motifs of APP and the APP glycine 
residue labeled with asterisks in the figure abolished dimerization [42]. Online 
dimerization prediction software for TM helices called PREDDIMER 
(http://model.nmr.ru/preddimer/) predicts the TgAMA1 transmembrane domain to 
dimerize with a maximum FSCOR of 1.58. Six different predictions were made with their 
own score, angles of rotation and crossing angle (Figure 6.3).  
 It would be interesting to use the in-vitro ToxR system to test if the 
transmembrane domain of TgAMA1 homodimerizes and to test the functional importance 
of this motif with mutational studies [42]. Briefly, this system uses a chimera composed 
of maltose binding protein (MBP), the transmembrane segment of interest (TMS) and an 
intracellular ToxR transcription activator protein. MBP directs the chimeric fusion to the 
membrane while the intracellular ToxR activates transcription of a reporter gene (e.g., β-
galactosidase) upon dimerization induced by TMS. When the reporter gene used is 
chloramphenicol acetyl transferase, the system is called TOXCAT [44]. FRET-based 
microscopy using C-terminally tagged TgAMA1-ECYP and TgAMA1-YFP [45] could 
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be used to test if TgAMA1 can form homodimers in tachyzoites via its transmembrane 
helices and if this dimerization is dependent on TgAMA1-RON2 interaction. One 
advantage of FRET is that interactions can be visualized in real-time but this method can 
be complicated when introduced into a new system. If homodimerization of TgAMA1 
requires binding of TgRON2, then this interaction would be most prominent in an 
invading parasite at the moving junction. By analogy with APP, it is possible that the 
reduction in cleavage of TgAMA1 due to interaction with TgRON2 at the junction could 
be a consequence of the formation of homodimers of TgAMA1.  
6.6.2. Mutations in the GxxxG motif of TgAMA1 and its role in cleavage 
 Mutational analysis of the GxxxG motif has already revealed its importance for 
cleavage of TgAMA1 and invasion [4]. Mutation of AG (the first Gly in GxxxG) to FF 
reduced cleavage of TgAMA1 by >95% while mutation of both AG and GG (which 
includes both first and the last Gly in GxxxG) to FF inhibited cleavage by rhomboid 
proteases to undetectable levels. Conversely, mutation of Leu within this motif to Gly 
increased cleavage of AMA1 [4]. Perhaps mutating L within the GLAVG sequence 
inhibits dimerization of TgAMA1, causing helix instability and leading to excess 
cleavage by rhomboid proteases. In contrast, mutating the first Gly within the motif to a 
large aromatic amino acid might increase helix stability and render it resistant to cleavage 
by rhomboid proteases, overcoming the need for helix dimerization to protect TgAMA1 
from cleavage. It would be interesting to test using the FRET-based assay whether 
homodimers are formed in AMA1
WT
 parasites and absent in AMA1
AG/FF+GG/FF
 or 
AMA1
L/G
 parasites.  
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6.7. The fence and picket model of the plasma membrane 
 Even though some lipid components of the parasite plasma membrane have been 
identified, membrane dynamics in Toxoplasma are not well characterized. In other 
systems, the fence and picket structure of membrane organization is widely accepted. In 
this model, the plasma membrane is compartmentalized where membrane proteins and 
GPI-anchored proteins form fence pickets. The cytoplasmic tails of TM proteins help to 
establish a connection with the cytoskeletal components, bringing the actin and the 
molecular motors closer to the membrane to form a fence. In this model, proteins and 
lipids have limited range for “hop diffusion” within microdomains formed by TM 
proteins that usually contain lipid modifications. Monomers have slow hop diffusion rates 
compared to dimers and oligomers of proteins. When a ligand binds a receptor exposed 
on the surface of plasma membrane, it could induce the formation of an immobile 
signaling complex which can no longer escape the fence and picket due to its large size 
[46]. One could imagine the formation of an immobile signaling complex of TgAMA1 
upon its interaction with TgRON2 and its C-tail interacting partners as a consequence of 
dimerization, absence of rhomboid cleavage or both. The dynamics of the plasma 
membrane and maintenance of its inhomogeneity are regulated in several ways such as 
exocytosis, endocytosis, membrane displacement by actin- or tubulin-based motors, and 
distribution of membrane-bound kinases and phosphatases [47]. Acidic phospholipids are 
known to be present in the inner leaflet of the plasma membrane and form micro or 
nanodomains by reversibly binding to polybasic sequences in TM proteins in a calcium-
dependent manner [48]. These polybasic sequences are present in the cytoplasmic tail of 
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TM proteins or close to a residue that undergoes post-translational modification and in 
between hydrophobic amino acids which serve to stabilize interaction with phospholipids 
[49]. 
 Analysis of the phospholipid profile of the plasma membrane of T. gondii 
tachyzoites reveled that it is composed of 75% phosphatidylcholine, 7.5% 
phosphatidylinositol, 10% phosphatidylethanolamine, 6% phosphatidylserine (PS) and 
1% phosphatidic acid [50]. Two out of the 4 predicted lipid flippases in the T. gondii 
genome are P-type ATPases (Toxodb) which can regulate the translocation of 
phospholipids from the outer leaflet to the inner leaflet of the plasma membrane in an 
ATP dependent manner [49]. It would be interesting to test if PS can interact with basic 
amino acid residues sequences in the cytoplasmic tail of AMA1 which are in close 
proximity to its two phosphorylation sites and possibly control the timing of 
dephosphorylation on TgAMA1 in a calcium dependent manner. This would require the 
use of a fluorescent marker (e.g., BODIPY) to track the localization of PS with respect to 
TgAMA1 in parasite membranes [51]. 
6.8. A model for TgAMA1-TgRON2 interaction at the moving junction of invading 
parasites 
 Here we propose a model (Figure 6.4) in which rhomboid proteases and 
microneme adhesins reside in different local microdomains within the plasma membrane. 
Palmitoylation on AMA1 could help to maintain lipid rafts on the plasma membrane of 
the parasites, without which the “fence” in the parasite plasma membrane may be 
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unstable leading to increased cleavage of adhesins by rhomboid proteases as a 
consequence of increased hop diffusion of proteins between the compartments. Initial 
attachment is established through microneme proteins interacting with host cell receptors 
(e.g., TgMIC2 with its host receptor, ICAM1) [52]. After initial attachment, microneme 
adhesins translocate to the posterior end of the parasite where they are cleaved by 
rhomboid proteases [53]. In parallel, TgAMA1 interacts with TgRON2 at the apical end 
of the parasite to form a ring-shaped moving junction [54]. The moving junction 
functions like a molecular sieve excluding host cell plasma membrane proteins from the 
forming parasitophorous vacuole [55]. Perhaps the TgAMA1 on the surface of an 
invading parasite serves to maintain membrane stability potentially by binding to other 
host proteins. Interaction of TgAMA1 with TgRON2 could make the cytoplasmic tail of 
AMA1 accessible to dephosphorylation by phosphatases (possibly in a calcium-
dependent manner) [25].  TgAMA1-TgRON2 interaction also prevents TgAMA1 
cleavage by rhomboid proteases, and may induce dimerization of TgAMA1 at its TM 
helices. This would lead to the formation of an immobile signaling complex where the 
cytoplasmic tail can bind to the “connector” protein which enables the parasite to connect 
to the motor machinery of the parasite. Towards the end of invasion, TgAMA1 becomes 
accessible to cleavage by TgROM5 at the basal end of the parasite, releasing the 
parasite’s grip on the host cell and enabling the parasitophorous vacuole to pinch off from 
the host cell membrane. 
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Figure 6.1: GST-D3 reduces cleavage of TgAMA1 in Δr4 parasites 
Parasites lacking TgROM4 (Δr4) and these same parasites complemented with TgROM4 (Δr4/R4) were 
pretreated with either GST or GST-D3. After a microneme secretion assay, the pellet (P) and supernatant 
(S) fractions were run on a gel and blotted with anti-TgAMA1antibody and anti-TgMLC1. Pellet fractions 
were normalized to the TgMLC1 band intensity and the signal intensity ratio of the shed ectodomain over 
full length was calculated and plotted for each parasite line. A one-tailed paired t-test was used to test for 
significance. Both lines showed a significant reduction in cleavage of TgAMA1 upon GST-D3 treatment. 
Paired values from each of the four biological replicate are represented with the same colors. 
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Figure 6.2: Sequence alignment highlighting the transmembrane domains of human APP and 
TgAMA1 
Black dotted line indicates the transmembrane domain of amyloid precursor protein (APP) and red dotted 
line indicates transmembrane domain of TgAMA1.The boxed residues represent the GxxxG dimerization 
motif. The glycine indicated by * in the GxxxG domain of APP, which is an important residue for 
transmembrane helix dimerization, is also present in TgAMA1. 
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Figure 6.3: PREDDIMER prediction for dimerization of transmembrane helices of TgAMA1 
The model for dimerized TM helices of TgAMA1 obtained from PREDDIMER is depicted on the left. On 
the right, the table depicts seven different models that were generated for dimerization of transmembrane 
domain of TgAMA1 and ranked based on Fscor, which is a measure of the dimer packing quality of the 
transmembrane helices. The angle at which the two helices cross is depicted by chi, and alpha1&2 depict 
the angle of rotation of the two helices. http://model.nmr.ru/preddimer/.  
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Figure 6.4: Model for host cell invasion by Toxoplasma gondii 
(A) Extracellular parasites express adhesins such as TgAMA1 and TgMIC2, which are secreted from 
micronemes to the plasma membrane. (B) When microneme proteins such as TgAMA1 and TgMIC2 are 
located within the same lipid micro-domains as the major rhomboid protease, TgROM4, they are cleaved 
based on the stability of their transmembrane helices. From our data, we hypothesize that most full-length 
TgAMA1 molecules on the surface of extracellular parasites are phosphorylated on S527 (star). (C) 
TgRON2 and other members of the RON complex namely, TgRONs4,5 and 8 are inserted into the host cell 
where they interact with cytoskeletal components. When TgAMA1 binds TgRON2, the parasite is 
committed to invasion and forms the moving junction. We have shown that interaction of TgAMA1 with 
TgRON2 causes dephosphorylation of S527 on the cytoplasmic tail of TgAMA1 and makes TgAMA1 
resistant to cleavage by TgROM4. The dephosphorylation of TgAMA1 may allow for binding of the 
"connector" protein that can bind to actin and connect the TgAMA1-RON complex to the myosin motor 
complex. The rearward movement of the motor translates into  forward movement of the parasite into the 
host cell. (D) At the end of invasion, the disassembly of the moving junction is enabled by cleavage of 
TgAMA1 by TgROM5, which is localized at the basal end of the parasite. This cleavage event allows for 
the parasite to be completely internalized into the parasitophorous vacuole within the host cell. 
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APPENDIX I - YEAST TWO-HYBRID SCREEN TO IDENTIFY PROTEINS 
THAT INTERACT WITH THE CYTOPLASMIC TAIL OF TgAMA1 
Method 
 The Gal4 transcription factor consists of an activation domain (AD) and a DNA 
binding domain (BD). When the BD binds to the upstream activating sequence (UAS) of 
a reporter gene in the proximity of the AD, reporter transcription is activated. The BD, 
fused to the cytoplasmic tail of TgAMA1, is cloned into the bait plasmid, pGBKT7, 
which also has the TRP nutritional marker. The AD, fused to a nuclear localization 
sequence and a T. gondii cDNA library, is cloned into the prey plasmid, pGADT7, which 
also has the LEU2 nutritional marker. These plasmids are co-transformed into the yeast 
strain, AH109, which contains four reporter genes (HIS3, ADE2, LacZ and MEL1) under 
the control of the Gal4 UAS. Binding of the cytoplasmic tail of TgAMA1 to an 
interacting partner will bring the bait and the prey in close proximity, which enables the 
AD and BD to activate the reporter genes downstream the GAL4 UAS (Figure AI.1). The 
co-transformed yeast strains are grown in media lacking tryptophan and leucine to retain 
the bait and prey plasmids [1].  
Proof-of-principle 
 As proof-of-principle, a bait plasmid containing the cytoplasmic tail of 
TgAMA1 (c-tail) was co-transformed with prey plasmid containing TgALD1. The FW 
domain in the cytoplasmic tail of AMA1 was previously shown to bind to aldolase in an 
in-vitro binding assay [2]. The bait plasmid expressed either wild-type c-tail or c-tail with 
the F
546
W
547
/AA mutation (Figure AI.1). After co-transformation of bait plasmid with 
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WT c-tail and prey plasmid containing TgALD1 into competent AH109 yeast cells, 
transformants grew in dropout plates lacking tryptophan, leucine and the selective 
marker, histidine.  After co-transformation of bait plasmid with FW/AA c-tail and prey 
plasmid containing TgALD1, the yeast grew in dropout plates lacking tryptophan and 
leucine but not in plates lacking the selective marker, histidine. This confirmed that 
TgALD1 interacts with cytoplasmic tail of AMA1 and that the FW/AA mutation on the 
cytoplasmic tail of AMA1 disrupts this interaction.  
Results from the yeast two-hybrid screen 
 
 A library-scale yeast transformation was performed using the manufacturer’s 
protocol (Matchmaker
 TM
 GAL 4 Two Hybrid system 3). Briefly, 1ml of YPDA media 
was inoculated with 2-3 colonies of AH109 yeast strain and then transferred to a flask 
containing 150ml of YPDA for overnight incubation at 30°C until the OD 600was between 
0.2 and 0.3. The overnight culture was then transferred to a flask with 1ml of YPDA. The 
culture was centrifuged and the cell pellet resuspended in TE/LiAc to make the yeast 
cells competent for transformation. 293 µg of the bait plasmid containing WT c-tail was 
mixed with 1mg of the Toxoplasma cDNA library (generously provided by Michael 
White) along with 20 mg of herring’s testes carrier DNA, 8mls of AH109 yeast 
competent cells and 60ml of PEG/LiAc solution. The mix was then incubated for 30 
minutes at 30°C after which 7ml of DMSO was added to the mix. The mix was then heat 
shocked at 42°C for 15 minutes and allowed to recover on ice for 2 minutes. The cells 
were centrifuged, resuspended in 1x TE and 200µl of the suspension was plated on 50 
plates that lacked tryptophan, leucine and histidine. 
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 Out of the 200 colonies recovered, only 100 subsequently grew in liquid dropout 
media lacking Trp, Leu and His. Frozen stocks of each hit were made. An in-plate β gal 
assay was also performed after replica plating isolated colonies. Colonies were also 
grown on selective media lacking Trp, Leu and Ade and media lacking Trp, Leu and His 
with varying concentrations of 3-amino-triazole (3-AT) to identify and eliminate false 
positives. Yeast plasmid was isolated from 17 colonies that were positive from these 
secondary screens for transformation into E. coli followed by minipreps to isolate 
plasmid DNA. The miniprepped plasmids were then sent for sequencing. The sequenced 
hits contained a few hypothetical proteins and ribosomal proteins, but none were 
recovered more than once. TgGAP45 was among the hits of potential interest (Table 
AI.1). To confirm that TgGAP45 is a true interacting protein, it would be need to be 
cloned into the prey plasmid for co-transformation with the bait plasmid containing the  
cytoplasmic tail of AMA1. We would also have to do the reciprocal cloning and perform 
Y2H co-transformations for further confirmation of true interaction. To avoid false 
positive hits, higher concentrations of 3-AT could be used. 
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Figure AI.1: The yeast two-hybrid system 
Two halves of the Gal4 transcription factor was cloned into the bait plasmid and the prey plasmid. The bait 
plasmid contained either wild type TgAMA1 c-tail or c-tail with the FW/AA mutation. The prey plasmid 
contained either the cDNA library of T. gondii or TgALD1. Binding of the TgAMA1 c-tail to its interacting 
partners would activate transcription of reporter genes downstream of the GAL upstream activating 
sequence (UAS). 
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Figure AI.2: Proof-of-principle for yeast two-hybrid system 
The combination of bait and prey plasmids used for co-transformations are indicated on the left. Three 
different yeast dilutions were plated on dropout plates after transformation. All transformants grew on 
plates lacking tryptophan and leucine, as expected, but only transformants with the wild-type (WT) 
TgAMA1 c-tail grew on plates lacking tryptophan, leucine and histidine. This indicates that the WT c-tail 
interacts with TgAldolase, but the c-tail with the FW/AA mutation does not. 
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Table AI.1: Sequenced hits from the yeast two-hybrid screen  
Seventeen individual transformants were shortlisted for sequencing based on their growth in selective 
media. The clone number, accession number from the Toxoplasma database and annotation are indicated in 
the table. 
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APPENDIX II – SCREENING SMALL MOLECULE INHIBITORS OF TgMyoA-
TgMLC1 INTERACTION IN A T. gondii INVASION ASSAY 
Aim 
 A two-color invasion assay was used to test whether two small molecules (C3-
21 & PU065) that were designed to inhibit interaction between T. gondii Myosin A and 
its light chain, TgMLC1 (Kortagere 2011 and data not shown), have an effect on 
invasion. This was a collaborative project with Dr. Sandhya Kortagere from Drexel 
University, Philadelphia.  
Method 
 Δku80ΔHXG parasites were used in the two-color invasion assay and small 
molecules were tested at 1, 10 and 20μM along with a DMSO control. Two biological 
replicates were performed, each in duplicate. Invasion assays were performed as 
described in chapter 2 for 60 mins at 37°C.  
Result 
 Invasion of parasites treated with DMSO was set to 100%. At 1μM, C3-21 did 
not inhibit invasion of tachyzoites and mean invasion was 115%. At this concentration, 
parasites treated with PU065 had a 20% defect in invasion (Figure AII.1). At 10μM, 
invasion in parasites treated with C3-21 decreased to 42% while PU065 treated parasites 
had mean invasion of 13.75%. At the highest concentration tested, invasion of parasites 
treated with C3-21 was 41.75% while those that were treated with PU065 showed a 90% 
drop in invasion efficiency. PU065 was therefore more potent in inhibiting parasite 
invasion than the parent compound C3-21, as predicted by Dr. Kortagere’s structural 
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modeling work (data not shown). It would be interesting to test directly if PU065 disrupts 
MyoA-MLC1 interaction in Toxoplasma [3] and if this inhibition leads to a growth 
defect. The specificity of the compounds for TgMyoA/TgMLC1 also needs to be 
determined. 
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Figure AII.1: Two-color invasion assay testing the effect of C3-21 and PU065 on T. gondii invasion 
Small molecules were tested at three different concentrations for an effect on invasion using a laser 
scanning cytometer-based assay. Invasion of parasites treated with DMSO was set to 100%. Mean invasion 
from two biological replicates, each done in duplicate, is shown. Error bars represent mean with SD. 
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APPENDIX III – LOCALIZATION OF TgCBAP DURING INTRACELLULAR 
REPLICATION 
Aim 
 TgCBAP (Conserved Basal Apical Peripheral Protein) was identified as a novel 
cytoskeletal component of tachyzoites found in ring-like structures at the apical and basal 
end of the parasite and in punctate bands around the parasite periphery [4]. We wanted to 
test its localization in during parasite replication by endodyogeny. 
Method 
 Intracellular indirect immunofluorescence was performed using knock-in 
parasites containing a 3xmyc-tagged copy of TgCBAP. Parasites were allowed to invade 
HFFs on coverslips and fixed 12 hours post infection. IFA was performed as described in 
[4].  
Results 
 Parasites were co-stained with anti-TgIMC1 to visualize the growing daughter 
cells. TgCBAP in dividing parasites showed the same distinct localization (rings at the 
ends of the parasites and punctate peripheral bands) in intracellular parasites as had been 
observed in extracellular parasites (Figure AIII.1). A second group that independently 
discovered this protein subsequently reported similar localization results [5]. 
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Figure AIII.1: TgCBAP localizes to the daughter parasites during endodyogeny 
3x-myc-TgCBAP was localized with anti-myc antibody and samples were counterstained with anti-
TgIMC1. Arrowheads point to TgCBAP on the mother cell while arrows point to punctate peripheral spots 
of TgCBAP on the daughter cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
242 
APPENDIX IV- SMALL MOLECULE ENHANCER 112762 AND TgPRMT1 
Introduction 
 Arginine and lysine methyl transferases catalyze the transfer of a methyl group 
from S-adenosylmethionine (AdoMet) to arginine and lysine residues in proteins, 
influencing the modified protein’s function [6]. Arginine methyl transferases can be 
subdivided into four types based on the symmetry and number of methyl groups they add 
[7]. There are five protein arginine methyl transferases (PRMTs) in T. gondii, TgPRMT1-
5, with TgPRMT1 and TgPRMT4 (TgCARM1) being the predominant ones [6]. Both 
TgPRMT1 and TgCARM1 modify histones in vitro and are implicated in chromatin 
remodeling and gene activation or silencing ([8], [9]).  Small molecule inhibition of 
TgCARM1 induces parasite differentiation [8]). Proteins other than histones are modified 
by methylation. For example, tubulin is methylated at its C-terminal end [10]. Argonaute 
protein is methylated by TgPRMT1 and functions in RNA silencing [11]. A conditional 
knockout of TgPRMT1 displayed abnormal cell division, for reasons that remain unclear 
[11].  
 There are at least 19 predicted lysine methylases in T. gondii based on their 
conserved SET domain. TgSET8 methylates histone and is implicated in cyst formation 
and cell cycle progression [8]. TgSET13 or KMTox associates with peroxiredoxin1 to 
regulate anti-oxidant defense mechanisms and cellular homeostasis [12]. In addition to 
arginine methylation, tubulins are methylated on Lys40 [13]. Apical complex lysine 
methyl transferase (AKMT) relocalizes from the apical end to the parasite surface in 
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response to increased parasite cytosolic calcium and decreased host potassium levels, 
both of which trigger parasite egress [14]. AKMT plays a role in parasite motility and 
parasites that lack AKMT have defects in invasion, egress, and growth [14].  
 Like phosphorylation, methylation is a reversible post-translational modification 
and T. gondii encodes at least seven demethylases containing the JmjC (jumonji) domain, 
out of which only two are involved in histone demethylation [6]. The substrates of the 
remaining demethylases remain unidentified. Despite limited knowledge on the role of 
methylation, drastic growth phenotypes exhibited by parasites in its absence [3] suggests 
its importance in parasite biology. 
 A small molecule enhancer of invasion and microneme secretion, compound 
112762 [15], was covalently attached to resin and used in affinity chromatography 
experiments to identify potential targets  (J. Haraldsen and R. Morgan; unpublished data). 
TgPRMT1 was one of the proteins binding to the 112762 resin but not to a resin 
displaying an inactive 112762 analog (unpublished data). Pull-down experiments using 
parasites expressing myc-TgPRMT1 confirmed interaction of the myc-tagged protein 
with active 112762 but not the inactive analog. Compound 112762 also inhibited the 
enzymatic activity of bacterially-expressed TgPRMT1 (unpublished data). Finally, 
3
H-S-
adenosyl-methinione metabolic labeling of parasites showed that a variety of parasite 
proteins were methylated and this metabolic labeling was inhibited by 112762. Taken 
together, these preliminary data suggested that TgPRMT1 might be the biologically 
relevant target of invasion enhancer 112762. 
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Aim 
 In order to validate TgPRMT1 as the biologically relevant target of compound 
112762, we generated TgPRMT1 knockout parasites to determine if the lack of 
TgPRMT1 altered the sensitivity of parasites to compound 112762. 
Results 
Generation of two independent TgPRMT1 knockout clones by double homologous 
recombination 
 Our knockout strategy involved use of the pGraBle vector with 5’ and 3’ 
sequences of TgPRMT1 flanking the phleomycin resistance (Ble) cassette. This plasmid 
was used to transfect Δku80ΔHXG parasites to replace genomic TgPRMT1 with the Ble 
cassette through double homologous recombination. The transfected parasites were 
selected twice with phleomycin and cloned by limiting dilution. Clones were tested for 
the absence of TgPRMT1 and the presence of the Ble cassette by PCR. Clones 9 and 23 
(from two independent transfections) met the diagnostic PCR criteria (Figure AIV.1) and 
were used for subsequent experiments.   
Testing the sensitivity of TgPRMT1 knockout clones to compound 112762  
 Parasite motility was assayed on glass coverslips as described (in Section 
2.3.10). Wild-type and TgPRMT1 knockout parasites showed similar enhancement of 
motility with increasing concentrations of 112762 (Figure AIV.2).  
 A two-color invasion assay was also performed with the TgPRMT1 knockout 
parasites in the presence and absence of compound 112762. Parasites treated with 
different concentrations of 112762 were allowed to invade BSC-1 cells for 1 hour and the 
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samples were fixed with 2.5% (v/v) paraformaldehyde. Extracellular parasites were 
stained with anti-SAG1, followed by AlexaFluor546-conjugated secondary antibody 
(red). The samples were then permeabilized with Triton X-110 and intracellular parasites 
were stained with the same anti-SAG1, followed by AlexaFluor488-conjugated 
secondary antibody (green). The plates were scored based on the number of green only 
(intracellular) parasites. Compound 112762 enhanced invasion in the two TgPRMT1 
knockout clones in a manner indistinguishable from its effect on wild-type parasites 
(Figure AIV.3).  
In the absence of TgPRMT1, there was no up-regulation of other TgPRMTs 
 We had predicted that, if TgPRMT1 was a true target for 112762, the TgPRMT1 
knockout parasites would show a significantly reduced sensitivity to compound 112762. 
Since we did not see any noticeable difference in the invasion and motility trail assays, 
we then asked if other TgPRMTs are upregulated in the absence of TgPRMT1. T. gondii 
expresses four other arginine methyl transferases, PRMT2-5, and their levels of 
expression change throughout the cell cycle (Figure AIV.4a). PCRs to amplify TgPRMTs 
1-5 were performed with the cDNA obtained from first strand cDNA synthesis from 300 
and 500 ng of RNA recovered from both WT and TgPRMT1 knockout parasites (Figure 
AIV.4b). The products were run on a gel and the intensity of the band was measured 
using Quantity One software (BioRad). The band intensities were normalized to that of 
tubulin, which is a constitutively expressed gene in Toxoplasma (Figure AIV.4c). This 
semi-quantitative analysis suggests there was no up-regulation of the other TgPRMTs; 
however, a quantitative RT-PCR would be required to provide a conclusive result.  
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 These results suggest that TgPRMT1 is not the target of compound 112762 and 
that this small molecule has other as yet unidentified targets that contribute to its 
enhancing effect on invasion. 
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Figure AIV.1: Generation of TgPRMT1 knockout clones by double homologous recombination 
TgPRMT1 knockout parasites were generated by replacing the endogenous TgPRMT1 allele with a Ble 
resistance cassette through double homologous recombination (left panel).  Diagnostic PCRs were 
performed to confirm insertion of Ble at the endogenous TgPRMT1 locus (right panel). 
 
 
 
 
 
 
 
 
 
  
248 
 
Figure AIV.2: TgPRMT1 knockout and wild-type parasites show similar sensitivity to compound 
112262 in a two-dimensional motility assay  
SAG1-positive trails were scored blind by three members of the lab and were plotted with mean and 
standard deviation. Motility of parental Δku80ΔHXG parasites with DMSO was considered score 0  
and scores were assigned ranging from 1 to 4 with 4 being the maximum score for motile parasites. On 
the right panel some wells containing Δku80ΔHXG with DMSO were scored in blind and hence have 
scores over 0.  The two graphs represent scores from two independent experiments with different wild 
type (RH, Δku80ΔHXG) and TgPRMT1 knockout parasite lines (clones 9, 23).  
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Figure AIV.3: TgPRMT1 knockout and wild-type parasites show similar sensitivity to 
compound 112262 in a two-color invasion assay. 
 
Wild-type (Δku80ΔHXG) and TgPRMT1 knockout parasites treated with 4 different 
concentrations of enhancer112762 were tested in the two-color invasion assay. DMSO (carrier) 
was used as a control and Δku80 ΔHXG parasites treated with DMSO was scored as 0. Based on 
the number of invaded parasites with each treatment, scores were assigned from 1 to 3 with 3 
representing the maximum number of invaded parasites. Error bars indicate SD. The graph plots 
scores from one biological replicate with technical triplicates. 
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Figure AIV.4: Expression of other PRMTs in the TgPRMT1 knockout parasites 
(a) Cell cycle expression profiles of TgPRMT 1, 3, 4 and 5 from the Toxoplasma database 
(http://www.toxodb.org/toxo/) 
(b) Gel showing TgPRMT1-5 and tubulin amplified from cDNA from the different parasite lines:  A = 
Δku80ΔHXG; B = TgPRMT1 knockout clone 9; C = TgPRMT1 knockout clone 23. Taq = Taq 
polymerase; Phu = Phusion polymerase.  
(c) Intensity of bands normalized to tubulin. Error bars indicate SD. 
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